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Abstract
The effects of a number of naturally occurring anutrients on 
various hepatic drug-metabolizing enzyme activities have been studied 
in rats. These enzyme activities include aromatic hydroxylation 
(biphenyl-4~ and -2- hydroxylases), reduction (p-nitrobenzoic acid 
reductase), conjugation (4-methylumbelliferone glucuronyl transferase), 
cytochrome P-450 and cytochrome b^. The1 groups of anutrients studied 
were terpenoids, alkaloids, flavonoids, esters,o t h e r s , and 
methylenedioxyaryl compounds. Some of these compounds have shown no 
immediate effect on the drug-metabolizing enzymes, others have shown 
a modest induction of some of the above enzymes to the order of 10-15^, 
a few compounds have shown inhibition.. One of the terpenoids, p-ionone, 
and two of the methylenedioxyphenyl compounds, safrole and iso-safrole, 
have exhibited marked induction of all the parameters studied.
These three compounds have also been found to decrease the liver 
glycogen content and to enhance the glucuronic acid pathway of carbohydrate 
metabolism manifested by an increased excretion of ascorbic acid in the 
urine. Differences in the enzyme inductive effects of p-ionone, safrole 
and iso-safrole dependent on species, age and sex, have also been studied.
The enzyme inductive effects of these three compounds have been
I
compared qualitatively and quantitatively to those of phenobarbitone and 
3-methylcholanthrene, potent representatives of the two known groups of 
inducers. The mechanisms of induction of the hepatic drug-metabolizing- 
enzymes by these naturally occurring anutrients have been studied, and 
in this connection the inhibitors of protein synthesis, actinomycin D 
(m-HNA synthesis) and thioacetamide (m-KNA release), and of haeme 
synthesis, 3-amino~l,2,4-triazole, have been used. Other studies have
3
g
been made, using II-leucine on the rates of synthesis and turnover of 
proteins in the microsomal and other sub-cellular fractions of the 
liver.
From these experiments it has been shown that p-ionone, like 
phenobarbitone, results in a type of enzyme induction which is very 
largely dependent on the DNA.-directed synthesis of new enzyme proteins. 
Safrole and iso-safrole, on the other hand, are like 3-methylcholanthrene, 
and result in a type of enzyme induction which is in part dependent on 
the synthesis of new enzyme proteins and partly results from changes in 
the conformation of the enzyme or from alterations of its membrane 
environment.
Pretreatment with safrole or iso-safrole has been shorn to result 
in the appearance of a new hepatic microsomal haemoprotein which is 
normally not detectable in tissue homogenates of untreated animals.
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91* Metabolism of Drugs and Foreign Compounds
The environment in which we live contains innumerable chemicals of 
different nature and origin. Although a great number of these compounds 
are generally of little or no nutritive value to the body, since they 
cannot be utilized for the production of energy or for the build up of 
tissue, they can find their way into the organism by various means such 
as in food we eat, in the air we breath and as drugs we ingest. Hardly 
any food material'ingested by animals or human beings contains nutrients 
only; since nutrients are always associated with varying amounts of 
anutrients. Moreover, the non-nutrient chemicals may be added intentionally, 
incidentally or by accident, to the environment. These non-nutrients include 
food additives, such as preservatives, antioxidants, sweetners, flavours 
and colours; therapeutic drugs, cosmetics, detergents, pesticides and 
industrial chemicals, and may be of natural origin or products of man's 
chemical ingenuity. These non-nutrients are "foreign” to the major 
metabolic pathways of the body concerned with the metabolism of nutrients, 
and are therefore classed as "foreign compounds". The drugs are distinguished 
from other foreign compounds by the fact that they produce a pharmacological 
effect, but as far as the body is concerned they are also treated in the 
same way as all other foreign compounds. Since these compounds are alien
y
to the body it is necessary for the animal to eliminate them as early as
10
possible, otherwise if allowed to remain they would accumulate and 
eventually lead to poisoning of the animal* The body, however, 
possesses a complex system of chemical defence which deals efficiently 
with these anutrients, transforming them chemically so that they can be 
readily excreted# The term "drug metabolism" is applied to these 
transformations that occur# All the foreign compounds including 
therapeutic drugs are treated in a similar manner by the body and its 
defence system, and the principles of "drug metabolism" are therefore 
applicable to all foreign substances#
As a result of these transformations most of which occur in the 
liver, the activity and/or toxicity of a compound may be altered# 
Furthermore, the administration of one compound may affect the metabolism 
of another (Fouts, 1964), so that it is important to know the metabolic 
interactions of these different classes of compound.
The study of drug metabolism and of factors affecting it are therefore
of interest since they help to explain "what the body does to the drug"
*
as distinct from pharmacology which is concerned with "what the drug does 
to the body" (Williams, 1967a). Much information on the subject prior to 
1958 has been covered by Williams in his book "Detoxication Mechanisms" 
(1959), while more recent information is covered by Parke in his book 
"The Biochemistry of Foreign Compounds" (1968^-# During recent years
11
several reviews also have appeared that emphasize various aspects of 
drug metabolism (Williams, 1960, 1964, 1965; Maynert, 1961; Parke, 1962, 
1968b; Boyland and Booth, 1962; Gillette, 1963; 1967; Shuster, 1964; 
Williams and Parke, 1964).
2# Drug-metabolizing Enzymes and their Localization
The metabolic changes of foreign compounds described above are, 
in general, brought about by enzymes located in the endoplasmic 
reticulum of the liver, and to a lesser extent in other organs such as 
lungs, gastrointestinal tract and kidneys. The description of the 
hepatic microsomal system responsible for the metabolism of foreign 
compounds was first given by Mueller and Miller (1953). Shortly 
afterwards, Brodie et_ al^  (1955) reported that the enzymes responsible 
for the metabolism of many drugs are localized in hepatic microsomes.
These enzymes are referred to as "microsomal” enzymes and they play a 
.major role in the oxidation and reduction of foreign compounds. The
a
metabolism of foreign compounds is also catalyzed by certain other enzymes 
which are not associated with the endoplasmic reticulum; but located at 
other sites. These "non-microsomal" enzymes, however, have only a minor 
role in drug metabolism. A  few foreign compounds may also be metabolized 
by some of the enzymes of the normal intermediary metabolism such as 
alcohol dehydrogenase and aldehyde oxidase.
12
The endoplasmic reticulum of the cells of the liver and other tissues 
is a lipoproteinjsubmicroscopie?tubular network extending from the cell 
wall throughout the whole of the cytoplasm. The reticulum is of two types, 
namely, rough endoplasmic reticulum (RER) and smooth endoplasmic reticulum/ 
The surface of the former is studded with "ribosomes" which are small dense 
particles, the sites of protein synthesis; the smooth endoplasmic reticulum 
has no ribosomes (Palade and Siekevitz, 1956). The ribosomes, which have 
an important role in protein synthesis, do not contain the enzyme systems 
which catalyze the oxidation of drugs?for many, but not all, drug- 
metabolizing enzymes are preferentially concentrated in the smooth 
endoplasmic reticulum (Orrenius and Ernster, 1964-; Gram and Fouts, 1967). 
However, according to Ernster and Orrenius (1965) the synthesis of the 
drug-metabolizing enzymes, appear to occur in the rough reticulum, and 
this when saturated with enzyme appears to lose its ribosomes to become 
smooth reticulum.
Solubilization of the microsomal drug-metabolizing enzyme system, 
which is desirable for a comprehensive study of its characteristics and 
components, has proved exceptionally difficult from which it may be 
inferred that the enzymes are closely associated with the lipoprotein 
membrane of the endoplasmic reticulum. However, it is possible to 
undertake a preliminary study of the characteristics of these systems 
using fractions of homogenized tissue. Centrifugation of the homogenised 
tissue in isotonic KC1 solution at 10,000 x g. for ten minutes deposits
cell debris, mitochondria and nuclei, leaving the endoplasmic reticulum 
which is now broken into small vesicles and therefore called "microsomes", 
in the supernatant. Further centrifugation of this supernatant at 100,000 
x g* for one hour deposits the "microsomes" and leaves the "soluble fraction" 
as supernatant (Mitoma at ad , 1956). Dallner (1963) has described a 
method for separating the RER and SER by centrifugation in a density 
gradient. However, the system containing both RER and SER is generally 
used for the assay of drug-metabolizing activity. Since the microsomal 
enzymes have a requirement for certain factors (see later) present in the 
"soluble fraction", investigations of the enzyme activity are usually 
carried put on the 10,000 x g. supernatant fraction.
The microsomal enzymes generally metabolize lipid soluble foreign 
compounds (Gaudette and Brodie, 1959) forming products which are less 
lipid soluble, but polar compounds may also be metabolized by these 
enzymes (Mazel and Henderson, 1965). They catalyze reactions involving 
both oxidations (oxygenations) and reductions.
3. Metabolic Reactions of Drugs and Foreign Compounds
Metabolic reactions of drugs and foreign compounds have been classified 
intwo two types - Phase I and Phase II (Williams, I960). In the first 
phase the compound undergoes one or more of a variety of oxidations, 
reductions or hydrolyses which result in the introduction or unmasking
of functional groups rendering a non-polar compound polar, or a polar 
compound,to be more polar and hence more readily excreted than the 
original compound. These functional groups often act as a centre for 
the second phase of metabolism in which a synthetic step occurs so that 
the compound is conjugated with an endogenous molecule. The products 
of the second phase, so-called conjugated products, are usually water 
soluble acids which are readily excreted. The majority of these 
conjugation reactions involve glucuronic acid and sulphuric acid, 
but conjugation with amino acids, methyl and acetyl groups may also 
occur.
The majority of compounds are metabolized by both phases of 
reaction, for example biphenyl is chiefly metabolized as follows:-
Biphenyl phasoti°n > 4-hydroxybiphenyl biphenylyl
glucuronide
When a compound already possesses a functional group it often 
undergoes only phase II reaction. Benzoic acid is therefore primarily 
conjugated with glycine and glucuronic acid to form hippuric acid and 
benzoylglucuronide respectively, and undergoes oxidation to give 
hydroxybenzoic acid only to a small extent.
These transformations can influence the pharmacological activity 
and the toxicity of the compounds. Phase I reaction majr activate or
15
deactivate a drug, or alter its toxicity so that it becomes either more 
toxic (intoxication) or less toxic (detoxication). The new functional 
group may also subsequently undergo phase II reactions (conjugations) 
generally resulting in deactivation of drugs and usually a decrease in 
toxicity. Examples of some of these processes are shown below.
Phenobarbitone .-- > p-Hydroxyphenobarbitone £fo-a.se- ---■ ■>
/ \ deactivation \
Vactive) • (^inactive) j
p-Hydroxyphenobarbitone 
• glucuronide
(inactive excretory product)
Prontosil j -. > Sulphanilamide ^ — > M'-Acetylsulphanilamide
/. , . \ activation / x- \ /• x- ,^inactive; ^active) (^inactive excretory
product)
Some foreign compounds are quite similar to normal endogenous 
compounds and participate in the pathways of intermediary metabolism to 
become incorporated into the tissues, a process which is sometimes toxic1, 
when it is known as lethal synthesis. Other foreign compounds interact 
with tissues resulting in alkylation and arylation of proteins and nucleic 
acids, a process thought to be a cause of chemical allergy and 
carcinogenesis.
4* Phase I Reactions
i) Oxidations (Oxygenations) by Microsomal Enzymes
Biological oxidations (oxygenations) catalyzed by the microsomal 
enzyme systems include a wide range of reactions, all of which may be 
ascribed to one common mechanism, namely, hydroxylation (see Parke, 1968^:
Aromatic hydroxylation: R-CgHg OH y R-CgH^OH
Acyclic oxidation:: R-CHr> OH s R-CH^OH
O-Dealkylation: R-O-CHg OH ^ R-OGH^OH ____________ ROH + HCHO
N-De al hy 1 at 1 on: R-NCHg ---- OH > p ^ c i ^ O H  _________^RNI^ + H C R O
Deamination: R \  nTIXTTT nrr n/ATrWrr
0
,CHNH„ OH . C(OH)NH„ . ^ C O  + NH,
R 2 ~ ' R 2 : :> R
Sulphoxidation: R-S-R’ -  -~-H--- ->[R-S+ (OH)-R' ] ------- — -----^ S - R ' t  H
All these reactions have the paradoxical requirement for both reduced
18
coenzyme NADPH2 and oxygen (Brodie et al, 1958) . Experiments with 0^
18
and Hg 0 have shown that the oxygen of the hydroxyl group introduced
* ■ •
into the foreign compound is derived from molecular oxygen and not from 
water (Mason, 1957; Hayaishi, 1962). The microsomal oxidation of a 
foreign compound is therefore proportional to the oxidation of NADPHg, 
and may be competitively inhibited by other foreign compounds which also 
undergo microsomal oxidation (Rubin et al, 1964).
It has been shown that the liver microsomes contain NADPH^- dependent
17
enzyme systems which catalyse the hydroxylation of various steroid 
hormones (M ueller and Rumney, 1957; King, 1961; Breuer et al, 1962;
Conney and Klutch, 1963; Kuntzman et^  al_, 1964-; Kuntzman and Jacobson,
1965)# Many similarities have been observed between these enzyme
systems which metabolize steroids and those responsible for drug
hydroxylation (Kuntzman et a l , 1964; Conney et al, 1965; 1966; 1968;
Tephly and Mannering, 1968). Besides this, certain hepatic microsomal
NADPB'g-dependent enzyme systems catalyze the peroxidation of lipids
(Orrenius et al, 1964), and,the endogenous compounds such as tryptamine
and tyramine are also hydroxylated by some similar hepatic microsomal
enzyme systems (Lemberger et al, 1965). It is for these reasons, the
i
microsomal hydroxylating enzymes have been classified as "mixed function 
oxidases" (Mason, 1957; 1965).
ii) Mechanism of Microsomal Hydroxylation
In view of the findings stated above Gillette (1962) suggested that
microsomal hydroxylation occurs by a coupled redox reaction in which
*
NADPHg reduces a coenzyme which then combines with oxygen to form 
"active oxygen". This finally reacts with the foreign compound in the 
presence of various hydroxylases to give the hydroxylated compound. The 
postulated sequence is shown as follows:
1. NADPH + H+ + A. ------- :---- — > API2 + NADP+ .
2. AHg + Og ___________  ^ "Active oxygen".
o a«4.* , j ' s oxidized drug + A  + IRO.3. Active oxygen + drug --------- > & g
where A  represents a reducible coenzyme. Gillette (1962) further 
suggested that this reducible coenzyme was a microsomal flavoprotein.
Later Omura and Sato (1962; 1964a; 1964b) suggested that it was a 
hemoprotein and this was further confirmed by Omura et al^(l965) who 
named the hemoprotein "cytochrome P-450". This cytochrome was so 
called because of its anomalous spectral behaviour after treatment 
with carbon monoxide. This ligand complex of reduced cytochrome P-450 
■with carbon monoxide gives a Soret peak at 450 mp,. Such a CO-binding 
pigment had been first observed in mammalian liver microsomes earlier 
by Klingenberg (1958) and Garfinkel (1958).
The concept of this involvement of cytochrome P-450 in the liver 
microsomal hydroxylating process is based on the demonstrations that 
the process is inhibited by CO (Conney et al, 1957a; Orrenius et a l ,
1964; Cooper et al, 1965) but is reactivated by light of wavelength 
450 mp. (Cooper el al^ 1965) . Furthermore the cytochrome P—450 content 
of liver microsomes increases parallel to the increase in hydroxylating 
activity of liver microsomes upon treatment of animals with barbiturates 
or polycyclic hydrocarbons (Orrenius and Ernster, 1964; Remmer and Marker, 
1965b; Ernster and Orrenius, 1965).
Although the electron transport system of hepatic microsomal mixed 
function oxidases«has proved too labile for solubilization or separation 
of its components, the steroid hydroxylating system of beef adrenal
cortex mitochondria has been solubilized and separated into a flavoprotein 
NADPH^ diaphorase, a non-haeme iron protein, and cytochrome P—450 (Omura 
et al, 1966). The authors (Omura et al, 1965) consequently formulated
the following transport system for hepatic microsomal hydroxylation#
Fe++ RCIIgOH
NADPHn Flavoprotein Protein ^Cytochrome P-450 'T
'  (ox) V /  \ /  (ox)
Cyt.P-450-0
\| y \ q
NADP Flavoprotein Protein Cytochrome P—450 2
(Red) Fe+++ (Red) |
°*
Kato (1966) accumulated much evidence in support of this view.
Remmer et ai (1966), however, showed that it was the oxidized form 
of cytochrome P-450 that forms the complex with the substrate, suggesting 
that P-450 first reacts with the substrate and is then reduced by NADPRg*
The reduced cytochrome P-450 substrate, complex rapidly combines with 
molecular oxygen to form an Og-cytochrome P-450-substrate complex which 
quickly decomposes to form the oxidized substrate and the oxidized form 
of the cytochrome. The sequence may be represented as f ollows (&ro<kc; «q67>
NADPH
Drug + P-450 (ox) iN> Drug - P-450 (ox) ■ n------ > Drug - P-450 (red)
P-450 
reductase
°2
> Drug — ^*-45^.0^   > Oxidized drug + P-450 (ox)
According to this view the hydroxylation by liver microsomes is more closely 
related to NADPH^ - cytochrome P-450 reductase activity than to the amount
• 20
of cytochrome P-450.
Whatever may he the sequence, it is now certain that cytochrome 
P-450 is the key component of the microsomal hydroxylase system.
During the last few years a great deal of attention has been focused 
on this hemoprotein and it has been further characterized:
iii) Cytochrome P-450
Although there is a considerable evidence that many microsomal 
hydroxylation reactions correlate with the cytochrome P-450 concentration 
(Remmer and Merker, 1965b; Ernster and Orrenius, 1965; Kato, 1966;
Eato and Takanaka, 1968c), there have been reports that the concentration, 
assayed as the reduced cytochrome P-450 carbon monoxide complex, does 
not always parallel the hydroxylations occuring in microsomal reactions 
(Greim and Remmer, 1966; Kato e4 al, 1968a).
The hemoprotein referred to as cytochrome P-450, on the basis of its 
spectral changes when CO is used as'4igand, also combines with ethyl 
isocyanide and exhibits two absorption maximum of 430 mp, and 455 mp.
(Omura and Sato, 1962; 1964a; Imai and Sato, 1966a). Imai and Sato 
(1966b, 1968a), thus provided evidence for the existence of two inter­
convertible states of cytochrome P-450 in microsomes, their interconversion 
being dependent on pH (imai and Sato, 1968b). The ethyl isocyanide has 
the unexpected effect, depending on its concentration, of both activating
and inhibiting aniline hydroxylation, the activation being caused by a 
change in reactivity of the cytochrome P-450 on combining with the 
isocyanide (imai and Sato, 1968c).
Treatment, of rats with phenobarbitone or the polycyclic hydro­
carbon, 3-methylcholanthrene (3-MC), increases the apparent concentration 
using ethyl isocyanide as ligand, 3-MC causes an induction of only one of 
the peaks of the isocyanide spectrum, that at 455 mp (Sladek and Mannering, 
1966; Alvares et al, 1967b), whilst phenobarbital increases both the 
430 mp, and 455 mp, peaks (Alvares et al, 1967a). It was thus suggested 
that 3-MC treatment causes the formation of a new hemoprotein called,
P^450 (Sladek and Mannering, 1966; Alvares et^  al, 1967a). In further 
support of this idea it was found that the hemoprotein induced by
phenobarbitone is not the same as that induced by 3-MC: when CO is used as
ligand,the 3-MC-treated, reduced,microsomal hemoprotein exhibited a shift 
in absorption maximum from 4-50 mp, to 448 mp (Sladek and Mannering, 1966;
Alvares et al, 1967a; Kuntzman et al, 1968; Hildebrandt et^  al, 1968).
Recently it has been shown that treatment with 3-MC changes the Michaelis 
constant for the hydroxylation of 3,4-benzpyrene, and it is possible that 
this effect is due to a greater affinity of 3,4-benzpyrene for the 
hemoprotein preferentially formed in 3-MC-treated rats (Alvares eib a l ,
1968; Gurtoo et al, 1968).
These considerations posed the questions whether more than one 
hemoprotein of the cytochrome P-450 type is present, or whether a single 
cytochrome P-450 exists in two or more spectrally distinguished forms 
in the microsomes or whether the binding of 3-MC to the hemoprotein 
causes changes in its spectral properties. The last possibilit}7- was 
excluded since the in vitro addition of 3-MC to rat liver microsomes 
did not change the spectral properties of the cytochrome P-450 and the 
spectral change did not occur immediately after the administration of 
3—MC in vivo (Kuntzman at al, 1968). The prior treatment of rats with 
either ethionine or actinomycin D prevented the spectral changes in 
microsomal hemoprotein caused by 3-MC treatment, which suggests that thi 
polycyclic hydrocarbon results in the synthesis of a new hemoprotein or 
a different form of the original cytochrome P-450 (Alvares at al, 1967a; 
Kuntzman et al, 1968).
For characterization of cytochrome P-450 attempts have been made to
isolate this hemoprotein in the active form using snake venom, various
■ *
solvents, chemicals and enzymes, but all those treatments that have 
resulted in its solubilization have simultaneously resulted in its 
conversion to a spectrally modified form called cytochrome P-420 
(Omura and Sato, 1962; 1964a; Mason et al, 1965; Ichikawa and Yamano, 
1967) which has partly been purified (Omura and Sato, 1964b). The
reconversion of P-420 to P-450 can be brought, about with polyols and 
glutathione (Ichikawa and Yamano, 1967), but the full activity of the 
membrane-bound enzyme is never restored (Ichikawa et al, 1969).
However, various techniques have been developed for measuring the 
absolute spectrum of cytochrome P-450 (Kinoshita and Horie, 1967;
Remmer et al, 1968; Miyake et_ al, 1968; Nishibayashi and Sato, 1968).
When the absorption of cytochrome b^ is cancelled by dilution of 
microsomal preparations, the absolute spectrum of the oxidized state 
of cytochrome P—450 has a peak at 4-20-422 mp,; and after reducing the 
preparation with dithionite, the absorption peak shifts to 407-408 mp,.
Ininvestigation of the absolute spectrum of cytochrome P-450 in 
animals pretreated with phenobarbitone or- H-methylcholanthrene, different • 
types of spectrum are obtained (Hildebrandt et al, 1968; Schenkman et al, 
196^). Hildebrandt et al, (1968) suggest that two spectrally distinct 
hemoproteins exist which are interconvertible forms of a single hemoprotein# 
Schenkman £t al, (196?) however, suggest that one of these forms is the 
native hemoprotein and the other is the hemoprotein substrate complex.
It has been shown(Narasirnhulu et^  al, 1965; Remmer et al, 1966;
Camraer e_t al, 1966; Imai and Sato, 1966a; Maclean, 1967; Oldham et al,
1966; Whysmer and Harding, 1968; Wada et al, 1968; Mitani and Horie,
1969), that the addition of various drugs to liver microsomes changes 
the absorption spectrum of oxidized cytochrome P—450 and gives rise to
24
two different types of difference spectra which have been called type I 
and type II, on the basis of which different drugs may be classified 
into two groups as type I and type II substrates*. The type I spectral 
change, characterized by a difference spectrum with a trough at 420 mp, 
and a peak at 385-390 mp, is caused by the addition of hexobarbitone, 
phenobarbitone, aminopyrine, chlorpromazine and imipramine, while 
type II spectral change is characterized by a peak at 430 nin and a trough 
at about 390 mp, and results from the addition of aniline, nicotine, 
nicotinamide, pyridine and p-aminophenol etc., to the liver microsomes.
These observations would also tend to suggest that, more than one
hemoprotein or form of hemoprotein is involved in microsomal drug oxidation.
Explanation of these two types of characteristic spectral changes, however,
can be given to fit either hypothesis as to the number of microsomal
hemoproteins that exist (Mannering et al, 1969). Thus two binding sites
could exist on a single hemoprotein, the different drugs combining
preferentially with one site or the other, or two hemoproteins could
*
exist which combine selectively with different drugs#
iv) Microsomal Reductions
In addition to the oxidative enzyme systems the endoplasmic reticulum 
of the liver also contains enzymes that reduce foreign compounds# These 
enzymes catalyze the reduction of aromatic nitro and azo compounds to 
amines (Mueller and Miller, 1950; Fouts £t al_, 1957). The best known
t
example of azo reduction is the classic discovery of Tr6fon61 et_ al,
(1935) that prontosil is reduced, to form sulfanilamide. Other well 
known examples are reductive, cleavage of dimethylaminoazobenzene 
(Stevenson eib al^ , 194-2) and azobenzene (Elson and Warren, 1944).
All the azo compounds are however not reduced by mammalian azo 
reductase. A  number of such compounds have been found to be 
reductively cleaved after oral administration but not after intraperitoneal 
injection (Daniel, 1962; Barrett et al, 1965). These compounds are then 
apparently reduced by bacterial azo reductase. Nitro compounds such 
as chloramphenicol, p-nitrobenzoic acid, and nitrobenzene etc., are 
reduced to primary amines by the enzyme(s), localized mainly in microsomes 
of liver, and are relatively minor in amounts in kidney and lung. Nitroso 
and hydroxylamine derivatives are presumably intermediates in the reduction 
of nitro compounds. Unlike the microsomal azo-reductase, the nitro 
reductase is active only under anaerobic condition. Moreover, azo- 
reductase can be solubilized by pancreatic lipase whereas nitro­
reductase is largely destroyed by this process. Both reductase systems 
are flavoproteins, having FAD as their prosthetic group, and their 
enzymic activities are greatly increased by addition of riboflavin, FMN 
or FAD. It was suggested (Kamm and Gillette, 1963) that microsomal 
enzymes, e.g. NADPHg - cytochrome C reductase^ or NADII^ - cytochrome bg 
reductase?reduce FAD to FADH^ which then reduces the foreign substrates
26
n on-en zymi c al ly;
NADPHg- cytochrome C 
reductase
FAJDH2 + NADP
NADPH2 + PAP
3 FAPH2 + RN02
non-enzymic
■> 3 FAD + KNH2 + 2 H20
Thus the reductase systems can use either NADPH or NADH as the electron 
donor (Fouts and Brodie, 1957), and it has been suggested that both the 
NADPH and NADH dependent systems are apparently mediated through 
cytochrome P—450 (Gillette and Sasame, 1965; Sasame and Gillette,
1969).
v) Other Metabolic Transformations
Foreign compounds, including drugs, also undergo a variety of non­
micros omal metabolic transformations. These include the enzyme systems 
present in the mitochondria such as amine oxidases which catalyse the 
conversion of amines to aldehydes, and enzymes which aromatize saturated 
acyclic compounds into benzoid derivatives. In the soluble fractions are 
found the enzymes alcohol dehydrogenase, aldehyde oxidase and xanthine 
oxidase which oxidize alcohols and aldehydes. Many other enzymes, such 
as amino oxidases and esterases, that metabolize foreign compounds are 
found in the blood plasma, and enzymes of the intestinal flora are 
responsible for certain other metabolic transformations. Besides these, 
there are many metabolic transformations of foreign compounds for which 
the enzymes and enzyme locations are as yet unknown (Parke, 1968$-,
27
5. Phase II Reactions
i) Con,jugations
Conjugations are biosyntheses in-.which foreign compounds or their 
metabolites combine with readily available endogenous substances to 
form conjugates which are more polar, less lipid-soluble, and therefore 
more readily excreted from the animal body. In many conjugation 
reactions the endogenous substrate is transferred from the coenzymes that 
participate in intermediary metabolism, but the enzymes which catalyze 
the transfer are usually specific for the formation of conjugates of 
foreign compounds.
Conjugation with glucuronic acid is probably the most important 
conjugation mechanism, and occurs in all vertebrates. The formation of 
glucuronides, like most other conjugations, is a two stage process, 
involving first the biosynthesis of the coenzyme donor, UDPGA, and 
secondly the transfer of the glucuronyl moiety from UDPGA to the aglyeone 
as shown below:
*
UDPG
dehydrogenase ™  ^
UDPG + 2 NAD ------ :---------- — > Uijrua + ^
(uridine diphosphate a-glucosiduronic acid)
UDP
UDPGA + ROH — *ransgluopronylase>Roc „ Q +
o 9 o
(j3-D~glucopyranosiduronic acid)
The glucuronyl transferases (otherwise known as transglucoronylases) are 
located in the endoplasmic reticulum, primarily of the liver (Dutton and 
Storey, 1954), but the first stage, involving the oxidation of UDPG, is
brought about in the soluble fraction of the cell; (Strominger et al ,
1957). The conjugation involves a Walden inversion, since the 
conjugated compounds are p-D-g 1 ucos.iduronic acids, whereas the glucuronyl 
moiety in UDPGA has the a-configuration. The transferase reaction is 
not reversible by the same enzyme.
Glucuronidation takes place especially in the liver, and to a lesser 
extent in the kidney, gastrointestinal tract and the skin. Originally 
it 'was supposed that the microsomal UDP-glucuronosyltransferase activity 
in the liver is dependent on one enzyme with a low specificity and a 
wide pH optimum. The same enzyme was thought to conjugate endogenous 
substrates such as bilirubin, thyroxine and steroid hormones as vrell as 
drugs and drug metabolites. More recent findings give strong evidence 
that in liver more than one transferase is present (isselbacher et al, 
1962; Dutton, 1966; Gram et al, 1968a).
Glucuronides are classified as O-glucuronides, N-glucuronides and 
S-glueuronides, formed from oxygen-, nitrogen— and sulphur-containing 
compounds respectively, O-glucuronides are formed from phenols and 
alcohols (ether type) and carboxylic acids (ester type); N-glucuronides 
from amines, and S-glucuronides from thiols. •
The other types of conjugation reactions are sulphate conjugation, 
methylation, acetylation, peptide conjugation and glutathione conjugation 
which-are not as common as glucuronide formation.
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6* Factors Affecting the Metabolism of Foreign Compounds
Most of the foreign compounds including drugs are metabolized by more 
than one of the reactions described above, and thus form a m d e  variety 
of metabolites# The rate at which a foreign compound or drug is altered 
and the relative importance of the metabolic pathways obviously depend 
on the activities of the drug-metabolizing enzyme' systems in the body. 
The activity of these enzymes can be affected by a variety of factors 
resulting in altered metabolism of a compound and thereby possibly 
altered activity or toxicity (Conney and Bunss,, 1962; Fouts, 1963; Parke, 
1968b). Increased enzyme activity resulting from their stimulation leads 
to a more rapid metabolism which can lead to either an increased or 
decreased duration of action depending on whether phase I metabolism 
activates or deactivates the drug. Alternatively, decreased enzyme 
activity resulting from inhibition will produce the opposite effect.
Phase II metabolism on the other hand always deactivates drugs. Hence 
stimulation or inhibition of this pkase leads to decreased or increased 
duration of action respectively.
The factors that affect the metabolism of foreign compounds may be 
genetic, physiological, pharmacodynamic or environmental in origin.
Such factors include species, strain, age, sex, pregnancy, hormones, the 
nutritional status, disease, stress and ingestion of other foreign 
compounds.
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i) Species Differences in Drug Metabolism
It is now the common practice to assess the safety of drugs, food 
additives, and other chemicals to he used by man, by tests including 
metabolic reactions on laboratory animals. As a result the metabolic 
data of a wide variety of compounds in quite a large number of species 
are available and considerable differences in the metabolism of foreign 
compounds have been found in different species* Some species differences 
are due to the qualitative differences in the metabolism of the foreign 
compounds, for example cats do not form glucuronides (Dutton and Greig,
1957; Robinson and Williams, 1958); dogs are unable to acetylate aromatic 
amines (Marshal e_t al, 1937); Guinea pigs do not appreciably acetylate 
S-cystrinyl derivatives, although they do acetylate aromatic amines 
(Bray £t al, 1959); aniline is hydroxylated in the para position in rabbits 
and in the ortho position in cats (Parke, i960); and coumarin is hydroxylated 
to 7-hydroxycoumarin in rabbit, guinea pig, coypou, cat, hamster and hen 
but not by rat, mouse and ferret (Creaven et al, 1965a). Phenacetin is 
metabolized by de-ethylation to p-acetamidophenol in man, but in the dog 
it undergoes deacetylation yielding p-phenetidine and p-aminophenol#
In the rat aromatic hydroxylation is the major route of metabolism of 
amphetamine; whereas in man, dog and rabbit the major route is oxidative 
deamination (Dring et al, 1966) • In man, rhesus monkeys, baboon and 
green monkey?quinic acid administered orally is extensively aromatized 
and excreted in the urine as hippuric acid; whereas in the squirrel
monkey, capuchin monkey, hedgehog, dog, cat, ferret, rat, mouse, guinea 
pig, hamster, fruit-bat and pigeon^oral quinic acid is not extensively 
aromatized (Adamson et. a J , 1970; Bridges et al_, 1970).
Most species differences, however^ are quantitative, that is they 
are accounted for by variation in the rates of metabolism of foreign 
compounds, for example, 50 mg./kg. of hexobarbital maintains anaesthesia 
in man or dog for even five hours, but 100 mg./kg. in mice produces 
anaesthesia for only about 12 minutes (Quinn at.al,■1958); the 
insecticide dimethoate is 70 times more toxic to the cockroach and 
325 times more toxic to the housefly than to the mouse (Uchida et al,
1964). Imipramine is metabolized by N-demethylation to desmethyl- 
imipramine (DMl) and desdimethylimipraraine (DDMl), and by hydroxylation 
at 2— and 10- positions. In rats the transformation of imipramine to DMI 
is rapid but further transformation is slow. In man, conversion of 
imipramine to DMI is slow and further metabolism is even slower so that 
the pharmacologically-active DMI accumulates in the tissues of both man 
and rat. In contrast, the rabbit and mouse rapidly metabolize both 
imipramine and TMI, so that the latter compound does not accumulate, 
and in consequence the drug has little pharmacological activity in these 
two species (Dingell et al, 1964). Sulphadimethoxine (Madribon) which 
is metabolized by acetylation and glucuronidation, is fairly readily 
excreted by rabbit and monkey, more slowly by man, .flog and guinea pig
and the rate of excretion is very slow in the. rat (Bridges et al, 1965; 1^66 
Bridges et al, 1968).
Species differences in the metabolism of foreign compounds (see 
Williams, 1967a, 1967b; Smith, 1968) depend mainly upon variations in 
the enzymes which control phase I and phase II reactions. These 
variations in en2yme activity can be due to differences in the 
following: (i) the absolute amount or specific activity of an enzyme;
(ii) the amount or nature of natural inhibitors of an enzyme; (iii) the 
activity of an enzyme reversing the reactions; or (iv) the activities 
of enzyme reactions competing for the same substrate (Parke and 
Williams, 1969).
ii) Strain Differences in Drug Metabolism
Differences in the individual susceptibility to toxic substances, 
and idiosyncrasies towards certain drugs and food-stuffs, are often the 
results of impaired.detoxication of.these compounds resulting from 
genetically determined variations in the enzymes concerned. Differences 
in phase I metabolism have been observed in the rate of metabolism in vitro 
of a number of foreign compounds in different strains of rats (Quinn 
et al, 1958), rats and dogs (from Parke and Williams, 1969; Siegert 
et al , 1964), and rabbits (Cram et^  aJ , 1965)•
Individual differences in the ability to metabolize drugs may have
v?‘
considerable bearing on therapeutic efficacy and toxicity. For example
hydrazine derivatives, such as isoniazid (isonicotinic acid, hydrazide) , 
hydralazine and phenelzine., and. the sulphonandde, sulphadimidine are 
all deactivated by acetylation, but the rate of activity of liver 
acetyltransferase varies with the individual human subject with the 
consequent variation in the duration of pharmacological activities of 
these drugs (Evans, 1965). Wide individual variability in the detoxication 
of phenazone (antipyrine), an antipyretic metabolized by hydroxylation, 
has been observed also in rat, and man (Vessel and Page, 1968). Besides 
these, the toxicity of foreign compounds may also be affected by genetic 
variations in the activity of enzymes that are concerned only indirectly 
in the metabolism of these substances. For example, a number of drugs and 
other compounds such as divicine and isouramil, pyrimidines that are 
present in the broad bean, produced haemolytic anaemia in certain 
susceptible individuals who have been found to have abnormally low levels 
of glucose-6-phosphate dehydrogenase activity in their red blood cells. 
(Mager et al, 1965).
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iii) Age Differences
In general, foetal and newborn animals have a limited capacity to 
metabolize drugs (jondorf et al, 1958; Fouts and Adamson, 1959). The 
hepatic microsomal phase I enzymes, including cytochrome P-4-50, together 
with the phase II' enzymes responsible for the formation of glucuronic 
acid, glycine and glutathione conjugates are all at a low level or absent
at birtli# The enzymes which catalyze the formation of sulphate and 
acetyl conjugates are present however at normal adult levels in some 
species (Vest and Rossier, 1963)* In rats the glucuronyl transferase 
activity towards certain substrates is as high in the newborn as in the 
adult liver (Dutton,' 1964). From birth onwards the phase I enzymes 
develop rapidly, reaching adult levels in about 30 days in the rat and 
in about 8 weeks in humans (Kato et al , 1964$; and the glucuronosyl 
transferase activity in mouse, rabbit, guinea pig and man increases 
gradually to adult levels depending on the species and substrates 
(Dutton, 1963). The hesitancy of clinicians to give drugs to mothers 
during parturition and to young children thus seems well founded. Kato
I
and Takanaka (1968a; 1968b} have recently shown from their in vivo 
and in vitro studies that the rate of drug-metabolizing activities is 
slower in old rats than in young rats.
iv) Sex Differences _
It has long been known that the duration and/or intensity of drug
*
action is often greater in the adult female rat than in the adult male 
(Hoick et al, 1937; Poe et^  a l , 1936; Kreams et al, 1941). It was 
shown later by Quinn et al (1958) that these sex variations were due to 
higher drug-metabolizing activity in the male rat than in the female. 
Not all metabolic reactions show a sex difference. For example, Kato
and Gillette (1965^ found that although the aliphatic hydroxylation of 
hexobarbitone and pentobarbitone and N-demethylation of aminopyrine and 
morphine show sex differences, the aromatic hydroxylation of aniline 
and zoxazolamine exhibits no such difference. The higher drug- 
metabolizing activity seen in the liver microsomal fraction of male rats 
is due to sex hormones, as it appears only at puberty and may be abolished 
by castration* Moreover, administration of androgens to female rats 
increases the activities of the microsomal enzymes to the level of the 
males, while the administration of oestrogens to males decreases the drug- 
metabolizing enzyme activity (Quinn et^  al_, 1958; Murphy and Dubois, 1958). 
The sex variation may be viewed as another kind of species difference 
since mice, guinea pigs, rabbits and dogs show no sex differences in 
the metabolism of hexobarbital (Quinn et^  al, 1958). Moreover, the 
administration of testosterone or estradiol does not measurably change 
the metabolism of barbiturates in mice and rabbits (Quinn et al, 1958). 
There does seem to be a sex difference, however, in mice with respect to 
phenobarbitone and hexobarbitone metabolism but tbe effect is opposite 
to that observed in the rat (Westfall ejfc al, 1964; Novick et al, 1966).
The effects of these sex differences on the toxicity of foreign 
compounds depends on whether the microsomal metabolism gives rise to 
metabolites less toxic or more toxic than the parent compound. The 
formation of glucuronides, the N-demethylation of morphine and meperidine, 
and the metabolism of hexobarbitone, aminopyrine and strychnine, occur
more rapidly in male than in female rats, and since these are deactivating 
reactions female rats show a more prolonged response than males to these 
drugs. The insecticides aldrin, isodrin and heptachlor are also more 
rapidly metabolized into their epoxides by male rats, but since the 
epoxides are more toxic than the original insecticides, female rats are 
less susceptible to the toxic action of these compounds (Wong and 
Terriere, 1965).
v) Effect of Homones on the Metabolism of Foreign Compounds
In addition to the effects of male and female sex hormones, the 
hormones of the adrenal glands, the thyroid and pancreas are also 
known to have some effects on the metabolism of foreign compounds. 
Adrenalectomy of male rats impairs the metabolism of foreign compounds, 
and this is reversed by administration of prednisolone. Pretreatment 
with anabolic steroids such as 19-nortestosterone also stimulates the hepatic 
microsomal enzymes (Booth and Gillette, 1962). Administration of ACTH, 
adrenaline or thyroxine impairs the metabolism of foreign compounds, 
but only in the male rat and only with those drugs, such as hexobarbitone, 
and aminopj^rine which show sex dependence, that is, are metabolized at 
a higher rate by the male (Kato and Gillette, 1965b). Alloxan-induced 
diabetes in male rats also reduces the metabolism of hexobarbitone and 
aminopyrine iii vitro, and these effects are reversed by insulin (Dixon 
et al, 1963); thyroxine produces a decrease in the liver monoamine
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oxidase and catechol O-methyltransferase in rats, and diiodo and 
triiodo-thyronine also inhibit catechol 0~methyltransferase (D'lorio 
and Mavrides, 1963). On the other hand prolonged treatment with 
thyroxine increases the weight of the liver, the activity of the 
hepatic NADPH^-generating system, and consequently accelerates the 
metabolism of many drugs in vivo (Conney and Garren, 1961).
vi) Nutritional Status and Metabolism of Foreign Compounds
The activities of many of the enzymes that metabolize foreign 
compounds can be affected markedly by the nutritional status of the 
animal. Rats maintained on a diet deficient in protein show a diminished 
rate of metabolism of foreign compounds involving oxidative or reductive 
pathways, due to decreased activity of the hepatic microsomal enzyme 
systems (Dingell £t a l , 1966; Kato et al, 1968b) and a similar effect 
is shorn by rats fed on a low calcium diet (Dingell et^  al^ , 1966) .
This results in the prolonged activity of certain drugs, such as an 
increased sleeping time with hexobarbitone. Toxicity may also increase, 
for example, acetylsalicylic acid has been shown to be more toxic to 
animals maintained on a diet deficient in protein and magnesium (West,
196f), Starvation in mice leads to a decrease in the rate of hydroxylation 
of acetanilide, demethylation of pethidine and deactivation of hexobarbitone. 
In the rat, the effect of fasting on the oxidative pathways of metabolism 
of foreign compounds varies with the nature of the Compound and it is sex
Metabolism of drugs is also affected by other physiological 
conditions such as pregnancy (Moya and Thorndike, 1962; Hsia et al, 1963; 
King et al, 1963; Arias and Gartner, 1964; Creaven and Parke, 1965; 
Crawford and Rudofsky, 1966; Juchau and Fouts, 1966; and Pulkkinen, 1966) 
and stress (inscoe and Axelrod^ 1960, Dewhurst, 1963a); and some 
pathological conditions such as jaundice (Gillette at al, 1957;
McLeuene and Fouts, 1961), abdominal carcinoma (Kato ut al_, 1968c;
1968d), and hepatic carcinoma (Adamson and Fouts, 1961; Gram et al, 1968)1
38
dependent as well. In the male rat some of the microsomal enzymes show
increased activity and the others become less active, but in the female
rat the metabolism of foreign compounds is enhanced by fasting (Kato
and Gillette, 1965a). Recently Marshal and McLean (1969) have shown
that rats fed on a low protein diet show a decrease in the hepatic
microsomal cytochrome P-450 content which is considered to be very
closely associated with hydroxylation of foreign compounds.
For other similar factors see opposite page,
vii) Effect of Other Foreign Compounds
Simultaneous administration of more than one foreign compound or
drug can lead to either accelerated or decelerated metabolism of one
or both of those compounds depending on whether the compounds inhibit
or stimulate drug-metabolizing enzymes. .These aspects have, therefore,
received much attention during the last- decade or so, because of the
great bearings that they confer on the action of drugs.
INHIBITION:
A  number of drugs and other foreign compounds (see Mannering, 1968) 
are known which inhibit the microsomal metabolism of foreign compounds 
and in consequence prolong the action of many drugs. Not all microsomal 
reactions are inhibited by all the known inhibitors and even a single 
enzyme may not be inhibited by one particular inhibitor in all species. 
SKF 525-A (2-diethylaminoethyl 2 ,2~diphenylvalerate hydrochloride) which 
is typical of these inhibitors (Gillette, 1963), for-example, inhibits
the in vitro oxidation of barbiturates, the demethylation of ethylmorphine 
(Anders and Mannering, 1966), the 0-dealkylation of phenaeetin by rat liver 
microsomes (see Gillette, 1967), and the hydroxylation of aniline and 
glueuronide formation by rat liver microsomes (ikeda £t al, 1968), but 
not the hydroxylation of acetanilide by rabbit microsomes (Fouts and Brodie, 
19ST5), the sulphoxidation of chloropromazine by guinea pig microsomes 
(Gillette and Kamm, I960), the reduction of nitro and azo compounds 
(Gillette, 1963) and the N-demethylation of 3-methyl-4-methylaminoazobenzene 
by mice microsomes (Takemori and Mannering, 1958) or the 0-dealkylation of 
phenaeetin by rabbit microsomes (Axelrod, 1956a). These facts would suggest 
that a variety of inhibitory mechanisms or loci of enzyme activities may 
exist. The general nature of the inhibition by SKF 525-A, retarding as 
it does not only oxidative reactions but also hydrolysis and glucuronidation 
as well, prompted Brodie (1956) to suggest that it may produce its inhibitory 
effect by interacting with the microsomal membrane so as to change its 
permeability to drugs. However, as Gillette (1963) has pointed out, it is 
.difficult to explain the action of SKF 525-A on the basis of altered microsomal 
membrane permeability when it blocks the metabolism of lipid soluble 
substances such as nicotine, codeine, hexobarbital and aminopyrine, but 
does not affect the oxidation of other lipid soluble compounds such as 
monomethyl-4-aminopyrine, methylaniline and acetanilide. It has been 
shown that SKF 525-A' inhibits the N-demethylation of ethylmorphine in rat 
liver microsomes competitively, suggesting that SKF 525-A combines with
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the active site of the demethylase as an alternative substrate (Anders 
and Mannering, 1966), whereas Ikeda et al_ (1968) showed that the inhibition 
of the hydroxylation of aniline and of glucuronidation of 0~aminophenol 
by SKF 525-A and DPEA. (2,4-dichloro-6-phenylphenoxy ethylamine) have 
a much greater affinity than have aniline, hexobarbitone or aminopyrine 
for cytochrome P-450 which according to them explains the inhibitory 
actions of SKF 525-A and DPEA:.
Many compounds which inhibit the hepatic microsomal enzyme systems 
also have a stimulatory phase and exhibit both effects in a biphasic 
manner, first inhibiting then stimulating. Prolonged administration of 
SKF 525-A induces increased microsomal enzyme activity by the synthesis 
of a hew enzyme protein, but both the old and new enzymes are inhibited 
by a further dose of SKF 525-A (Anders and Mannering, 1966). The steroid 
norethynodrel has also been shown to produce similarly a biphasic effect 
on hexobarbitone metabolism (juchau and Fouts, 1966). The time for 
reversal of action to occur, however, varies with the different drugs
I * . ' • .
(Kato et al, 1964.$-. Other known inhibitory substances are, e.g. 
metyrapone, disuflfirum, ethanol and carbon monoxide.
INDUCTION:
The stimulatory-effects of foreign compounds on liver microsomal 
enzyme activity was first noticed by Brown, Miller and Miller (1954) 
while studying the influence of diet on the N-demethylase activity of
rat and mouse liver for detoxication of the carcinogen 4-d.imethyl- 
aminoazobenzene. They observed that liver microsomes from mice fed a 
chow diet demethylated 3-methyl-4-methylamino-azobenzene more rapidly 
than microsomes from mice fed a purified diet. Demethylating activity 
was also enhanced when the purified diet contained certain oxidized 
steroids or hydrogen peroxide itself (Reif et_ al_, 1954). It was 
further revealed that small amounts of polycyclic aromatic hydrocarbons, 
such as 3-methylcholanthrene , 3,4— benzpyrene , and 1,2 ,5,6-dibenzanthracenc , 
induced greatly the activities of the hepatic microsomal enzymes that 
N-demethylate and reduce the azo linkage of amino azo dyes (Conney et al ,
1966) and hydroxylate 3,4-benzpyrene, 2-acetylaminofluorene, and several 
drugs (Conney ejt al, 1957b; Conney et^  al_, 1959; Cramer et al, I960).
Almost at the same time the stimulating effect of barbiturates was 
discovered by Remmer (1958a; 1959a; 1959b) while he was searching for 
possible mechanisms responsible for barbiturate tolerance, and also by 
Conney, Burns and associates during investigations on the effects of 
barbiturates and several unrelated drugs on ascorbic acid biosynthesis 
and drug metabolism (Conney and Burns, 1959; Conney et_ al^ , 1961a;
Conney et al, 1961b). Many other compounds (see Conney, 1967 and 
Mannering 1968) have since been shown to have inductive effects on the 
drug-metabolizing enzymes. Research in this field has thus expanded 
rapidly during recent years and several reviews have appeared that
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emphasize various aspects of induction and inhibition of hepatic 
microsomal drug-^metabolizing enzymes (Burns, 1964; 1965; Ernster and
Orr’enius, 1965; Gillette, 1963; Conney, 1967; Mannering, 1968; Kuntzman,
1969)•
a) Characteristics of the stimulants of drug metabolism
More than two hundred drugs and other compounds are known'to stimulate 
drug metabolism (see Mannering, 1968). The phenomenon of induction is 
seen to relate to no particular pharmacological classification of drugs; 
hypnotics, sedatives, central nervous system stimulants, anticonvulsants, 
tranquilizers, hypoglycemic agents, anti-inflammatory agents, and steroid 
hormones have all been shown to induce drug metabolism. Halogenated 
insecticides and many aromatic hydrocarbons are particularly potent 
inducing agents. In general, these drugs and other compounds possess a 
fair degree of lipid solubility at physiological pH, and this would seem 
important if drugs are to serve as inducing agents. Remmer (1964) 
illustrates the role of lipid solubility with the following example:
tolbutamide, which is quite lipid soluble, is one of the best inducers; \
carbutamine, with lower lipid solubility, has a lesser inductive effect;
and the related sulfonamides, which have very low solubility in organic •
solvents, are entirely ineffective. Replacement of the fc-NHg group of 
the sulfonamide by fc-CHg group makes the compound both more lipid soluble 
and capable of stimulating microsomal activity.
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The quantity of inducer necessary to have an appreciable effect 
on the enzyme varies considerably. Induction has been demonstrated in 
all mammalian species that have been studied. In general, agents that 
induce the metabolism of a drug in one species do so in another.
There is also good correlation between inductive effects measured 
in vivo and ija vitro. However, these generalisations are not completely 
dependable because notable exceptions do exist. The degree to which 
an inducing agent will act, or in some cases, whether it will act at all, 
may depend upon such factors as sex, strain and age of the species under 
investigation, and even on the interval of time between the administration 
of the agent and the measurement of the response. Many good inducing 
agents actually inhibit drug metabolism during the first 6 hours after 
administration (Kato et al, 1962; Remmer, 1962n; Rumke, 1963; Serrone and 
Fujimoto, 1962).
Rats and mice differ in their response to DDT. DDT stimulates drug
metabolism in the rat, but not in the mouse (Hart and Fouts, 1965) . On
*
the other hand, pyrene stimulates the metabolism of 3-methyl-4-methyl- 
aminoazo benzene in the mouse but not in rat (Brown at a l , 1954). 
Tolbutamide stimulates the oxidation of hexobarbital in rats, rabbits 
and dogs, but increases the rate of its own metabolism only in dogs 
(Remmer et al, 1964).
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Genetic heterogeneity within a species may be important in 
determining the magnitude of response to an inducing agent. The 
degree of stimulation of bishydroxycoumarin and diphenylhydantoin 
metabolism by phenobarbital varies greatly in man (Cucinell ejb al-,
1965), These differences may be due to genetic variability, although 
possibilities of influence of environmental factors viz. exposures to 
previously administered drugs or to the insecticides, food additives, 
and other foreign compounds cannot be excluded in such observations 
particularly in human beings.
The effect of strain difference on inducibility may be nicely 
illustrated by the work of Cram ejfc ad_ (1965) who studied phenobarbital 
stimulation in six strains of rabbits. The rates of hexobarbital and 
aminopyrine metabolism were greatly increased in the Cottontail rabbit, 
but in the English rabbit hexobarbital oxidation was only slightly 
enhanced and aminopyrine metabolism was not affected. Hexobarbital 
metabolism was increased in all six strains, but the degree of stimulation 
varied from 2- to 26-fold in the different strains; 3,4-benzpyrene 
hydroxylation was stimulated in only two of the strains.
The inductive effects are also influenced by age of the animals.
The magnitude of the inductive effect is greatest in young animals 
(Cramer eh al, 1960; Remmer, 1962*; Kato et al, 1961). Stimulation
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is more pronounced in immature male and. adult female rats than in adult 
males possibly because high levels of activity are normally present in 
the adult male.
Whether or not a given agent will act as an inducing agent may 
depend in part on its own rate of metabolism. If the agent is metabolized 
too rapidly, it mny not reach a concentration high enough or remain in 
the tissues long enough to produce a stimulatory effect. Hexobarbital is 
metabolized very rapidly in rats and elicits only a weak inductive response 
unless administered frequently (Remmer, 1959a and 1959b).
The times required by different agents to produce their inductive 
effects vary greatly. The polycyclic hydrocarbons are generally 
characterized by the rapidity with which they act. Chlordane is a very 
potent inducer of the drug metabolism, yet its stimulatory effects are 
seldom apparent within 72 hours and do not become maximal until a week 
or two after administration (Hart ejb al, 1963).
Induction studies have been concerned largely with processes that 
result in the oxidation or reduction of drugs, but other drug-metabolizing 
systems are also known to be stimulated by administration of foreign agents. 
Phenobarbital induces increased acetylation of antipyrine in dogs (Remmer, 
1959b), glucuronidation of sulfadimethoxine in dogs and rats (Remmer,
1964) of bilirubin in mice (Catz and Yaffe, 1962) and rat (Adlard et a l ,
1969), and of salieylamide in man (Yaffe £t al_, 1966).
Although mainly liver is responsible for drug metabolism, low 
levels of drug metabolizing enzymes have been demonstrated in organs 
such as the lung, gastrointestinal tract and kidney, and certain 
polycyclic hydrocarbons and other compounds, notably phenothiazine 
derivatives, induce enzyme activity in these tissues (Wattenberg and
e
ijpng, 1965).
b) Tests for enzyme induction '
The inductive properties of an agent can be demonstrated in several 
ways by determining the effect of the agent on:
(a) the duration of action of a drug;
(b) the rate of metabolism of a drug in vivo;
(c) the urinary excretion of certain.normal metabolites (L-ascorbic acid, 
D-glucarie acidj 6j3-hydroxycortisol) ;
(d) the activity of the drug-metabolizing enzymes.; of the liver measured 
in vitro;
(e) the amount of cytochrome P-450 in the hepatic microsomes;
(f) the electron microscopic appearance of the hepatic endoplasmic 
reticulum.
Hexobarbital and zoxazolamine are generally used as test drugs 
for determining the effect of an agent on the duration of action of a
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drug. Hexobarbital-induced sleeping time is decreased by phenobarbital 
and many other inducing agents (Conney et al_, i960), but not by 
3-methylcholanthrene, 3,4-benzpyrene and the polycyclic hydrocarbons 
(Conney et al, 1960; Arcos crfc al, 1961). In contrast, zoxazolamine- 
induced paralysis is markedly decreased by polycyclic hydrocarbons 
wherea's phenobarbital has less effect (Conney e_t al_, I960).
The rate of metabolism of barbiturate in rats and dogs has been
used as test for the induction of enzymes (Remmer and Siegert, 1964).
The phenylbutazone test has been found to be very useful in measuring
induction, particularly in dog; this drug remains in the plasma at
convenient levels 7 hours after an intraperitoneal injection of 25 mg./kg.
and some of the inducers of liver microsomal enzymes given chronically
cause the plasma level of phenylbutazone to be much lower at this
interval (Burns et al, 1963). Antipyrine is distributed through body
water and does not bind, appreciably to plasma proteins, and the rate of
its metabolism in dogs, measured by determining blood levels, is accelerated
* -
after chronic treatment with representative inducers of the phenobarbital 
type (Cucinell e^fc aJ, 1965) . Remmer (1962a; 1964) and Remmer and 
Siegert (1964) gave dipyrone to man, dog and rat and measured, the urinary 
excretion of its metabolite 4-aminoantipyrine as an indicator of enzyme 
induction.
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The compounds that induce microsomal enzymes also stimulate the 
metabolism of glucose and galactose via the glucuronic acid pathway 
through glucuronic acid and gulonic acid to ascorbic acid with the 
consequent increase in its excretion in the urine of those species 
that are capable of synthesizing this vitamin (Burns et al, 1960;
Conney and Burns, 1959; Conney et al, 1961a). The inability to 
synthesize ascorbic acid excludes the possibility of using ascorbic 
acid excretion as a measure of the induction of an enhanced glucuronic 
acid pathway in guinea pigs and in man and other primates* However, 
the excretion of D-gluconic acid, which like ascorbic acid is also formed 
through* the glucuronic acid pathway, was found to be elevated in rats
(L
(Marsh and Reid, 1963) and guinea pigs (i^rts, 1965) after administration
a-
of phenobarbital and aminopyrine and it has been suggested by J^ rts (1965) 
that urinary excretion of D-gluconic acid may be useful as an indicator 
of induction of drug metabolizing enzymes in man.
Drugs that stimulate drug metabolism also stimulate the rate of 
hydroxylation of steroids by the hepatic endoplasmic reticulum (Bur stein 
and Klaiber, 1965; Conney et aJ, .1965; Kuntzman et al, 1966; Werk jet al,
1964). It has been suggested by Conney. (1967) that the measurement of 
urinary excretion of the metabolite of cortisol 6j3-hydroxycortisol, in 
relation to the total 17-hydroxycorticosteroids which remains unchanged
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by inducers, may be useful index of liver microsomal hydroxylase 
activity in man#
Many drugs, e.g. phenobarbital, tolbutamide, nikethamide, chiordans . 
and DDT, that induce drug metabolism also cause a morphological change 
in the hepatic parenchymal cell with a marked proliferation of the 
smooth-surfaced endoplasmic reticulum (Rernmer and Merker, 1965; Fouts 
and Rogers, 1965; Ortega, 1966). The polycyclic hydrocarbon inducers 
however have a smaller effect on the smooth-surfaced endoplasmic 
reticulum (Fouts and Rogers, 1965). Electron microscopic examination 
of the smooth-surfaced endoplasmic reticulum may be. a useful index 
of drug-induced changes in liver microsomal enzyme levels.
By far the most common and effecient method for testing enzyme 
induction is the measurement of the enzyme activities iii vitro# A  large 
number of compounds are used as substrates for such studies (see Mannering, 
1968)• For a variety of reasons some of these compounds ,are preferred 
over others. In the analysis of any reaction, itameasurement of a product 
rather than the disappearance of a reactant is preferred.
c) Significance of stimulation of drug metabolism in drug therapy
Where the enzyme that acts on a drug is induced, the drug is 
metabolized more rapidly, it disappears more quickly, and the metabolite 
is formed more quickly. The consequences for the organism depend upon
the relative activity of the drug and its metabolite# When the metabolite 
has little effect of its own, enzyme induction speeds the termination of 
action of the drug by accelerating its inactivation. Such an action may 
be well illustrated by data obtained in rats with zoxazolamine by 
Conney et al (1960)# They found that a high dose of zoxazolamine 
paralyzed rats for more than 11 hours, but.after treatment with pheno- 
barbitone for four days the same dose paralyzed rats for only 102 minutes, 
and after treatment with 3,4-benzpyrene twenty-four hours before the test, 
the same dose of zoxazolamine paralyzed the rats for only 17 minutes# 
Similar effects have been observed with several barbiturates (Conney, 
et a l , 1960; Kato and Chiesara, 1962; Remmer, 1962a) and some other 
drugs such as carisoprodol and meprobamate (Conney and Burns, I960), and 
diphenylhydantoin . (Cucinell et al, 1963). Arcos at al_;: (1961) showed 
that the stimulation of zoxazolamine hydroxylase activity by any of a 
series of polycyclic aromatic hydrocarbons paralleled their effectiveness 
in decreasing the muscle relaxing action of zoxazolamine.
On the other hand, when the metabolite has the same effect as the 
drug and is of comparable or greater potency, or when the effects seen 
on administration are actually those of the metabolite, enzyme induction 
may prolong the effects by accelerating the production of the metabolite# 
This may be exemplified by tremorine (Sjoqvist and Gillette, 1964), 
guthion (Murphy and Dubois, 1958), and schradan (Krgto, 1961).
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Enzyme induction alters not only the duration hut also the intensify 
of drug action. It was found that a dose of 150 mg. of zoxazolamine per 
kg. killed all control rats whereas none died when a single injection of 
3-methylcholanthrene was given 24 hours before this dose of zoxazolamine 
(Burns et al, 1965; Conney, 1965). Similarly, enzyme induction decreases 
the acute toxicity of a number of other drugs such as pentobarbital 
(Thompson jet al_, 1959), strychnine (Kato, 1961) , meprobamate (Burns ejfc al | 
Conney; 1965), bishydroxycoumarin (Cucinell jeib al_, 1965), warfarin (ikeda 
jet al, 1966), phenylbutazone (Welch et at , 1966) , malathion (Brodeur,
1967), paracetamol (Biich et al_, 1967), trichloroethane (leib ‘snan and 
McAllister, 1967), parathion (Alary and Brodeur,1969), heptabarbital 
(Aggeler and O ’Reilly, 1969), etc. The ppposite effect, however, is 
illustrated by schradan which is metabolized into a more toxic compound*
It was observed (Kato, 1961) that a certain dose of schradan killed 6$ 
of the control rats, but 80$ of the rats previously treated with enzyme 
inducers. Examples of other drugs of which toxicity is increased by 
enzyme induction are 4-aminobiphenyl (Uehleke and Nestel, 1967)
2-naphthylamine(Uehleke and Brill, 1968), acetylsalicyclic acid 
(Coldwell and Solomonraj, 1968), phenacetin (Uehleke, 1969), carbon 
tetrachloride (Gamer and McLean, 1969), etc.
Repeated administration of a drug often results in the induction of 
enzymes that metabolize the drug. Chronic treatment with any particular 
drug thus may accelerate its own metabolism, lower its blood level, and
decrease its effect bringing about a phenomenon called tolerance.
Rernmcr (1962b) showed that tolerance to several barbiturates is related 
to their accelerated metabolism in the liver. In many instances, however, 
little or none of this tolerance can be attributed to the induction of 
enzymes. This is true of tolerance to barbital in the ra.t? s.ince this 
compound is not appreciably metabolized (Ebert ejb al_, 1964-). Several 
drugs decrease the storage of dieldrin in body fat (Street, 1964;
Street and Blau, 1966) which suggests that inducing agents might be 
used to lower pesticide levels in man or livestock should such residues 
prove to be harmful.
Several examples are now known in which enzyme induction blocks 
chemical carcinogenesis. The metabolism of polycyclic hydrocarbon and 
aminoazo dye carcinogens can be stimulated with known inducers of drug- 
metabolizing enzymes (Conney et al, 1956; Conney eib al_, 1957b; Cramer 
ejt ad, 1960; Conney and Levin, 1966; Jellin.ck and Goudy, 1966) ; then 
the cancers normally produced by these agents are prevented (jellinick 
and Goudy, 1966; Tawfic, 1965). This suggests the possible prophylactic 
use of relatively innocuous inducing agents in the prevention of cancer 
caused by environmental carcinogens (Wattenberg, 1966).
Pretreatment of rats with phenobarbital increases the glucuronyl 
transferase activity of liver and increases their capacity to conjugate 
bilirubin (Adlard et al, 1969). This particular enzymic induction has
been utilized therapeutically in the treatment of adults and infants 
suffering from congenital, non-haemolytic, uneonjugated hyperbilix’ubinaemia 
Administration of phenobarbital to these subjects results in a marked 
decrease in the serum bilirubin concentration and in the bilirubin 
half-life period (Cr .igler and Gold, 1969; Kreek and Sleisenger, 1968).
d) Influence of inducing agents on the components of the drug metabolizing 
system
Animals exposed to drugs and. other foreign substances show changes 
in their livers which can be observed grossly, microscopically, ultra- 
microscopically and biochemically. It is now well known-that a large 
number of compounds not only stimulate drug metabolism but also increase 
liver growth and the synthesis of hepatic microsomal proteins, frequently, 
by as much as 40$, Increased synthesis of protein in other fractions of 
the cell also occurs. In fact, polycyclic hydrocarbons such as 3-methyl- 
cholanthrene, which stimulates the rates of metabolism of certain compounds 
increase liver size and total hepatic protein, but produce no increase in 
the amount of microsomal protein per gram of liver weight (Conney et al, 
1956; Conney and Gilman, 1963). Increased mitosis was seen in the 
enlarged livers of rats treated with phenobarbital (Connejr and Gilman, 
1963; Hei^son et al, 1964) and other compounds (Schmidt and Martin, 1965; 
Schulte -Hermann jet al, 1966).
Remmer and Merker (1965) and Fouts and Rogers•yl965) observed a 
marked proliferation of the smooth membranes.with-little or no increase
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in rough membranes of the liver cells of animals treated with pheno­
barbital, tolbutamide or chlordanel Their studies have been confirmed 
and further extended by others (Burger and Herdson, 1966; Ortega, 1966; 
Orrenius at ad, 1965; Orrenius and Ericsson, 1966)* In keeping with 
the observation that polycyclic hydrocarbons produced little increase 
in microsomal protein (Conney eib ad, 1956; Conney and Gilman, 1963), 
3-methylcholanthrene and 3,4-benzpyrene have been shown to produce no 
appreciable proliferation .of endoplasmic reticulum (Fouts and Rogers,
1965).
Early studies suggested that the microsomal drug-metabolizing 
enzymes are concentrated almost exclusively in the smooth mici’osomes 
(Fouts, 1961), but subsequent studies showed that a number of drugs 
were metabolized equally well by rough and smooth microsomes (Orrenius 
and Emstey, 1964; Fouts et^  al, 1966; Gram at al_, 1967a). The 
relative distribution of drug-metabolizing enzymes between rough and
smooth microsomes appears to depend not only upon the substrate employed
. > * 
but also upon the species studied and the method used to separate the
two membranes (Fouts £t ad, 1966; Gram et al, 1967a) and is related
particularly to the time following administration of the inducing agent
(Ernster and Orrenius, 1965; Orrenius, 1965). After about 6 hours
there is the first measurable increase in the content of the microsomal
hydroxylating system and this early increase is found exclusively in the
ribosome-carrying ’rough-surfaced’ fractions of the endoplasmic 
reticulum, whereas the enzyme content in the smooth-surfaced membranes 
is yet unchanged (Orrenius, 1965). During the latter half of this first 
24 hour period following drug administration, the enzyme content begins 
to increase in the smooth-surfaced microsomes and it is at about 24 
hours that the enzyme contents of the smooth- and rough-surfaced 
microsomes become equal. After this time, provided that the drug 
administration is repeated, the smooth microsomes continue to increase 
in enzyme content and exceed the hyd.roxylating enzyme level found in 
the rough microsomes (Remmer and Merher, 1963; Orrenius and Ernster, 
1964-).
Evidence based on the use of known inhibitors of protein sjuithesis
and on the incorporation of labelled amino acids suggests that the
inductive process involves the synthesis of increased amounts of drug-
metabolizing enzymes. The inductive effects of phenobarbital and
3-methylcholanthrene are prevented by ethionine (Conney ejb al^ , 1956;
*
Conney et al, 1960; Fujimoto and Plaa, 196l)? puromycin (Orrenius and 
Ernster, 1964; Gelboin and Blackburn, 1964; Conney and Gilman, 1963) 
and actinomycin D (Orrenius and Ernster, 1964-; Conney, 1965; Gelboin 
and Blackburn, 1964; Orrenius et al , 1965), substances known to block 
protein synthesis' by different mechanisms. Gelboin and Sokoloff (1961) 
using 3-methylcholanthrene and phenobarbital, and Von der Dec ken and 
Hultin (i960) using ..3-methylcholanthrene, showed that livers induced by
these compounds metabolized drugs at an increased rate and were better
able to incorporate amino acids into microsomal protein in vitro.
Kato and associates (1965a; 1965b) showed that the treatment of rats
with phenobarbital stimulated the in vitro and in. vivo incorporation 
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of C-leucine into microsomal protein, but not into the proteins of 
other subcellular fractions. Gelboin and Sokoloff (1961) showed further 
that 3-methylcholanthrene administration stimulated the incorporation 
of soluble ENA-bound amino acids into liver protein in vitro. This 
last finding suggested that the hydrocarbon was acting on steps between 
transfer ENA and the formation of protein on the ribosomes but at least 
part of the increased incorporation of amino acids was due to an increase 
in the messenger ENA content of the microsomes (Gelboin, 1964; Gelboin 
and Sokoloff, 1964). These studies illustrate some interesting effects 
of 3-methylcholanthrene and phenobarbital on mechanisms of protein 
synthesis, but questions may be raised as to their specific relationship 
to the induction of drug-metabolizing enzymes. One study that suggests 
that the inductive effect of 3-methylcholanthrene is not due to protein 
synthesis was performed by Jondorf and co-workers (1966), who showed that 
phenobarbital caused an increase in the incorporation of phenylalanine 
into hepatic microsomes from adrenalectomi&ed or hypophysectomized rats, 
but that 3-methylcholanthrene did not. It is, however, well known that
3-methylcholanthrone stimulates drug metabolism in both adrenaleetomized 
and hypophysectomized animals (Conney et_ al^ , 1956) .
Shuster and Jick (1966) concluded from their studies of the 
incorporation of tritiated L-leucine into rat liver proteins that the 
increase in total microsomal liver protein that occurs after pheno­
barbital administration results from both a decreased rate of breakdown 
and an increased rate of synthesis. The turnover rate of microsomal 
NADPHg-cytochrome c reductase was also studied by Jick and Shuster 
(1966) and they suggested that treatment of mice with phenobarbital 
increased liver microsomal NADPE^-cytochrome c reductase levels by 
increasing its rate of synthesis as well as by decreasing its rate of 
breakdown.
Treatment with 3-methylcholanthrene (Bresnick, 1966; Gelboin et al,
1967) or with phenobarbital (Gelboin £t al, 1967) stimulates rat liver 
DNA-dependent ENA polymerase. Loeb and Gelboin (.1964-) reported that 
treatment of rats with 3-methylcholanthrene increased the content of 
messenger ENA in isolated liver nuclei and. stimulated the incorporation 
of orotic acid into nuclear ENA. Bresnick and associates (1966) , 
however, .found no increase in the incorporation of orotic acid into 
nuclear or total hepatic ENA after administration of 3-methylcholanthrene
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From studies on the incorporation of P into the phospholipid of 
smooth and rough endoplasmic reticulum it was concluded that an increased 
phospholipid synthesis is an early step in the phenobarbital-induced 
proliferation of the smooth vesicles (Ernster and Orrenius, 1965;
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Orrenius, 1965; Orrenius et_ al^ 1965; Orrenius and Ericsson, 1966) . 
Holtzman and Gillette (1966), however, observed that there was no 
significant increase in total phospholipid until at least 24- hours 
after the initial dose of phenobarbital and that the increase was 
caused not by enhanced synthesis but by inhibition of the catabolism 
of phospholipid*
The inducing agents markedly increase the levels of components 
of the electron transfer system, which are thought to function in the 
metabolism of drugs. Phenobarbital and certain other compounds were 
found to stimulate NADPH^ oxidase activity in liver microsomes, but 
had little or no effect on NADH^ metabolism (Rubin et al, 1964-; Conney
' ' I ■
et al , 196lj; Conney and Burns, 1963; Remmer and Marker, 1963; Kato,
1966). Chlordane (Hart and Fouts, 1965a) and several testosterone 
derivations (Booth and Gillette, 1962) were found to stimulate NADPH^ 
oxidase activity, but 3-methylcholanthrene had only a slight effect
‘ I
(Conney ? et al, 1 9 6 Conney and Burns, 1963). NABPH^-cy to chrome c 
reductase activity was found to be enhanced after administration of 
phenobarbital, 3-methylcholanthrene and certain other compounds (Orreniis 
and Ernster, 1964; Ernster and Orrenius, 1965; Kato, 1966). Cytochrome 
P-450 in hepatic microsomes is also markedly increased as a result of 
the administration of phenobarbital, 3-methylcholanthrene and a number of 
other compounds (Orrenius and Ernster, 1964; Ernester and Orrenius, 1965;
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Remmer and Merker, 1965; Kato, 1966; Sladek and Mannering,'1966;
Gram ejb al, 1967 ) and microsomal cytochrome b^ was found to increase 
as a result of phenobarbital administration by Remmer and Merker.(1965) 
Schmid’ et al (l966) but not by others (Emster and Orrenius, 1965;
Baron and Tephly, 1969a}.
Phenobarbital administration causes stimulation of a number of
metabolic processes which are not directly related to drug or steroid
metabolism. Pretreatment of rats with phenobarbital stimulates the
microsomal demethylation of 6-dimethylaminopurine and 6-methylaminopurine
(Mazel et al, 1964; 1966), known constituents of hepatic ENA (Dunn, 1959).
Phenobarbital causes increased activity in the liver tryptophan pyrrolase
(Sclimid et_ al, 1966), o-aminolevulinic acid synthetase (Granick, 1966),
glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase
ex
(Bresnick and Yang, 1964) and UDPG-dehydrogenase (Conney et al, 1961^.
Barbiturates and other inducing agents stimulate the metabolism of
bilirubin in experimental animals (Arias elb al^ , 1963; Roberts and Plaa ,
1966) and in man (Crigler and Gold, 1966). Inducing agents also stimulate
the metabolism of glucose and galactose through the glucuronic acid
pathway to D-glucuronic acid, L-gulonic acid and L~ascorbic acid (Conney 
(x
et al, 196l|), Increased formation of D-glucaric acid, which is formed 
through the same pathways, also results when barbital is administered 
(Marsh and Reid, 1963).
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e) Mechanism of stimulation
It has been well recognised that inducing agents could be 
classified into two groups:. (i) those that induce metabolism of a 
large number of drugs, exemplified by phenobarbitone and (2) those which 
stimulate a more limited group of reations, typified by 3-methylcholanthrene 
(Conney, 1967). •
That the phenobarbital-type and 3-methylcholanthrene-type of
inducing compounds should differ in the specificity of their inductive
effects immediately suggests that more than one mechanism of induction
may exist. A  number of other observations which support this view are:
(a) phenobarbital produces a marked increase in microsomal protein
synthesis and the proliferation of smooth endoplasmic reticulum (Fouts 
' CL
and Rogers, 1965; Remmer and Merker, 1965^, whereas 3-methylcholanthrene
does not (Fouts and Rogers, 1965); (b) phenobarbital stimulates the
microsomal N-demethylation of both 3-methyl-4-methylaminoazobenzene and
ethylmorphine, whereas the polycyclic hydrocarbons stimulate the
N-demethylation of only the former compound (Sladek and Mannering, 1969a),
(c) in rats or mice, 3 ,4-benzpyrene stimulates the 2-hydroxylation of
biphenyl but not its 4-hydroxylation, whereas phenobarbital causes a
large increase in the 4-hydroxylation but only a small increase in the
2-hydroxylation (Creaven and Parke, 1966); (d) thioacetamide completely
annuls the induction produced by phenobarbital, bu^has little or no
effect on 3-methylcholanthrene or 3 ,4-benzpyrene induction (Sladek and
Mannering 1966; 1966a); (e) SKF 525-A in low concentration inhibits 
the N-demethylation of 3-methyl-4-methylaminoazobenzene by hepatic 
microsomes from untreated and phenobarbital treated rats, but not by 
microsomes from rats treated with 3-methylcholanthrene, whereas similar - 
concentration of SKF 525-A inhibits N-demethylation of ethylmorphine 
whether the source of microsomes is untreated, phenobarbital-treated 
or 3-methylcholanthrene-treated rats (Sladek and Mannering, 1966; 1969b);
(f) when the rats were given doses of the inducers that were maximal 
for their characteristic enzyme inductions, the liver microsomes were 
more active in metabolizing drugs when both 3 ,4-benzpyrene and phenobarbital 
had been given than when either had been given separately (Gillette, 1963; 
1963a); (g) substrate kinetic studies using both ethylmorphine and 3-methyl- 
4- methylaminoazobenzene as substrate, further supported the conclusion 
that there is more than one mechanism for the induction of drug metabolism 
(Sladek and Mannering, 1966a),
y
The mechanism of induction is not yet fully elucidated. However,
one of the most intricate problems in connection with the chronological
sequence of events starting with binding of the drug to the endoplasmic
reticulum immediately following its administration, and followed by the
decrease in the microsomal phospholipid turnover, then induction of
*
the enzymes, increase in biosynthesis of cholesterol and the concomitant 
membrane proliferation, concerns the mechanism by which the inducing 
agent stimulates the synthesis of messenger-BNA.
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Conney (1967) suggested that the enzyme inducer could stimulate the*
formation of more enzyme by interacting directly with DNA in such a 
way as to stimulate the DNA-directed synthesis of specific messenger 
ENA. According to him it is also possible that enzyme inducers may 
interact with the endoplasic reticulum so as to enhance the translation 
of messenger ENA on the ribosomes; alternatively, the inducers could 
interact with the finished end-product of gene activity, the microsomal 
drug-metabolizing enzyme itself. In the last case, the interaction might 
lead to increased enzyme levels by inhibiting the degradation of the 
microsomal enzyme in vivo or by preventing a feed-back inhibition of 
enzyme synthesis,
Parke (1968a) suggested that activation of the enzymes which 
metabolize foreign compounds may be due to induction of one or more 
genetic system by de-repression of an operator gene(s), In this view, 
the activating compound would combine with the repressor substance which
s'
would result in stimulation of the synthesis of messenger-ENA and 
induction of enzyme system (see Figure l.l). Simultaneous administration 
of actinomycin D, which blocks messenger ENA synthesis would thus inhibit 
the induction of enzymes which follows de-repression. It would also 
inhibit the regression of activation which occurs on cessation of 
pretreatment, by blocking the synthesis of repressor messenger ENA.
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Fig. 1.1. Possible mechanism for the induction of the hepatic 
microsomal drug-metabolizing enzymes.
*
These proteins could be mixed-function oxidases or components 
of the electron transport chain involved in microsomal 
hydroxylation.
Orrenius £t al^  (1969) on the other hand considers a direct inter­
action between the drug and the genetic apparatus to be'unlikely in 
view of the great variety of compounds that can act as inducers (Conney 
and Burns, 1962) and the highly specific nature of the induction. They, 
however, suggest that the induction is mediated by a physiologically- 
occuring substance of high specificity, the metabolism of which is 
influenced by the inducing drug; and according to them, steroid hormones 
are these probable substrates, since drug and steroids compete with 
each other when incubated with liver microsomes in vitro in the presence 
of NADPH and 0^ (Orrenius, S., referred by Orrenius et al, 1969).
However, this problem probably needs still more attention for its 
final solution.
7. Development of the Drug-Metabolizing Enzymes in the Newborn
It is known that the young, both animals and human beings, are more
susceptible than adults to drugs and toxic compounds. This greater .
*
sensitivity of the young could result from differences in the responsiveness 
of the receptors or from differences in the fate of the drug—  that is 
with respect to absorption, distribution, excretion or metabolism —  or 
from both. In fact, Jondorf et^  al^  (1958) showed that newborn mice and 
guinea pigs lack the necessary enzyme activity to metabolize drugs such 
as monomethyl-4-amino-antipyrine, amidopyrine, phenacetin, hexobarbitone,
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phenolphthalein etc. Soon after, Fouts and Adamson (1959) observed 
that the newborn rabbit is essentially unable to metabolize hexobarbital 
(alicyclic oxidation)3pyramidon (N~dealkylation), amphetamine (N- 
dealkylat.ion) , acetanilid (hydroxylation of aromatic ring) , 
chloropromazine (oxidation of ring sulfur) and p-nitrobenzoic acid 
(aromatic nitro group reduction). Dutton (1963) and Arias et al (1963) 
almost simultaneously found that glucuronyl transferase is deficient 
in fetal livers as well as in the livers of newborn animals and 
premature infants. All these groups of workers found that these enzyme 
activities begin to appear during the first few days of life and reach 
a maximum during the first 4-6 weeks. Out of these observations arise 
the question how these drug-metabolizing enzymes develop after birth.
It has been shown by Fouts and Hart (1965) that these enzyme activities 
in the foetus or neonate may be induced by treatment with phenobarbitone 
and other foreign chemicals. Strikingly enough it has further been 
shown that mice kept on red-cedar chip bedding exhibited significant 
reductions in sleeping time when administered hexobarbitone or pento­
barbitone sodium (Ferguson, 1966). Soon af'terwards, Vessel (1967) showed 
that this effect was produced by a factor in the cedar wood which 
induced the liver microsomal enzymes responsible for metabolizing 
hexobarbitone, aniline and ethylmorphine. Wade et al (1968) have since 
shown that the constituents of cedar wood oil, cedrol and cedrene , are 
inducers of drug-metabolizing enzymes.
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These observations lead one to assume that the drug-metabolizing
enzyme activity which is either completely absent or inadequate in the
foetus or neonate, develops rapidly after birth through a process of
substrate induction - that is, a change is brought about in the endoplasmic
reticulum causing synthesis of the enzyme by foreign chemicals of the
environment particularly the naturally occurring anutrients present in
the food. With such an idea in mind the present work was taken up to
elucidate the role of naturally occurring anutrients on the activities
of the enzymes concerned in drug metabolism.
8 . Proposed Thesis 
The thesis to be experimentalinvestigated is summarized thus:
1. The drug metabolizing enzymes of the liver are primarily concerned 
with the metabolism of the naturally-occurring anutrients present 
in food.
2. These enzymes may be induced by a variety of anutrient compounds 
(drugs, pesticides, food chemicals), which constitutes 'substrate-
induction' rather than 'hormonal-induetion'.
/
3. Since the anutrients of the food, are the natural substrates of these 
enzymes they will produce induction of these enzymes similar to that 
resulting from treatment with drugs, pesticides, etc.
4. The increase in the activities of these enzymes shortly after birth 
is due to the substrate-induction.of these enzymes bj^  the anutrients 
of the diet and by anutrients produced microbiologieally by the 
gastrointestinal flora.
c
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In order to study the inductive effects of various groups of naturally 
occurring anutrients it was necessary to select a number of parameters of 
hepatic function which would give a quantitative measure of enhanced activity. 
It was desirable to use sensitive methods based on the formation of product 
rather than on the disappearance of substrate, and as the basic problem 
concerned the development and induction of the drug-metabolizing enzymes of 
the hepatic endoplasmic reticulum it was decided to follow the activities of 
the following enzymes:
a) Aromatic hydroxylases using as substrate biphenyl which is metabolised
ii
by oxidation to 2- and 4-hydroxybiphenyl. ..
b) Nitroreductase using p-nitrobenzoic acid as substrate which is 
metabolised by reduction to p—aminobenzoic acid.
c) Glucuronyl synthetase using 4-methylumbelliferone as the substrate 
which is conjugated to give 4-methylumbelliferone glucuronide.
d) Cytochrome P—450 which is regarded as the major, if not the only,
terminal mixed function oxidase in hepatic microsomal hydroxylations•
•; I
Drugs are metabolised mainly in the liver, and the induction of drug 
metabolizing enzymes is often accompanied by hepatic enlargement and increased 
synthesis of protein. It was therefore necessary to measure the liver weight 
and determine the content of microsomal protein after pretreatment of animals 
with the different anutrients.
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Since rats have been the most widely used experimental animal in 
previous work on the hepatic drug-metabolizing enzymes, these animals 
were mainly used for this work.
It is well established that neonates are deficient in most of the 
drug-metabolizing enzymes. In newborn rats these enzymes become fully 
developed by the fourth'to sixth week after birth, the activities reach 
a maximum and then slowly decrease with age. Therefore, rats of 5-8 weeks 
of age were generally used, except for investigations concerning the 
influence of age on the.inductive effects of different compounds.
It is also known that rats, particularly, show sex differences in the 
activities of some of the drug-metabolizing enzymes, so in some of the 
experiments rats of both sexes were used.
Furthermore, strain and species differences in the activities of drug- 
metabolizing enzymes are also known. Hence for some of the experiments rats 
of different strains and other animals such as rabbits and mice were used.
MATERIALS 
Substrates:
Biphenyl, m.p. 70°C (B.D.H.), was purified as described by Bridges et al 
(1965); 4-methylumbelliferone (Koch-Light), was recrystallized as described 
by Mead at al (1955); coumarin (B.D.H.),was recrystallized from water 
(carbon); and p-nitrobenzoic acid (B.D.H., Analar Grade),was used as supplied.
Standards:
p-aminobenzoic acid, m.p. 187°C (B.D.H.)ywas recrystallized from aqueous • 
ethanol; 2-hydroxybiphenyl, m.p, 57°C, and 4-hydroxybiphenyl, m.p. 167°C 
(B.D.H.), were purified as described by Bridges et al (1965); 7-hydroxycoumarin 
(umbelliferone), m.p. 225°C (HopldLns and Williams),was recrystallized from 
water (carbon); glycogen (Sigma), and bovine albumin (Koch Light), were used 
as obtained; and 4-methylumbelliferone glucuronide was obtained as a gift 
from Dr. M.G. Neale.
Enzymes:
j3-glucuronidase (K & K Lab.) .. ~ ‘
Cofactors;
Nicotinamide-adenine dinucleotide phosphate, NADP, (Sigma); NADPH^ (Sigma); 
NABIIg (Sigma); glucose-6-phosphoric acid, disodium salt (Koch-Light); 
flavin mononucleotide (Sigma); and UDPGA (Sigma), were all used as supplied.
Buffers:
Phosphate buffer (0.02M, 0.1M and 0.2M) were prepared from sodium hydrogen 
phosphate (A.R.) and disoaium hydrogen phosphate (A.R.); Tris-IICl buffer 
(0.1M, pH 8.1) were prepared from Tris(hydroxymethyl)aminomethane and 
hydrochloric acid; acetate buffer was prepared from sodium acetate and acetic 
acid; glycine buffer (0.5M) was prepared from glycine and sodium hydroxide; 
and glycylglycine buffer (0 .25M) was prepared from glycylglycine and
sodium hydroxide (Dawson et al, 1959).
Other reagents:
Potassium chloride (B.D.H. Analar) was used as a 1*15$ (W/v) solution;
succinic acid (B.D.H.) was recrystallized from water; diphenylamine (B.D.H.)
was reciystallized from ethanol; carbon monoxide (B.O.C.); sodium nitrite
(B.D.H.) ; ammonium sulphamate (“B.D.H.); sodium dithionite (Hopkins and 
<
Williams); 2,6-dichlorophenolindophenol (Sigma); N-l-naphthy 1-ethyl ene- 
diamine dihydrochloride (B.D.H.); Tween 80 (polyoxyethylene sorbitan mono- 
oleate, Koch-Light); and Eolin and Ciocalteu’s reagent (B.D.H.) were all 
used as supplied.
Solvents:
All solvents were obtained from British Drug House Chemicals Ltd., and were 
used as supplied.
Terpenes, alkaloids and other anutrients used as enzyme inducers:
Terpenoids: Citral (3,7-dimethyl-2,6-octadienal), b.p. 92-93°; linalool
(3,7-dimethyl-2,6-octadiene), b.p. 198-200°; {3-ionone (4-[2,6 ,6-trimethyl-
1— cyclohexen-l-yl]-3 buten-2 one)^b.p. 126-128°; carvone (p~mentha— 6 ,8-dien-
2-one); D-limonene (p-mentha-1,8-diene or 4-i sopropeny 1-1-methyl eyelohexene) , 
b.p. 175-178°; nerolidol (3,7,ll-trimethyl-l,6,10-dodecatrien-3-ol), b.p.
78°; terpineol (p-mentha-len-8-ol), b.p. 220°; dl-borneol(2-hyd.roxyeamphane- 
2-camphanol), m.p. 210.5°; were all obtained from Sigma Chemicals.* Squalene 
(2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracoshexaene), b.p. 285° 
(Koch-Light).
Flavonoids: Quercetin (3* ,4* , 3,5,7-pentahydroxy flavon.e), m.p. 316-317°;
rutin (quercetin-3-rhamnoglucoside), m.p. 182-185°; hesperetin(3,5,7- 
trihydroxy-4'-methoxy flavone), m.p. 227-228°; hesperidin(hesperetin-7- 
rhamnoglucoside), m.p. 258-260°; were all purchased from Koch-Light.
Esters: Ethylbenzoate, b.p. 211-213° (Koch-Light); ethylcinnamate (ethyl
phenylacrylate), b.p. 271° (Koch-Light); chlorogenic acid(l,3,4,5-tetra- 
hydroxycyclohexane-carboxylic acid 3-(3,4-dihydroxycinnamate), m.p. 208° 
(Kodak Ltd.). V
Alkaloids: Caffeine (1,3,7-trimethylxanthene), m.p. 238° (Koch-Light;
gramine (3-[dimethylaminomethyl]indole), m.p. 138-139° (Koch-Light); 
arecoline (methyl 1,2,5,6-tetrahydro-l-methyl-nicotinate), b.p. 209°
"(Sigma Chemicals); piperine (l-piperonylpiperidine), m.p. 130° (K & K  Lab.) 
tyramine (4-hydroxyphenethylamine), m.p. 164-165° (Koch-Light); tryptamine 
(3-[2-aminoethyl]indole), m.p. 118° (Koch-Light).
Ethers: Vanillin (3-methoxy-4-hydroxybenzaldehyde), m.p. 80-81° (Koch-Light)
coumarin (l,2-benzopyrene), m.p. 68-70° (Koch-Light; piperonal (3,4-methyl- 
enedioxybenzaldehyde), m.p. 37° (R.N. Emanuel); piperonyl alcohol (3,4- 
methylenedioxybenzyl alcohol), m.p. 58° (Phase separations); piperonylic acid 
(3,4-methylenedioxybenzoic acid), m.p. 229° (R.N. Emanuel); piperonyl acrylic 
acid (3,4-methylenedioxyphenylacrylic acid) , m.p.233°(Phase separations); 
safrole (4-allyl— 1 ,2-methylenedioxybenzene), b.p. 232-234° (Hopkins and 
Williams); iso-sat -ole (4-propenyl-l,2-methylenedioxybenzene), b.p. 253°
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All these were checked for purity by thin-layer chromatographic 
procedures and where necessary were purified by fractional distillation 
or recrystallization.
Animals:
Rats: Two strains of rats were used, namely, Chester Beatty black-hooded
for most of the experiments, but occasionally Wistar albino rats. The . 
Chester Beatty hooded rats originated from Forton Down, and have been 
randomly bred for about 25 generations in the University Animal House under 
normal lighting and heating conditions. The Wistar albino rats originated 
from the Medical Research Council Laboratory Animal Centre, and have also 
been randomly bred for 8 to 10 generations in the same animal house and f
under similar conditions. The rats were all free from specific pathogens.
The mother rats were littered on hard wood chippings and the young reared 
to weaning (3 weeks) on the same bedding in polyethylene cages with zinc 
plated tops (North Kent Plastics Ltd.) before being transferred and maintained 
in similar cages on ’Sterolite* bedding (u.P. Usher Ltd.). The rats were fed 
on autoclaved small animal diet (Spiller’s Ltd.) and water aH libitum and 
were kept in a room with no other animal species. For one experiment, 
however, a batch of 72 hooded rats were purchased from the Medical Research 
Council Laboratory Animal Centre.
Rabbits: Only Dutch White (Richard Stude Ltd.) were used; these were housed
in individual metal cages in a room with no other species and were fed on a 
diet of Dexons rabbit pellets and water ad libitum.
Mice: Albino 2 €rlaxo (AgG) strain of mice were used; these were obtained
from the Medical Eesearch Council Laboratory Animal Centre, Carshalton, 
Surrey.
METHODS
Preparation of liver fractions
The species, strain, sex, age and weight of the animal used were 
routinely recorded and are given in the text where relevant.
Animals were killed by cervial dislocation at approximately the same 
time of day, i.e. 10 a.m. +_.! hour to avoid differences due to diurnal 
variation (Radzialowski and Bousquet, 1968). The livers were removed 
rapidly and placed in ice-cold potassium chloride solutions, chopped and 
weighed. In case of rabbits the gall bladder was removed before chopping 
the liver. The whole liver, or a portion of it was then homogenised in a 
glass homogeniser (2.4 cm. diameter) using a loose fitting Teflon pestle 
(Potter and Elvehjem, 1936). The pestle was driven by a Black and Decker 
electric drill at a speed of 2950 r.p.m. and two up and down strokes were 
used for each homogenisation. The homogenate was diluted to make a 1:4 
dilution, i.e. 1 ml. of KC1 solution contained the equivalent of 250 mg. of 
wet weight liver, and was then centrifuged in 50 ml. polypropylene centrifuge 
tubes in an M.S.E. ’High-Speed 18’ refrigerated centrifuge at 1° — 4°C at 
9500 r.p.m. (10,000 x g.) for ten minutes to remove debris, nuclei and 
mitochondria. The supernatant was carefully decanted and used in most 
enzyme assays as the '10 ,000 x g supernatant' . Ilomogenates were always kept
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cool in ico-water.
For the preparation of the microsomal fraction an aliquot of the
10,000 x g supernatant was centrifuged for one hour in an M.S.E. ’Superspeed 
50’ in a 10 x 10 ml. angle head or 8 x 25 ml. angle head at 40,000 r.p.m. for 
60 minutes or for 90 minutes in a 8 x 50 ml. angle head at 30,000 r.p.m.
giving an average of 100,000 x g in the centre of the tube, at a temperature
between 1° - 4°C. The supernatant was carefully decanted, the pellet was 
rinsed with a few ml. of ice-cold 1.15$ KC1 to remove adhering supernatant
fraction, and was then resuspended in the same volume of 1.15$ KC1 by gentle
homogenisation. This constituted the 'microsomal suspension1•
For isotope studies liver sub-cellular fractions were prepared as follows. 
The liver homogenate (one in four dilution) was centrifuged for 10 min. in 
8 x 50 ml. angle head in an M.S.E. ’High Speed 181 at 2,500 r.p.m. to give 
an average of 600 x g. for sedimentation of the nuclear fraction. The 
supernatant was centrifuged at 4,000 x g (7,000 r.p.m.) for 10 min. for 
isolation of mitochondrial fraction. Then the supernatant from this fraction
L
was centrifuged at 10,000 x g (9,500 r.p.m.) for 15 minutes in M.S.E. ’High 
Speed 18' for isolation of lysosomal fraction, and then was centrifuged in a 
M.S.E, ’Superspeed 50’ in an 8 x 25 ml. angle head at 40,000 r.p.m. for one 
hour to separate the microsomal and supernatant fractions.
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Determination of hydroxylation of biphenyl .
Rabbit liver preparations hydroxylate biphenyl to 2- and 4— hydroxy- 
biphenyl (Mitoma, Posner, Reitz & Udenfriend, 1956). These phenols are 
highly fluorescent and the quantitative aspects of these hydroxylations 
can be investigated fluorimetrically, as in the 7~hydroxylation of coumarin 
(Creaven, Parke &  Williams, 1965a)# The 2- and 4-hydroxybiphenyl can be 
estimated fluorimetrically in the same preparation because the 2-isomer 
shows excited-state ionization, whereas the 4-isomer does not (Bridges, 
Creaven & Williams, 1965). On the basis of these observations, a method 
for the assay of hydroxylation of biphenyl to 2- and 4-hydroxybiphenyl by 
liver homogenate was originally developed by Creaven, Parke & Williams 
(1965b) and was modified for use with rats by Neale & Parke (1969). In 
the beginning of the work the original method of Creaven (rfc al^  was used, and 
for the rest of the work Neale & Parke*s modified condition was followed.
In the original method of Creaven et al the incubation condition and 
mixture was as follows:
Tris-Hcl buffer, 0.05M, pH 8 .6. 1.0 ml.
NADP, 0.25 pmole, in 1.15$ KC1 0#5 ml.
Liver 10,000 c g supernatant (25$ ^/v) 1.0 ml.
Biphenyl substrate solution, 6 pmoles. 0«5 ml.
(in 1.15$ KC1 containing 2$ Tween 80) '
In a volume of 3.0 ml.
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The incubation was carried out in 20 ml-, glass stoppered tubes 
(unstoppered during incubation) in a Mickle shaking incubator for 30 
minutes at 37 °C.
The; modified incubation conditions described by Neale & Parke were 
as follows:'
Tris-HCl buffer, 0.05M, pH 8.1 0.5 ml.
NADP, 1.5 pmoles, in 1.15 KC1 0.25 ml.
KC1 (1.15$ W/v ) , 0.3 ml.
++ /
Mg , l0[Jmoles (Mgclg solution,
50 pmoles/ml.)  ^ 0.2 ml.
Biphenyl substrate solution (3.0 [Jmoles) 0.25 ml.
Liver 10,000 x g supernatant (25$ W/v) 0.5 ml.
In a total volume of 2.0 ml.
The incubation was carried out in a similar 20 ml. glass stoppered tube 
in a Mickle shaking bath for 20 minutes at 37°C.
The rest of the operation, the same in both cases, was as follows:
The hydrosylation reaction was stopped partially by cooling the tubes in 
ice-cold water and then completely by addition of 2N HC1 (0.5 ml.) to the 
incubation mixture. The tubes were then shaken mechanically with n-heptane 
(10 ml.) for 5 minutes to extract the phenols and cnntrifuged at 2,000 r.p.m. 
in an M.S.E. ’Super Magnum’ centrifuge at room temperature for 10 minutes.
An aliquot of 2 ml. of the heptane layer was then extracted in a similar 
manner by mechanical shaking in tubes with 0.1N NaOH (10 ml. prepared in
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all-glass-distilled water). The tubes were centrifuged at 2,000 r.p.m. in 
an M.S.E. ’Super Magnum’ centrifuge at room temperature for 10 minutes. To
2.0 ml. of the NaOH layer was added 0.5 ml. of 0.5N succinic acid to change 
the pH to 5.5 and the fluorimetric intensity was determined at 338 nm. and 
415 nm. with excitation at 280 nm. and 290 nm. respectively.
All tubes were prepared in duplicate. A  blank was prepared by adding
\
the substrate after incubation. Standards were prepared by the same 
procedure adding both substrate and known amounts of 2- and 4-hydroxy- 
biphenyl solutions after incubation.
Determination of the reduction of p-nitrobenzoic acid
Nitroreductase activity of liver homogenate was measured by following 
the reduction of p-nitrobenzoic acid to p-aminobenzoic acid using the method 
developed by Fouts and Brodie (1957) as modified by Gingell (personal
' ■ '/ i xcommunication). The incubation mixture consisted of NADP (0.25 pmolies) , 
flavin mononucleotide (0*125 ymoles), glucose-6—phosphate (25 pmoles) , 
magnesium chloride (25 pmoles) , p-nitrobenzoic acid substrate solution 
(20 pmoles in 2.0 ml.) k and 25$ liver 10,000 x g supernatant (l.O ml.) 
in a total volume of 5.0 ml., made up with 1.15$ KG1 solution.
The incubation was carried out under nitrogen. Initially, wide side** 
arm glass tubes stoppered with rubber bungs were used for incubation 
purposes. Oxygen-free nitrogen was passed into the tubes through needles:.
inserted through the rubber stopper, and flowed out via the side arm to 
the tubes connected in series by rubber tubings* Afterwards, plain tubes 
stoppered with rubber bungs were used for this purpose. Two needles were 
inserted through each rubber bung so that nitrogen could pass in through 
one of them and then come out through the other.
The incubation tubes were cooled in ice water, evacuated and then 
preflushed with nitrogen for ten minutes, after which time they were moved 
to a Mickle shaking incubator at 37°C and incubated for 30 minutes under’ 
continuous atmosphere of nitrogen.
The reaction was terminated by immersing the tubes in ice-cold water 
and flushing the system with oxygen for one minute, then adding 1*0 ml. 
of 25$ /v trichloracetic acid solution to precipitate the protein. The 
tubes were centrifuged at 2,000 r.p.m. in an M.S.E. ’Super Magnum’ centrifuge 
at room temperature for ten minutes. The .concentration of aminobenzoic acid 
present in the supernatant (4.0 ml.) was determined by the method of Bratton 
Marshall (1939) as follows:. 0.5 ml. of 0.1$ freshly prepared sodium nitrite 
solution was added, the contents of the tubes were mixed and allowed to 
stand for three minutes after which time 0.5 ml. of 0.5$ ammonium sulphamate 
solution was added and then shaken. After a period of a further three 
minutes, 0.5 ml. of 0.1$ Bratton-Mar shall reagent (N-(naphthyl)-ethyl- 
enediamine dihydrochloride) was added and the solution mixed. The volume 
was adjusted to 10 ml. with water and after standing for 30 minutes to allow 
the colour to develop, the optical density was measured in a Unicam SP500
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spectrophotometer at a wavelength of 545 nm.
All tubes were prepared in triplicate; a blank was prepared by adding 
the substrate after incubation, while standards were prepared in a similar 
fashion by adding both substrate and standard solutions of p-aminobenzoic 
acid after incubation. Eecovery of p-aminobenzoic acid was essentially 
complete (98$ + 4$). The;calibration curve for the standard is shown
in Fig. 2.1. (at the end of this chapter, page 91).
Determination of 4-methylumbelliferone glucuronyl transferase
Many substrates .have been used for determining the activity of 
glucuronyl transferase in various tissues. The most common are 
o-aminophenol., p-nitrophenol and phenolphthalein (Dutton 1966a). All 
these procedures are based on colorimetric determinations either of the 
amount of product formed or of the decrease in the amount of substrate#
The assay of glucuronyl transferase using 4-methylumbelliferone (4-MU)
as substrate is, however, based on fluorimetry, a far more sensitive 
procedure than colorimetry, and this method has been used by several 
workers working with different tissues (Arias 1962, - human liver; 
Taketa 1962, - mouse liver; Bollet et al, 1959, — rat stomach mucosa). 
Since this method is more sensitive for glucuronyl transferase activity 
in tissues it has been used to investigate the activity of this enzyme 
with liver preparations.
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The method used was essentially similar to that developed by Arias
(1962) for human liver, but with slight modifications, and is based on
the fact that 4-methylumbelliferone is highly fluorescent. After
initially incubating 4-methylumbelliferone with uridine diphosphate
glucuronic acid (UDPGA) and liver homogenate, the mixture is extracted
with chloroform to denature protein and to extract the unconjugated 
4-methylumbelliferone without removing the glucuronide formed in the 
incubation. This chloroform extract is discarded, 4-methylumbelliferone 
is then set free from its conjugate by further incubation of the aqueous 
mixture with p-glucuronidase (Mead et^  al_. 1955) and the subsequent 
increase in fluorescence is taken &s a measure of the glucuronyl transferase 
activity of the liver. It was reported by Dutton (1966) that rat liver has 
a high requirement for UDPGA in in vitro determinations of glucuronyl 
transferase activity because of the rapid breakdown of the coenzyme by 
pyrophosphatase activity. These higher amounts of UDPGA were added to 
the incubation mixture since rats were to be used as the experimental 
animals in the studies of enizyme induction.
The incubation medium was as follows: *.
o ’ litf
Tris-HCl buffer, 0,d5lM, pH 7.6 0.3 ml
UDPGA, 2.0 pmoles in 1.15$ HC1 0.2 ml.
4-methylumbelliferone 0.6 pmoles. 0.3 ml.
/  W  /  \
Liver 10,000 x g supernatant (1.25$ ’/v) 
(25$ W/v diluted 1 in 20 immediately
before use)
0.2 ml.
In total volume of 1.0 ml.
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The incubation of the mixture was carried out in 20 ml. tubes in a 
Mickle shaking incubator at 37°C for 30 minutes, 2.0 ml. of ice-cold 
water was then added to each tube followed by 10 ml. of chloroform and 
the tubes were shaken mechanically for 10 minutes. After this extraction 
the tubes were centrifuged at 2,000 r.p.m. in an M.S.E. !Magnum' 
centrifuge for ten minutes at room temperature. Aliquots of 0.5 ml. of
the aqueous layer were then incubated with 1.0 ml. of 0.1M acetate buffer,
/
pH 4.6, and 500 units of 1 {3-glucuronidase 1 , in a total volume of 2.0 ml. 
at 37°C for 30 minutes. The mixture was cooled in ice-cold water, 5 ml.
i
of 0.5M glycine buffer, pH 10.4 was then added and the fluorescence 
determined in a Baird Atomic fluorescence spectrofluoriineter• The blank 
fluorescence was determined in similar aliquots carried through the same 
, procedure but without the {3~glucuronidase. The excitation wavelength
was 368 nm. and the fluorescence measurement was made at 450 nm. (instrumental 
readings).
The increase in fluorescence following incubation with {3-glucuronidase 
was considered to represent the amount of 4-methylumbelliferone which had
x
been conjugated.with glucuronic acid in the first incubation. Known amounts 
of 4-methyTumbelliferone glucuronide were run through the same procedure and 
used as fluorimetric standards. Duplicate tubes were used in each case.
A  standard for the fluorescence of 4-methylumbelliferone was produced 
by measuring the fluorescence of varying amounts (0.001 — 0.01 pmoles) of
4-methylumbelliferone dissolved in 2.0 ml# of acetate buffer, pH 4.6 and 
diluting with 5.0 ml. of glycine buffer, pH 10.4, in a Baird Atomic ' 
fluorescence spectrofluorimeter at an excitation wavelength of 368 nm. 
and fluorescence wavelength of 450 nm. The concentration of 4—methyl­
umbellif erone plotted against fluorescence intensity gave a straight line 
(Fig. 2.2?page 91).
Determination of cytochrome P—450
The method used for the estimation of cytochrome P~450rwas essentially
that described by Sladek and Mannering (1966). The "microsomal suspension"
(5.0 ml.) was diluted by addition of 10*0 ml. of 0.2M phosphate buffer
pH 7.4, a few crystals of sodium dithionite were addedj to reduce the
haemoproteins present. After mixing by inversion 2 or 3 times 3.0 ml.
of the mixture was taken in each of two cuvettes, and carbon monoxide or
coal gas was bubbled through one (the sample) for 30 seconds. The second
cell was used as reference. The difference spectra between the two was
then determined between 550 and 400 nm. using a dual-beam Pye—Unicam SP800
spectrophotometer. The cytochrome P—450 was taken to be proportional to
the absorbance at 450 nm. less the absorbance at 490 nm., and the cytochrome
P—450 content was calculated using the molar extinction coefficient of 
- 1 - 1
91 cm mM as determined by Omura and Sato (1964a). A  typical trace is 
presented in Fig. 2.3. It was found that the use of carbon monoxide or 
coal gas produced similar difference .spectra with no difference in
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extinctions (Fig# 2#3); coal gas was, therefore, used routinely for the 
determination# Bubbling with coal gas for periods longer than 30 seconds 
did not alter the difference spectra in any way so that treatment was 
limited to 30 seconds (Fig.2.3* Page 92).
b '
Determination frf cytochrome 5.
The method used for determination of cytochrome ^5 was that described
by Schenkman crtal_ (1967)# ’Microsomal suspension* (l#0 ml.) was placed
in each of two cuvettes (l.O cm. optical path), 2,0 ml. of 0.2M phosphate
buffer, pH 7.4 was then added to both cuvettes and mixed well# To one of
these cuvettes 10 pi of 2fo NADHg was added. The difference spectra between
the oxidised and reduced microsomes was then traced at a wavelength between
600-400 nm# in a Uni cam *SP 800 recording spectrophotometer and the difference
b~
in absorbance between 424 and 410 nm. was measured and the cytochrome 5
content was calculated using an extinction coefficient increment ( E 424-410 m \l)
-1 -1
of 185 cm mM •
Petermination of protein
The protein content of whole liver and its subcellular fractions were 
determined essentially by the method described by Lowry, e^ b al_ (l95l)# The 
different liver fractions were diluted with distilled water as follows:
25^ liver homogenate,x 200; the 10,000 x g supernatant, x 50; the nuclear 
fraction, x 40; the mitochondrial, fraction, x 5; the lysosomal fraction, x 2.5;
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the microsomal suspension* x 20; and the supernatant fraction, x 80#
1#0 ml# of the diluted solutions were then taken for protein estimation# 
The reagents required for estimation were as follows
1#0 ml# each of B and C were mixed immediately before use, together 
with 100 ml# of A;# 10 ml# of the resulting mixture was added to 1#0 ml#
of the diluted protein solution. After mixing and standing for 15 minutes,
0#5 ml, of Folin and Ciocalteu’s reagent was added, and the solutions were 
mixed immediately# After allowing at least 40 minutes for the colour to 
develop the optical densities were read at a wavelength of 750 nm# in a 
Pye-Unicam SP500 spectrophotometer# All samples were run in triplicate#
A  reagent blank with water instead of. protein solution and standards of 
serum bovine albumin (100-1000 pg in 1#0 ml#) were also run through the 
same procedure. The standard curve for albumin is shown in Fig# 2#4 (page 93).
Determination of hepatic glycogen
Hepatic glycogen was extracted according to the procedure described 
by Good e_t al (1933) , and the glycogen determined by the method of 
Montgomery (1937), A  15 ml. pyrex test tube was charged with 30$ (W/v )
K0H, approximately 2.0 ml. per gm. of tissue, stoppered and weighed. The 
animals were killed, the liver quickly removed and a portion (O,5-1,0 gm,)
A# Na^COg (2.0$ W/v) in 0.1N NaOH
B. Sodium potassium tartrate
C. CuS04 , 51^0 (1.0$ W/v )
added to the KQH in the stoppered tube and weighed. The stopper was then 
removed and the tube immersed in a boiling water bath. When the tissue 
had dissolved, 1#1 to 1.2 volumes of 96$ alcohol was added to precipitate 
the glycogen. The mixture was heated again until it began to boil after 
which it was cooled to room temperature and centrifuged in an M.S.E. bench 
centrifuge. The mother liquor was decanted and the centrifuged pellet was 
allowed to drain. Any alcohol still present on the pellet was rapidly 
expelled by heating the tubes for a few minutes in a water bath# The
pellet was redissolved in water, and diluted to a known volume. An aliquot
i
of this was further diluted so that the concentration of glycogen would be 
about 10-60 pg/2 ml# This diluted solution was filtered‘through glass-wool 
plugs to remove extraneous insoluble polysaccharides. Aliquots of 2«0 ml# 
in triplicate, were transferred to test tubes, 0.1 ml. of 80$ phenol was 
then added followed by 5.0 ml. of concentrated sulphuric acid from a pipette 
with a delivery time of about 5 secs. The stream of acid was directed 
against the liquid surface rather than the side of tube in order to obtain 
good mixing, which was further ensured by shaking the tube after the addition 
of the acid. A  yellow/orange colour was produced in the reaction raising 
the temperature of the mixture to about 110°C and the colour was allowed to 
develop by leaving to cool at room temperature for 30-45 minutes. The 
intensity of the colour was then measured in a Unicam SP500 spectrophotometer 
at a wavelength of 490 nm; the amount of glycogen being determined by
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reference to a standard curve constructed from pure glycogen (Fig# 2#5, 
page 93).
Determination of ascorbic acid
The method used for the determination of ascorbic acid in urine was
that described by Owen and Iggo(l956). The reagents required for this
estimation were as follows
' Metaphosphoric acid solution (3fo W/v)
2 ,6~Dichiorophenolindiphenol, 0#1$ W/v (diluted 1 ml# to 10 ml# 
before use).
Sodium citrate dihydrate solution (4#37$ W/v )
p-Chloromercumbenzoic acid, 0.2J& in 0.05N NaOH.
Standard ascorbic acid solution, 0.8$ (in 4:6 water and 3fo ■
metaphosphoric acid). J
To 2.0 ml# of urine 3.0 ml. of 2>fo metaphosphoric acid was added, mixed
and centrifuged in an M.S.E. bench centrifuge. 2#0 ml. of the supernatant
was placed in a cuvette, 0.5 ml. of sodium citrate dihydrate was added and
well mixed. Diluted indophenol dye solution (l.O ml.) was then added,
i
mixed quickly, and the absorbance read after 30 seconds at 520 nm. against 
a water blank in a Unicam SP500 spectrophotometer# The reagent blank was 
prepared with 1.2 ml. 3fo metaphosphoric acid, 0.8 ml. water and 0#5 ml.
4.37$ sodium citrate dihydrate, and the standard was prepared with 2.0 ml. 
(16 tig.) standard ascorbic acid solution, and 0.5 ml. 4#37fo sodium citrate 
dihydrate which were run through the same procedure# This gave the 
absorbances Sc, Sb and ^s.
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To each cuvette a small pinch of ascorbi6 acid was added to 
decolorize excess dye. The solutions were mixed and the absorbances 
again read. These were represented by Axb, Sbb and "Sb and the calculation 
was made as follows:
'A r A bb)-(Ax"Axb)' 0.016
x
( T l b ) - x   
wg. ascorbic acid/ml. = _A -<
'A b b ' ~ ' A s ~ A s b ' 0,8
Determination of radioactivity by liquid scintillation counting
The "Gel" scintillator consisted of napthalene (60 g«), 2,5—diphenyl- 
oxazole "PPO" (4.0 g.), .1,4—bis(4-methyl-5-phenyl oxazolyl)-benzene 
"dimethyl P0P0P" (0.2 g.), methanol (100.0 ml.), ethylene glycol (20.0 g*)> 
CAB-0—SIL (100 ml.) and Dioxan (diethylene dioxide) to make one litre.
20.0 ml. of the scintillation fluid was placed in a glass scintillation 
vial and 0.5 ml* of the sample was added, mixed well and counted in a 
Packard 4-channel "Tri-Carb" liquid scintillation spectrometer. The 
counting efficiency was determined by the channel ratio method (Bush, 1963). 
The red channel was set at 50$ gain, with discrimination settings of 40-240; 
the green channel was also set at the 50$ gain, with discrimination settings 
of 40-1,000.
Tritiated water (Radiochemical Centre, Amersham} was used as the radio­
active standard and rat serum was the quenching agent used for the preparation 
of the quenching curve.
90
Determination of IMA
The method for the extraction of DNA was based on that of Schneider 
(1945) and of Ogur and Rosen (1950) modified by Burton (1955)* The 
determination of DNA was based on the colour reaction described by Dische 
(1930), partly modified by Burton (1956)*
.Liver homogenate (0.4 ml. of .a 25f> suspension in KCl) was placed in 
a centrifuge tube, 7-8 ml. of Qfo perchloric acid (PCA) was added, mixed 
well, chilled in a refrigerator for 15 minutes, and centrifuged in a 
Unicam bench centrifuge for 10 minutes. The supernatant was removed and
1
the deposit was digested twice with 10 ml. of alcohol, centrifuged, and the 
supernatant discarded. The precipitate thus obtained yas broken up with 
a glass rod and stirred with 3 ml. of Qfo PCA. A  further 2.0 ml. of, Qfo 
PCA was added and the suspension was heated at 90°C for 15 min., with 
occasional stirring. After centrifuging in a Unicam bench centrifuge, the 
supernatant was decanted into a 10 ml. graduated tube. The precipitate 
was re-extracted in the same way with a further 3 ml. of Qfo PCA, the two
extracts were mixed and the volume was made up to 10 ml. with Qfo PCA.
To 1.0 ml. of the DNA. extract, 2.0 ml. of diphenylamine reagent (1.5 g. 
recrystallized diphenylamine + 100 ml. acetic acid + 1*5 ml. conc. H^SO^) 
was added and heated in an oven for 16-20 hours at 25-30°C. After cooling
the mixture the optical density was measured in a Unicam SP500 spectro­
photometer at 600 nm. A  reagent blank, containing the diphenylamine reagent
only, and a standard with known amount of DNA, were rim through the same 
procedure. The standard curve is shown in Fig. 2.6 (page 94).
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CHAPTER III
INDUCTIVE AND INHIBITORY EFFECTS OF ANUTRIENT S 
ON HEPATIC DRUG-METABOLIZING ENZYMES
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1. Induction and inhibition of drug—metabolizing enzymes by terpenoids, 
alkaloids, flavonoids, esters and ethers
More than two hundred compounds are known at present which have a 
stimulating effect on the activity of drug-metabolizing enzymes of the 
liver microsomes (Conney, 1967), Most of the compounds which have been 
studied so far, are used in medicine as drugs such as hypnotics, < 
sedatives, anaesthetics, central nervous system stimulants, anticonvulsants, 
tranquilizers, antipsychotics, hypoglycemic agents, anti-inflammatory 
agents, muscle relaxants, analgesic and antihistaminic agents, etc*, and 
most of these compounds are of synthetic origin* Besides these, the 
insecticides and polycyclic aromatic hydrocarbons which have been found 
to be stimulators of hepatic drug-metabolizing enzymes are also mostly 
synthetic products* Of the compounds of natural origin only a few, such 
as alkaloids, nicotine and cotinine, certain coumarin derivatives, and 
a number of steroids, have so far been studied to evaluate their influence 
on drug-metabolizing enzymes* The animal system, however, receives, 
through food and the environment, a much greater number of foreign 
chemicals of natural origin than synthetic ones which are used as drugs, 
food additives or insecticides* For a general evaluation of the effects 
of such anutrients on the hepatic microsomal drug-metabolizing enzymes a 
number of compounds of different chemical groups, such as terpenoids, 
flavonoids, alkaloids, esters and ethers have been investigated*
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The terpenoids are common constituents of essential oils and are 
very widely used in perfumery and as flavourings in foods and drinks. 
Citral is widely distributed and occurs to an extent of 75-80$ in oil 
of lemon grass, the volatile oil of Cymbopogan Citratus or of Cymbopogan 
Flexusus; it is also present in oils of verbena, lemon and orange.. 
Borneol occurs in the essential oil obtained from Dryobalanops 
Aromatica, Dipterocarpaceae, and many other plants. Linalool is the 
chief constituent of linaloe oil; it also occurs in oils of Ceylon 
cinnamon, sassafras, orange and many other flowers. Limonene occurs 
in various oils, particularly in oils of lemon, orange, caraway, dill 
and bergamot; carvone is present in caraway seed and dill seed oils; 
nerolidol is present in many plants and, in particular, in the essential 
oils from flowers such as Melaleuca, Myrtaceae and Myroxylon, etc. 
Squalene is present in large quantities in shark liver oil and in smaller 
amounts in olive oil, wheat germ oil, rice bran oil and yeast. (3-Ionone 
is present in essential oils of various plants including Boronia.
Of the alkaloids, caffeine occurs in tea, coffee, mate leaves, guarana 
paste and cola nuts; gramine is present in mutants of barley and other 
plants; arecoline is present in leaves of Berginea, saxifragaceae, the 
blueberry, cranberry and. pear; it is also present in bettel nuts.
Piperine is present in black pepper (Piper nigrum L.) and in root bark 
of Piper geniculutum SW., Pipercaseae; tyramine is present in mistletoej
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putrified animal tissue, ripe cheese, yeast products such as Marmite 
and ergot, etc; tryptamine also occurs in meat products, cheese,
Marmite and various plants and fruits# Of the ethers, vanillin occurs
in vanilla essence, potato parings and in Siam benzoin; coumarin is
present in sweet clover, tonka beans, lavender oil and woodruff
(Asperula species); both vanilla and coumarin are used as flavouring 
agents. The flavonoids occur as pigments in various plants and flowers# 
Plant tissues also contain a great variety of organic acids, both as 
salts and as esters. Hence all these groups of compounds find their 
way into the animal organism in the food as natural anutrients#
As previously discussed in Chapter I, the chronic treatment of 
animals with different drugs produces an increase in the liver weight, 
which is not necessarily associated with degenerative or proliferative 
changes, but is accompanied by an increase in activity of certain of, 
the hepatic drug-metabolizing enzymes# Determinations have now been 
made in this work of changes in the liver weight, and in the activities 
of various hepatic microsomal drug-metabolizing enzymes, following the 
treatment of rats with various terpenoids, alkaloids, flavonoids, esters 
.and ethers. The drug-metabolizing enzymes studied include biphenyl-r4~ 
hydroxylase (aromatic hydroxylations), p-nitrobenzoic acid reductase 
(reduction of the nitro group), 4-methylumbelliferone glucuronyl
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transferase (conjucation with glucuronic acid) and cytochrome P-450 
(oxygenase). The results are represented in the Tables 3*1 — 3*5 
and the detailed results are given in the Tables A1 — A25 which are 
contained in the Appendix.
EXPERIMENTAL:
Materials and methods of enzyme assay for this study has already 
been described in general in Chapter II# Eor each experiment groups
of hooded rats of 125-150 gm. body weight were selected and kept on
' 1 '
!
normal food (Spiller's small animal diet) and water ad libitum.
Treated animals were kept in separate cages from the controls. The 
anutrient compounds, dissolved in a vehicle, vrere administered by 
intraperitoneal injection# The terpenes were dissolved in ethyl oleate; 
the alkaloids: arecoline, piperine and gramine were administered in ethyl 
oleate, except for tyramine, tryptamine and caffeine which were given 
in isotomie saline; flavonoids were dissolved in dimethylsulfoxide, with 
the exception of hesperetin which was dissolved in ethyl oleate; esters 
were dissolved in ethyl oleate except chlorogenic acid which was 
administered in saline; both vanillin and coumarin were dissolved in 
ethyl oleate. The concentrations of the different compounds in the 
vehicle "were of the order of 50 to 100 mg#/ml. The dosage of the 
different anutrient compounds used in the experiments is given in the
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respective tables (A1 - A  25). Treatment was by intraperitoneal 
injection once each day between 9 — 10 a.m. for three days# Each 
control group were given intraperitoneal injections of the same amount 
of vehicle alone. The animals were killed 24 hours after the last 
injection, their body weight noted, the liver was removed, weighed, 
chilled, then chopped and homogenised in 3 volumes of ice-cold 1.15$ 
(7v) KCl. The 25$ (W/v ) homogenate was centrifuged at 10,000 x g, 
for 10 minutes and the supernatant thus obtained was used for all the 
enzyme assays, except for glucuronosyl transferase where the 10,000 
x g supernatant was further diluted 20-fold before use. For the 
estimation of cytochrome P-450, the 10,000 x g supernatant was further 
centrifuged at 100,000 x g for 1 hour; the microsomal pellets thus 
obtained were resuspended in the same volume of cold KCl and this 
•microsomal suspension’ used.
RESULTS:
Of the terpenoids studied (see Table 3.1) only limonene and 
P~ionone produce any liver hypertrophy after this short period of 
treatment, and indeed this is only modest in extent, 5$ and 15$ 
respectively. Aromatic hydroxylase activity is increased by borneol 
(25$), terpeniol (20$), 1 imonene (20$) and |3-i onone (55$); only squalene 
decreased the activity, namely by about 10$, while the other terpenoids
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produced no significant effect. Reduction of p-nitrobenzoic acid is 
increased by nerolidol (40$), linalool (50$), and p-ionone (85$), other 
terpenes having no significant effect. Glucuronosyl transferase activity 
is increased after pretreatment of rats with p-ionone (45$), and is 
unaffected by other terpenes studied. The cytochrome P-450 content is 
increased only by p-ionone.(55$), others having no significant effect.
Of the alkaloids (see Table 3.2), caffeine increases aromatic 
hydroxylation (45$), but had no effect on the size of liver, its 
cytochrome P-450 content, or any of the. other parameters. Tyramine 
results in a slight decrease in aromatic hydroxylation, but affects 
no other parameter. Tryptamine produces no significant change in any 
of the parameters studied except that the liver weight is very slightly 
decreased (5$). Gramine increases the liver weight (15$) but does not 
significantly affect any of the hepatic enzymes measured. Arecoline, 
although it is given at a very low dose level because of its high acute 
toxicity, showed inhibitory action on aromatic hydroxylase activity.
Of the flavonoids (see Table 3.3), rutin exhibited inhibitory effect 
on glucuronosyl transferase (15$) and cytochrome P-450 (40$); and 
hesperetin produced an increase in liver weight (10$), and aromatic 
hydroxylation (20$) but a decrease in cytochrome P-450 (20$), whereas 
quercetin and hesperidin produced no significant change in any of the 
parameters studied. •
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The esters (see Table 3.4) have no significant effect on the
parameters studied except that ethyl cinnamate tends to cause a
H, '
slight decrease in liver weight (10$).
Of the two ethers (see Table 3.5), vanillin produced an increase 
only in aromatic hydroxylase (25$), while coumarin produced a marked 
decrease of cytochrome P-4I3 (35$) , having no significnat influence 
on any of the other parameters studied after pretreatment with these 
compounds for 3 days.
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Table 3.1,
Changes in liver weight and various microsomal enzyme levels after 
parenteral pretreatment of rats with terpenoids
Terpenoid *
(Dose: 150 mg/kg 
body weight )
Percentage change in:
Liver
weight
Aromatic
hydrozylase
Nitro
reductase
Glucuronyl-
transferase
Cytochrome
P-450
Citral - — — - -
Bomeol - + 25 . - - —
Terpineol - + 20 - - -
Nerolidol - — + 40 » »  .
Linalool - — + 50
Limonene . - ■ + 20 . - - ■ —
Carvone - — — —
P-Ionone + 15 + 55 + 85 + 45 + 55
Squalene - - 10 - - -
All parameters were determined, for each terpenoid, hut only significant 
differences are given in this table.
Fpr detailed results see Tables A.l - A.5 in the Appendix
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Table 5.4.
Changes in liver weight and various microsomal enzyme levels after 
parenteral pretreatment of rats with some esters
Ester 
(Dose: 150 mg/kg 
body weight)
Percentage change in:
Liver
weight
Aromatic
hydroxylase
Nitro
reductase
Glucuronyl
transferase
Cytochrome
P-450
*
Ethyl benzoate - - - -
Ethyl cinnaraate - 10 - - -
Chlorogenic acid - -
All parameters were determined for each of the esters except glucuronyl
transferase with chlorogenic acid.; srJil-r'v
For detailed results see Tables A.16 - A.20 in the Appendix. .
Table 3.5.
Changes in liver weight and various microsomal enzyme levels 
after parenteral pretreatment of rats with ethers
Ether Percentage change in:
(Dose: 150 mg/kg 
body weight) Liver
weight
Aromatic
hydroxylase
Nitro
reductase
Glucuronyl
transferase
Cytochrome
P-450
Vanillin - + 25 - -
Coumarin - - - *1 - -  35V
All parameters were determined for both the ethers but only significant 
differences are given in these tables.
For detailed results see Tables A.21 - A.25 in the Appendix.
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2. Induction of drug-metabolizing enzymes by orally administered 
'j terpenoids
As it was observed (see Table 3.1) that various parameters of hepatic 
activity are changed by pretreatment with different terpenoids administered 
parenterally, it was desirable to ascertain whether these compounds would 
have similar effects if given orally admixed with the food so as to 
administer as small continuous doses throughout the day, instead of the 
single intraperitoneal dose.
EXPERIMENTAL: I
For these experiments groups of hooded male rats (125-150 g.) were 
selected and kept as described before, their daily food?’intake being 
first ascertained. The terpenoids in ethyl oleate were mixed in known 
concentrations with the food. The control groups were given similar 
amounts of ethyl oleate only, in admixture with the crushed food#
After every twentyfour hours unused food was weighed and the doses of 
the terpenes consumed were calculated. Fresh food admixed with the 
terpenoids were given each day for a total of three days. The animals 
were weighed, killed and liver microsomal preparations made as before, 
for the assay of the different enzyme levels. The results are presented 
in Table 3.6 and the detailed results are given in Tables A26 - A30 of 
the Appendix.
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RESULTS
■J ■
From the results (see Table 3.6) and a comparison with those
obtained with parenteral administration (see Table 3.1) it is
confirmed that p-ionone results in an induction of the hepatic
microsomal drug-metabolizing enzymes. The other terpenoids (see
Figure 3.1 for structures) have only slight inducing activity,
the nature of which varies somewhat with the mode of administration.
It is possible that a greater inductive effect might result from
more prolonged treatment with these terpenoids.
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Table 3,6,
Changes in liver weight and various microsomal enzyme levels 
after oral administration of terpenoids in food to rats
Terpenoid 
(Dose: 150 
mg./kg. 
body weight )
Percentage change in:
Liver
weight
Aromatic
hydroxylase
Nitro
reductase
Glucuronyl
transferase
Cytochrome
P-450
Citral — - - — + 25
Borneol - . - - -
Terpineol - + 25 - - + 35
Limonene - , - + 20 - -
Carvone + 10 + 30 - - -
p-Ionone + 30 + 60 + 80 + 70 + 50
All parameters were determined for each terpenoid, but only significant 
differences are given in this table.
For detailed results see Tables A.26 - A.30 in the Appendix.
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3* Induction and inhibition of drug metabolism by methylenedioxyphenyl
and related, compounds
The duration of action and toxicity of many drugs in mammals and
of many insecticide chemicals in insects are greatly increased by
simultaneous administration with certain compounds containing the 
, <
methylenedioxyphenyl (l,3-benzodioxole) group. Such compounds prolong 
barbiturate-induced sleep in mammals (Fine and Molloy, 1964) and 
increase the toxicity of certain insecticidal chemicals (Bobbins, et al, 
1959) , and act as co-carcinogens with benzo-[a]-pyrene (Deome £t al , 
1949; Bischoff, 1957 and Falk £t al^ , 1955). They synergize the 
insecticidal activity of compounds of almost all classes, for example, 
pyrethroids, chlorinated hydrocarbons, organophosphorus compounds and 
carbamates (see Casida et al, 1966).
Certain of the compounds containing the methylenedioxyphenyl group^ 
for example safrole, are widely distributed in nature. Safrole is the 
principal component (80fo) of oil of sassafras, the volatile oil obtained 
by steam distillation from root of sassafras albidum. It is a component 
of many other essential oils, for instance 90$ of the oil of Illicium 
parviflorum is safrole, and it is a minor component of such essential 
oils as nutmeg oil, cinnamon leaf oil, Californian laurel oil, American 
wormseed oil, star anise oil and camphor oil. It is thus a component 
of much naturally-derived flavouring material, as in root beer and
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sarsparilla, and is used as a flavouring agent in soft drinks and 
some dental and mouth wash preparations. Safrole is also present 
as a natural ingredient of sassafras tea (Power and Kleber, 1896).
Studies have been made on the toxicity of safrole and on its 
action as a synergist to insecticides, but very little work has been 
done pn the influence of safrole and related compounds on drug metabolism. 
Considering the wide use of this compound to investigation of its effects 
on the hepatic microsomal enzymes was considered desirable. Furthermore, 
to elucidate the mode of action of safrole the effects of its isomer 
iso-safrole, some other methylenedioxyphenyl derivatives such as piperonal, 
piperonyl alcohol, piperonylie acid, piperonyl acrylic -acid, piperine, 
and certain related compounds such as eugenol, allylbenz^ie and 
g,^-dihydroxy benzoic acid were studied (see Figure 3-2 for structures).
EXPERIMENTAL:
Different batches of black-hooded male rats (125-150 g. body weight) 
were selected for treating with each different compound. Each batch
Safrole was withdrawn from the market in the U.S.A. in I96I on the
basis of scientific work done by the Food and Drug Administration 
(F.D.A.) showing that it was a weak hepatic carcinogen (Long, E.L., 
Hansen, W.H. and Nelson, A.A.: Liver tumors produced in rats by 
feeding Safrole. Federation Proc. 20, 287, 196l).
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Figure 3.2
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of animals was randomly separated into two groups, kept separately and 
were allowed normal food and water ad libitum. One group was treated 
intraperitoneally with one of the methylenedioxyphenyl or related 
compounds once a day consecutively for three days while the other group 
received the vehicle only. The dose level for safrole and iso-safrole 
was 125 mg./kg. body weight, for allylbenzene two levels of 100 mg. /kg. 
and 150 mg./kg., while the other compounds were given at a dose level of 
150 mg./kg. body weight. Safrole, iso-safrole, piperonal, piperonyl 
alcohol, piperine, eugenol and allylbenzene were administered in ethyl 
oleate whereas piperonylic, piperonyl acrylic acid and 3,4-dihydroxy- 
benzoic acid were given in isotonic saline. Animals were killed 24 
hours after the last doses, the livers were removed, microsomal 
preparations were made and the drug-metabolizing enzymes were determined 
in the manner described in Chapter II (Materials and Methods). The 
results are presented in Tables 3.7 and 3.8 and the details are given 
in Tables A.31-A.37 of the Appendix.
RESULTS:
Of the methylenedioxyphenyl compounds (see Table 3.7) safrole and 
iso-safrole markedly induce all the parameters studied and unlike p-ionone 
induce also the aromatic hydroxylation of biphenyl at the 2-position in 
addition to hydroxylation at the 4-position. Piperonyl acrylic acid
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produced an increase only in p-nitrohenzoic acid reductase (45$); 
and piperine produced an increase in liver weight (10$), p-nitro- 
benzoic acid reductase (30$) and glucuronosyl transferase (35$) , 
whereas piperonal, piperonylic acid and piperonyl alcohol produced 
no significant change in any of the parameters studied.
Of the safrole-related compounds (see Table 3.8), eugenol 
produced an increase only in p-nitrobenzoic acid reductase (20$), 
and allylbenzene produced an increase in p-nitrobenzoic acid 
reductase (35$), cytochrome P-450 (25$) and microsomal protein (20$), 
whereas 3 ,4-dihydroxybenzene produced no significant change in any
s
of the parameters studied.
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4. Strain differences in the inductive effects of P-ionone and safrole*
The activities of hepatic microsomal NADPH-dependent enzymes 
involved in the metabolism of steroids, drugs and other foreign compounds 
are influenced by a variety of factors including animal species, sex, age, 
endocrine and nutritional status, and drug-pretreatment etc. (Conney 
and B u m s ,  1962). Jay (1955) comparing twelve strains of mice reported 
highly significant differences in hexobarbital sleeping time. These 
differences were subsequently confirmed by Vessel (1968) and were found
to correlate with differences in microsomal enzyme activity. Quinn et al
• |
(1958) showed that various strains of rats metabolize antipyrine at 
markedly different rates. The Gunn strain of wistar rats cannot form 
O-glucuronides of foreign compounds and bilirubin (Axelrod et al, 1957; 
Schmid ejb al, 1958), but does form N-glucuronides (Arias, 1961). The 
extent of metabolism of 2—naphbhylamine into 2-amino~l-naphthol and its 
conjugates varies in different strains of mice (Dewhurst, 1963).
Cram eib al (l96S>) studying six strains of rabbits, found marked differences 
both in the basal levels of drug-metabolizing activity and in responsiveness 
to the enzyme inducer, phenobarbitone. It was therefore thought desirable 
to determine in at least one more strain of rat the normal activities 
of the drug-metabolizing enzymes studied earlier (see Tables 3.1 - 3.8) 
in black hooded rats, and also to investigate the inductive effects of 
administration of p-ionone and safrole on these enzymes.
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EXPERIMENTAL:
. Materials and methods of enzyme assay for this study were in 
general the same as described in Chapter II (Materials and Methods).
The animals used were, however, of two strains, namely black-hooded 
rats and Wistar albino rats but of the same sex (male). Nine rats 
(125-150 g.) of each strain were selected, randomly divided into six 
groups of three, each group being kept in a separate cage. The 
animals were allowed normal food and water ad libitum. One group 
of each strain of rats were treated intraoperitoneally with p-ionone 
at a dose level of 150 mg./kg. body weight once a day consecutively 
for 3 days; two similar groups of rats were treated with safrole at 
a dose level of 125 mg./kg., and the other two groups of rats received 
vehicle only in a similar manner. All the animals were killed 24 hours 
after the last dose, the livers were removed, microsomal preparations 
made and the drug-metabolizing enzymes determined as described earlier.
RESULTS: .
It may be seen (see Tables 3.9 and 3.10) that the normal liver 
weights and the normal activities of drug-metabolizing enzymes studied 
are very similar in the two different strains of rats except that the 
cytochrome P-450 content is about 25$ higher in the black hooded rats 
than in the Wistar albino rats. The changes produced (see Tables 3.9 
and 3. 10) in the liver weight and the different hepatic microsomal 
enzyme levels on pretreatment of the two strains of rats with p-ionone
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or safrole, are also of the same order, except that glucuronyl 
transferase is induced to a slightly greater extent, by both p-ionone 
and safrole, in the Wistar albino rats (see Table 3.10).
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5# Species differences in the inductive effects of fi-ionone and safrole
It is well known that there are variations in the metabolism of a 
number of drugs in different species (Smith, 1968). With some drugs the 
differences are qualitative, but in many cases species differences are 
accounted for by variation in the rates of metabolism of drugs.
Muenzen at ad (1926) and subsequently Marshal et ad (1937) showed that 
dogs do not acetylate aromatic amines; cats are unahle to form 
glucuronide (Dutton et. al, 1957); guinea pigs do not appreciably 
acetylate S-cysteinyl derivatives, although they do acetylate aromatic
j
amines (Bray et ad, 1959); the cat, dog, hamster, mouse, rabbit and rat 
N~demethylate 2-acetamidefluorene, but the steppe lemmiijg and guinea pig 
do not (Weisberger et al, 1964); coumar.in is hydroxylated in the cat, 
coypoxi;, guinea pig, hamster and rabbit but not by the ferret, mouse and 
rat (Creaven ufc a l , 1965a).
Species differences in the induction of hepatic microsomal drug~ 
metabolizing enzymes by different inducing agentshave also been evidenced. 
DDT stimulates drug metabolism in the rat, but not in the mouse (Hart and 
Fouts, 1965). On the other hand, pyrene stimulated the metabolism of
3-methyl~4-methylaminoazobenzene in the mouse (Brown et al, 1954), but 
not in the rat (Brown ut al , 1954-; Conney et al, 1956). Nikethamide 
induces the hypnotic effect of phenobarbital in rats, rabbits and mice,
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probably by stimulating the metabolism of the barbiturate, but not in 
guinea pigs (Brazda et_ al^ , 1965). Tolbutamide stimulates the oxidation of 
hexobarbital in rats, rabbits, and dogs, but increases the rate of its own 
metabolism only in dogs which species metabolize tolbutamide by 
N-dealkylation, whereas the other species use different enzymes for 
its bi©transformation which are not stimulated by tolbutamide (Remmer 
et al, 1964).
The present work with rats has confirmed that biphenyl is largely 
metabolized by hydroxylation, p-nitrobenzoic acid by reduction, and
4—methylumbelliferone by glucuronide formation, and has further shown 
that the enzymes involved in these reactions are induced by j3~ionone 
(see Table 3.1) and safrole (see Table 3.7). It was therefore thought 
desirable to investigate these different enzymic reactions and the 
inductive effects of {3-ionone and safrole in other species. Hence 
studies were made using the rat, rabbit and mouse for observing any 
species difference. .
EXPERIMINTAL:
Three groups of each species of animals (male) were selected 
and the nine groups were kept in separate cages with normal access to 
food and water aH libitum. One group of animals of each species was 
treated by intraperitoneal injection with p-ionone at a dose level of
126
150 mg./kg. body weight once a day consecutively for three days.
Three other groups were treated with safrole at a dose of 125 mg./kg. 
in a similar manner, while the remaining three groups received the 
vehicle only. Twenty-four hours after the last dose the animals were 
killed, the livers were removed, and in the case of rabbits, carefully 
freed from the gall bladder. Portions of rabbit livers, the whole 
livers of rats, and the pooled livers from two mice were homogenised 
and centrifuged separately for making the microsomal preparations#
The drug metabolizing enzymes were determined as described in Chapter 
II (Materials and Methods).
RESULTS:'
It can be seen (see Tables 3.11 and 3.12) that all the liver 
parameters namely, biphenyl-4 and 2-hydroxylases, p-nitrobenzoic acid 
reductase, glucuronyl transferase, cytochrome P-450 and microsomal 
protein are of the same order in the normal (untreated) rat and rabbit, 
but both biphenyl—4 and 2-hydroxylase activities are higher in the 
mouse than in the rat and rabbit although the cytochrome P-450 level 
is of the same order in all the three species.
P-Ionone administration (see Tables 3.11 and 3.12) did not produce 
any significant change in biphenyl-2-hydroxylase activity of any of 
the three species, nor did it stimulate the bipheny1-4-hydroxylase
activity in the mouse, although there was a slight increase (20$) 
in cytochrome P—450 in this species* In the rat and rabbit,'however, 
the parameters including biphenyl-4-hydroxylase, p-nitrobenzoic acid 
reductase, glucuronyl transferase, and cytochrome P-450 were induced 
by {3-ionone in a similar fashion. In the rat there was a parallel 
increase in the liver weight and microsomal protein content after 
P-ionone administration. Although there was increased activity of 
different enzymes after p-ionone administration in the rabbit, there 
was no significant change in either liver weight or microsomal protein 
content*
Safrole administration (see Tables 3.13 and. 3.14) however, gave 
altogether a different picture. Bipheny1-4-hydroxylase was induced 
(30$) in the rat, but both in the rabbit and mouse this enzyme activity 
was inhibited (20— 50$). Bipheny1-2-hydroxylase activity was induced 
extensively (600$) in the rat and significantly (30$) in the mouse, 
but was inhibited (70$) in the rabbit. p-Nitrobenzoic acid reductase 
was also more induced (100$) in the rat than in the rabbit (45$). 
Conversely glucuronyl transferase was more induced (105$) in the 
rabbit than in the rat (65$). Cytochrome P-450 induction by safrole 
was, however, of the sans order (90-110$) in the rat and rabbit, but 
to a lesser extent in the mouse. Increases in liver weight and
microsomal protein content in the rat were parallel, but in the rabbit 
although microsomal protein .increased considerably (30$) there was no 
appreciable change in the liver Weight.
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Physiological Factors
1. Effect of age on induction'by -
3-Ionone and safrole
Foetal and. newborn animals have a limited capacity to metabolise 
drugs (jondorf et^  al_, 1958). From birth onwards most drug-metabolizing 
enzymes develop rapidly, reaching adult levels in about 30 days in rats
I
and then slightly decrease with age (Kato at al_, 1964^. The induction 
of these enzymes by various drugs and other chemicals also decrease
V
with the increase of age (Kato and Takanaka, 1968c). While the 
investigation was made to evaluate the influence of various anutrients 
on the different drug-metabolizing enzyme activities, rats were usually 
selected from the age group of 35-45 days on the consideration that these 
enzyme activities are by that time fully developed. Though a number of 
anutrient compounds were found to alter the activities of some, but not 
all of the enzymes studied (see Tables 3.1 - 3.8 in Chapter III), all the 
enzymes were markedly increased by p-ionone, safrole and iso-safrole when 
administered to rats of 35-45 days (see Tables 3.1 and 3.7, Chapter III).
Because of Kato and Takanaka's results it was thought necessary to 
study the influence of the age of the animal on the inductive effects of 
p-ionone, safrole and iso-safrole. Accordingly, the following experiments 
were carried out to investigate the normal activities of drug-metabolizing 
enzymes in black-hooded and in Wistar albino rats of different ages and 
the extent of induction after p-ionone and safrole pretreatment.
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a.) Black-hooded rats 
EXPERIMENTAL: . '
For this set of experiments six 27 day-old, black-hooded, male 
rats and another six of 45 day-old rats were selected, kept separately 
three to a cage and were allowed normal food and water ad libitum*
Three rats of each group were treated by intraperitoneal injection 
with p-ionone (in ethyl oleate: 75 mg/ml.) at a dose level of 150 mg/kg. 
body weight, once a day consecutively for three days, while the control 
animals received the vehicle only. Animals were killed 24 hours after 
the last injection, livers were removed and weights were noted; 
microsomal preparations were made and the drug-metabolizing enzymes 
were determined as described in Materials and Methods (Chapter II).
RESULTS:
The results (see Table 4.1) show that although the liver enlargement 
in mature and immature rats after p-ionone administration was of the same 
order, induction of the drug-metabolizing enzyme activities varies. 
Biphenyl-4-hydroxylase activity, which is normally higher in immature 
rats, (see Table A. 39 of Appendix), is induced to a greater extent in 
the mature ones; the hepatic microsomal cytochrome P-450 and protein 
content are also induced to a greater extent in the mature animals (see 
Table 4.1). Glucuronyl transferase activity is of the same order (see 
Table A.39) in the two age groups of rats, and is also induced by p-ionone
T
a
b
l
e
P
P
CQ 
-P 
3 
3
3
rH
3
a
3
3
3o
o
,3
Js
oa
o
3
3
pa
3
o
3
3
p
.3
a
po
p
3<ya
p
3
o
3
p
3
3
3
PO
Po
3
P
P
W
TO
rH
3
r*
3
rH
N
3
3
b£
3•HN
•H
rH
O
P
3
P
3
f
b£
3
3
3
o
•H
P
3
3
3
rO
3
P
P
3o
3
3o
30
•rH
1co.
3
3
bj)
Po
•
3'
bD
3
3
P
3
o
3
3
3
3
I  aTO -H 
O 3 
3 P 
O O 
•H 3 
S 3
3
aO
3
P
o o
o in
p 3
1
o 3
3
rH TO
3 3 
O 3 
3 P 
3 TO 
O 3 
3 3 
rH 3 
O  P
3
TO
3 
I P
O 3
3 3 
P 3  
•H 3
iz; ^
1 3
3 TO
1 3
rH rH
kH b3
3 o
P 3
3  'O
•H >>PQ P
P p .  
O £ P
0 3 ^
•H 3' > 3  
H O
Ph H P
p
,3'--'
>> feD *3 -h a
O 3 bD pq Ssw'
O
rH
+
p
CM
co
CO
in
CO
CO
CO
CO
3
o
co
t-
00
a
CM s
+
in
tH
+
o
t-
I
CM
CO
in
in
co
M
•H
3
3
3
3
«§*
3
P
P
P
O
05
CO%
"<
3
8
00
CO
to
3
rH
P
3
Eh
3
*H
3
3
i>
•H
biD
3
3
3
TO
P
rH
3TO
3
3
•■3
3
rH
•H
3
P
&
3 TO
fe*
33
b-
CM
in
3
138
to a greater extent in the mature rats (see Table 4.1). On the other 
hand nitro-reduetase, which has a normal level of activity lower in 
immature rats, is more stimulated by p-ionone in the immature than 
in the mature ones (see Table 4.1).
b) Wistar rats
EXPERIMENTAL:
For these experiments six groups of Wistar albino male rats’of 
22, 35, 64, 132, 160 and 334 days old were selected. Two rats each of 
the different groups were treated with p-ionone (in ethyl oleate:
75 mg/ml.) at a dose level of 150 mg/kg. body weight; another similar 
batch from the different groups were treated with safrole (in ethyl 
oleate: 62.5 mg/ml.) at a dose level of 125 mg/kg. body weight, while 
a third batch received the vehicle only. Treatment was by intraperitoneal 
injection once a day consecutively for three days. Throughout the period 
of treatment the animals of different age and pretreatment were kept 
separately and were allowed normal food and water ad libitum. Twenty 
four hours after the last dose the animals were killed, livers were 
removed and weights noted, microsomal preparations were made and drug- 
metabolizing enzymes were determined as described in Methods and Materials 
(Chapter II).
RESULTS:
The results are presented in Tables 4.2 - 4.4 details of which
139
are given in the Tables A.40 - A.52 of the Ap'pendix.
It appears (see Table 4.2) that liver size and weight per 100 gm. 
body weight are of the same order in the normal (untreated) rats Up to 
a certain age and then gradually decrease proportionally with the increase 
of body weight. The normal biphenyl-4- and 2-hydroxylase activities are 
higher in the premature period and gradually decrease with age, the 
2-hydroxylation activity being completely abolished at the age of 64 
days. The normal level of nitro-reductase, on the other hand, is lower 
in the premature period, as in the black-hooded rats. Similarly, the 
normal microsomal cytochrome P-450 content is also lower in the premature 
period, and does not decrease with age. Normal hepatic microsomal 
cytochrome b^ content is almost of the same order in rats of all ages; 
and the microsomal protein content similarly shows little variation with 
age.
Treatment with p-ionone causes liver enlargement to the same extent 
in rats of different ages up to maturity and thereafter causes less 
hypertrophy with increase of age (see Table 4.3). After p-ionone 
administration (see Table 4.3) bipheny1-4-hydroxylase activity which is 
normally lower in mature rats is induced to a greater extent in mature 
than in immature ones, but with further increase of age the inductive 
effect generally decreases. Conversely, the rate of induction of 
nitro-reductase activity which is normally lower in immature rats, is
140
much greater in immature (see Tahle 4.3) than*in mature rats. Although 
the inductive effect declines with increase .of age (see Table 4.3), 
normal activity remains unaffected by ageing (see Table 4.2). The 
increase in cytochrome P-450 concentration after p-ionone treatment 
is higher in mature than in immature rats and the rate of induction is 
only slightly decreased with increase of age (see Table 4.3). The 
increase in cytochrome bg concentration (see Table 4.3) after p-ionone 
administration is, as with untreated rats, of a similar order in animals 
of different ages. The effect of age on the p-ionone induction of 
hepatic microsomal protein is also insignificant.
The increase in liver size after safrole treatment (see Table 4.4) 
is also of the same order until maturity is attained and thereafter 
gradually declines. After safrole administration (see Table 4.4) 
biphenyl-4- and 2-hydroxylase activities are induced to approximately 
the same absolute levels of activity in 22 and 35 day-old rats. The
4-hydroxylase activity shows inhibition not induction after the 
pretreatment of older rats; and 2-hydroxylation activity is increased 
in pretreated older rats to approximately the same absolute level 
that is found in untreated 35 day-old animals. Induction of nitro­
reductase activity (see Table 4.4) is twice as great in the immature 
rats than in the mature ones and this inductive effect further declines 
with increase of age. Induction of cytochrome P-450 (see Table 4.4)
is almost of the same order in mature and immature rats, hut with 
the increase of age the inductive effect declines. Induction of 
hepatic microsomal cytochrome bg is of the same order in mature and 
immature rats, and with ageing induction does not decline as much 
as cytochrome P-450. The safrole-induced increase in microsomal 
protein is also more in mature than in the immature rats and with 
ageing this inductive effect is not much affected (see Table 4.4).
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2. Sex differences in induction by (3-ionone, safrole, 
iso-safrole and phenobarbitone
It has long been known that there is a sex difference in the 
response of rats to treatment of drugs, i.e. male rats are more 
resistant to the effects of several drugs than female rats (Nicholas 
and Barton, 1932; Hoick e4 al, 1937). This difference in response 
is due to a higher rate of drug metabolism in the livers of male rats 
(Robiland et al , 1954) associated with an increased activity of the 
hydroxylating microsomal enzyme system (Quinn. et al_, 1954; Davison,
1955; Axelrod, 1956; Quinn ejb al^ , 1958; Remmer, 1958; Kato et al,
1962a). The higher drug-oxidizing activity seen in the liver microsomal 
fraction of male rats appears to be due to an androgenic effect, since 
Murphy and Dubois (1958) have shown that castration of male rats decreases 
the rate of metabolism of Guthion, while administration of testosterone 
to female rats enhances the metabolism of Guthion (Murphy and Dubois,
1958) and hexobarbital (Quinn et al, 1954). Kato and Gillette (1965a) 
and Schmidt-Volkmar*(1966) have shown that the sex-dependent difference 
of drug metabolism disappears during starvation of rats; drug oxidizing 
activity is increased in liver microsomes prepared from starved female 
rats and decreased in the liver microsomes isolated from starved male 
rats. It was shown by Remmer and Alsleben (1958) that a similar effect 
occurs upon treatment of rats with morphine. Administration of morphine 
increases the in vitro drug oxidation rate by liver microsomes of female
146
rats, but has the opposite effect on microsomes of male rats (Remmer 
and Alsleben, 1958)# In addition, Kato and Gillette (1965b) have shown 
that treatment of rats with different hormones affects the enzyme 
activity of microsomes prepared from male rat liver, but not from 
female rat liver#
y
Not all drugs, however, are oxidized at a faster rate, by microsomes^ 
isolated from male rat liver. For example, Kato and Gillette (1965b) 
found no sex difference in the metabolism of aniline and zoxazolamine.
In addition they found that various treatment of rats, such as starvation
.  ■  ' i
or hormone administration, which affect the metabolism of many drugs in 
the male animal were without effect on the metabolism of aniline and 
zoxazolamine (Kato and Gillette, 1965b).
With these observations in mind it was thought desirable to 
investigate whether or not the drug-metabolizing systems which have 
been studied in this work exhibit any sex differences, and in addition 
whether the induction of these enzymes (see Tables 3.1 and 3.7, Chapter 
III) exhibit sex differences.
a) {3-Ionone in rats
EXPERIMENTAL
For these experiments black-hooded 12 male (115-135 gm.) and 12 
female rats (90-110 gm.) of the same age (40 days) were used. Male and
147
female control and treated animals were kept separately and were 
allowed normal food and water ad libitum. Six male and six female 
rats were treated intraperitoneally with p-ionone at a dose level of 
150 mg./kg. body weight once every day consecutively for three days.
Two other groups of six male and female rats received.the vehicle.
«r
All the animals were killed 24 hours after the last injection, liver 
weights were noted and drug-metabolizing enzymes were determined as 
described in Chapter II (Materials and Methods)•
RESULTS; '
The results (see figures in parentheses in Table 4.5) show that all 
the parameters such as nitro-reductase, glucuronosyl transferase, 
microsomal protein level are of the same order in the male and female 
rats but aromatic hydroxylase activity and cytochrome P-450 content are 
slightly higher in male rats than in female rats. Upon treatment with 
P-ionone, however, biphenyl-4-hydroxylase activity is induced more in 
female than in the male so that this hydroxylase activity in the female 
now exceeds the induced level in male rats; but cytochrome P-450 which 
is considered to be a rate-limiting factor in hydroxylation is induced 
less in the female than in the male (see Table 4.5).
b) Safrole in rats
EXPERIMENTAL:
For these experiments black-hooded 6 male (130-160 gm.) and 6 
female rats (110-125 gm.) of same age (47 days) were used. Treated and
148
control male and female rats were kept separately and were allowed
normal food and water ad libitum. Three male and three female rats
were treated intraperitoneally with safrole at a dose level of 125
mg./kg. body weight once every day consecutively for 3 days and two
other groups received the vehicle. All the animals were killed 24 
*
hours after the last injection, liver weights were recorded and drug- 
metabolizing enzymes were determined as described before.
RESULTS: .
The results (see Table 4.5) show that safrole induces liver 
enlargement and microsomal protein content to the same order in male 
and female rats; cytochrome P—450 and bipheny1-4-hydroxylase activity 
are induced more in male, but the rate of reduction and conjugation 
and biphenyl-2-hydroxylation are induced more in the female.
c) Phenobarbitone in rats 
As it was observed that there is a marked sex specificity in the 
induction effect of p-ionone on the biphenyl-4-hydroxylase activity 
(see Table 4.5), it was considered desirable to investigate whether 
phenobarbitone which has similar inductive effects to p-ionone on this 
enzyme in males, would also show a sex difference.
EXPERIMENTAL:
For these experiments six male (130-155 gm.) and six female rats 
(115-130 gm.) of same age (45 days) were used. Three male and three
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female rats were given i.p. injections of phenobarbital sodium at a 
dose level of 50 mg./kg.' body weight in isotonic saline (25 mg./ml.) 
once a day consecutively for 3 days and the control rats received the 
vehicle. Animals were killed 24 hours after the last dose, liver 
weights were noted and drug-metabolizing enzymes were determined as 
described in Materials and Methods (Chapter II).
.RESULTS: .
The results (see Table 4.5) show that induction of biphenyl-4- 
hydroxylase activity by the microsomes prepared from phenobarbitone 
treated male or female rats is of the same order, although cytochrome 
P-450 is induced more in the male rats.
These findings suggest that the mechanism of induction of at 
least one enzyme, namely, biphenyl-4-hydroxylase, differs with different 
inducing agents; for with (3-ionone the enzyme is more induced in the 
female, with safrole it is induced more in the male, and with 
phenobarbitone induction is of the same order in both sexes.
d) P-Ionone, safrole and iso-safrole in mice 
EXPERIMENTAL:
Four groups each of male and female mice were taken. Different 
groups were treated intraperitoneally with (3-ionone (150 mg./kg.), 
safrole (125 mg./kg.), or iso-safrole (125 mg./kg.), and control groups 
were given the vehicle only once a day consecutively for three days.
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The mice were killed 24 hours after the last injection and liver from 
two mice were pooled for each sample. Liver microsomal preparations 
were made and the hiphenyl-4- and 2-hydroxylase activities and the 
cytochrome P-450 content were determined as described before in 
Chapter II (Materials and Methods).
RESULTS: .
It appears from the results that biphenyl-4- and 2-hydroxylation 
activities are comparatively higher in both male and female mice 
(see Table 4.6) than in male and female rats (see Table 4.5), although 
the cytochrome P-450 content in both sexes: of mice is of the same order 
as in rats. As regards the influence of J3-ionone, safrole and iso-safrole 
in mice (see Table 4.6), cytochrome P-450 was induced also in this species 
the extent depending on the inducer used and the sex of the animal; 
(3-ionone induced only about 10$ in the male , but about 120$ in the 
female; induction by safrole was almost of the same order (35-40$) in 
both male and female mice; whereas iso-safrole induced about 115$ in 
the male and about 165$ in the female. Biphenyl-4-hydroxylase activity, 
however, was induced (40$) after p-ionone administration in female mice 
without having significant effect in males, but it was inhibited (25$) 
by safrole and iso-safrole pretreatment in both male and female mice. 
Biphenyl-2-hydroxylase activity on the other hand was induced (25-50$) 
by both safrole and iso-safrole administration in either sex although 
to a lesser extent, and was rather inhibited in both male and female mice 
by p-ionone (l5-55$)•
152
Table 4*6
Effect of pretreatment of male and female mice 
with {3-ionone, safrole and iso-safrole on the 
different liver parameters
Treatment Sex
■X-
Percentage change in:
Cytochrome
P-450
Biphenyl-4-
hydroxylase
Bipheny1-2- 
hydroxylase
p-ionone
Male + 1 2  (26)^ n.s. (8,2) - 13 (0.55)
Female +118 (17) + 42 (4.5) - 57 (0.5l)
Safrole .
Male + 35 - 24 '- + 24
Female + 41 - 24 + 47
Iso-safrole
Male + 115 - 38 + 64
Female + 165 - 18 + 65
■¥?
For detailed results see Tables A.58-A.60 in the Appendix.
^The figures in parentheses are values for untreated animals, and 
are expressed as [Jmole product/g.liver/hr. for the two enzyme 
activities, and as mpmole/g.liver for cytochrome P-450.
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3. Effect of different doses of p-ionone and safrole 
on the drug-metabolizing enzyme levels 
of rat liver microsomes
Y/hile investigating the inductive effects of p-ionone and safrole 
on the drug-metabolizing enzymes, the dose levels used were respectively 
150 mg,/kg, and 125 mg./kg, body weight, as already mentioned in 
Chapter III. Both p-ionone and safrole treatment of rats at the 
above dose levels were found capable of inducing all the enzymes studied 
to variable extents (see Tables 3.1 and 3.7). It was, therefore, thought . 
desirable to examine the effects of varying the doses of these inducing 
agents, Furthermore, it has been observed that inductive effect of 
p-ionone on aromatic hydroxylase activity is much higher in females 
than in males, which is not the case with safrole (see Table 4.5).
Hence the effect of different doses of p-ionone was examined in rats of 
both sexes and that of safrole in males only.
EXPERIMENTAL:
For the former set of experiments male and female black-hooded 
rats (120-140 gm.) were used; for the other set (safrole treatment) 
only male rats of this strain were used. Rats we re maintained as 
described earlier for other experiments. Different groups of rats were 
treated by a single intraperitoneal injection (0.2 ral./lOO gm. body weight) 
of different doses of p-ionone and safrole as given in the respective 
tables of- results, p-Ionone-treated rats were killed 24 hours aftesr
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dosing, whereas safrole-treated rats were killed after different periods 
as indicated in Tables 4.8 and A.63 - A.66. The levels of hepatic 
microsomal aromatic hydroxylase and cytochrome P-450 were determined 
as described in Materials and Methods (Chapter II).
RESULTS:
*
The results concerning p-ionone are presented in Table 4.7 and 
Figure 4.1, the details of which are given in Tables A.61 and A.62 
of the Appendix; and the results concerning safrole are presented in 
Table 4.8, the details of which are given in Tables A.63 - A. 66 in the 
Appendix.
The induction of both aromatic hydroxylase and cytochrome P-450 
increases with the dose of p-ionone (see Table 4.7) the maximum effect 
being produced with a dose of 150-200 mg./kg. body weight. Moreover, 
the induction of aromatic hydroxylase in females is greater than in 
males at all levels of p-ionone administered (see Table 4.7).
In the male rat induction of this enzyme by p-ionone does not occur 
at doses of less than 100 mg./kg., whereas with the female rat a dose 
of 100 mg,/kg. produces induction of more than 100$ and even a dose of 
10 mg./kg, results in 30$ increase in activity (see Table 4.7 and 
Figure 4.1). The induction of cytochrome P-450, however, is 
approximately of the same order in both the males and the females.
Reimner and Marker (1965) and Orrenius and Eras ter (1964) found that
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the activity of the liver microsomal drug oxidizing enzyme system 
paralleled the microsomal cytochrome P-450 both in content and in 
the time-course of induction after treatment of rats of both sexes 
with phenobarbital. The results of the present experiment also show- 
some correlation between biphenyl-4-hydroxylase activity and the 
content of cytochrome P-450 in untreated male and female rats; but 
after pretreatment with p-ionone the female shows a greater increase 
in the hydroxylase.than in the cytochrome P-450, whereas the male 
still shows a close correlation between these two parameters. The 
controlling factor for this excessive induction of hydroxylase 
activity in females seems to be something other than cytochrome P-450 
and is possibly due to sex differences in the induction of some other 
enzyme involved, e.g. cytochrome P-450 reductase, or to differences in 
the membrane environment.
The effect of variation of the dose of safrole on the biphenyl 
hydroxylation is bimodal. As has already been described in Chapter III, 
safrole pretreatment for 3 days at a dose level of 125 mg./kg. body weight 
causes induction of biphenyl hydroxylation both at -4 and -2 positions 
(see Table 3.7 in Chapter III) and it will be shown later in this chapter 
that treatment with safrole at the above dose level for 24 hours also 
causes induction of hydroxylation at both the positions. Treatment for 
different periods within 24 hours with doses lower or higher than 125 mg./kg. 
body weight, however, gives a different picture (see Table 4.8). Treatment
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with any dose from 12.5 to 500 mg./kg. body weight for any period 
between 1 to 6 hours causes inhibition of biphenyl hydroxylation at 
-4 position. 'However, after 24 hours this activity has been found 
to be induced with a dose level of 12.5-100 mg./kg. body weight 
but again with higher doses this induction effect is decreased and 
above 100 mg./kg. inhibition still occurs (see Table 4.8). 
Hydroxylation at the 2- position on the other hand was found to be 
induced with lower doses even within one hour after treatment. With
the increase of dose, however, induction effect is gradually decreased
i
i
during the first 3 hours, but after 3-4 hours this parameter is 
induced by any dose level of safrole from 12.5-500 mg./kg. body 
weight. Jaffe £t aly (1969) found that piperonyl butoxide which is 
a synthetic methylenedioxyphenyl derivative, and is widely used as a 
synergist with various pesticides, also produces a bimodal effect in 
the 2- and 4-hydroxylation of biphenyl by male mice liver microsomes. 
Hence it appears that the methylenedioxyphenyl compounds including 
piperonyl butoxide and safrole exhibit a bimodal effect on aromatic 
hydroxylation.
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Fig. 4.1. Effect of different doses of p-ionone on hepatic
biplieny 1-4-hydroxylase activity in male and female
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4. Biphasic effects of g-ionone and safrole 
treatment of rats
Nearly all drags and chemicals known to he inducers of the, 
drug-metabolizing enzymes are lipid-soluble molecules, capable of 
penetrating the microsomes and acting as substrates of these enzymes. 
Many of these compounds have been shown to exert a biphasic effect on 
drug metabolism, giving rise to competitive inhibition during the 
first 6 hours and then to induction after 12 hours or so (Brazda and 
Baucum, 1961; Kat© et/al, 1962; Kato _et aJ, 1964; Remmer, 1962a;
Remmer, 1962b; Ruoke, 1963; Serrone and Eujimoto, I96l]r. Compounds 
that have been shown to exert a biphasic effect on drug metabolism, 
or duration of drug action, include chlorocyclizine, glutethimide, 
nikethamide, tolbutamide, trimethadione, mesantoin, N-methyl-3-piperidyl 
diphenyl carbamate (SKF 525-A). On the other hand, phenobarbital (Kato 
et al, 1964) and 3-methylcholanthrene (Conney et al, 1956) have little 
or no inhibitory effect on drug metabolism in rats, but both compounds 
are lipid soluble and Ernster and Orrenius (1965) have shown that 
after injection of phenobarbital into rats there is a rapid binding of 
this drug to liver microsomes.
{3-Ionone and safrole have been found to induce a number of drug- 
metabolizing enzymes and are also lipid soluble. The possibilities 
of these two compounds being capable of exhibiting a biphasic effect 
on drugs-metabolizing enzymes, have threfore been examined.
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EXPERIMENTAL:
For these experiments black-hooded male rats (100-150 gm.) were
used. The animals were maintained as described for other experiments.
For two sets of experiments different groups of rats were treated by i.
p. injection, with p-ionone at a dose level of 150 mg./kg. body 
*
weight and with safrole at a dose level of 125 mg./kg. body weight, 
at 0, 6, 12, 18, 21 and 23 hours* Groups of control animals received 
the vehicle only. All the animals were killed at 24 hours and hepatic 
microsomal aromatic hydroxylase activity and cytochrome P-450 content 
were determined as described previously in Chapter II (Materials and 
Methods).
RESULTS:
The results are presented in Table 4.9, in Figures 4.2 and 4.3 
and the details are given in Tables A.67 and A.68 of the Appendix.
It appears that both p-ionone and safrole immediately after 
administration inhibit both the aromatic hydroxylase activity and 
cytochrome P-450. Within 6 hours after p-ionone administration 
cytochrome P-450 is induced, and soon after, biphenyl-4-hydroxylase 
activity is also induced reaching the maximum value within 12 hours 
(see Table 4.9 and Figure 4.2). In the case of safrole, cytochrome 
P-450 and bipheny1-4-hydroxylase are inhibited until 6 hours after 
administration, and then gradually increase, reaching control values;
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after 18 hours; the biphenyl-2-hydroxylase activity, although 
inhibited during the first 1 or 2 hours of administration increases 
rapidly reaching normal activity within 4-5 hours and then increasing 
further to reach a maximum at 24 hours (see Table 4.9 and Figure 
4#3). These findings indicate that immediately after-treatment 
with p-ionone and safrole these substances bind with liver 
microsomes to form competitive substrates and their subsequent 
release varies according to the different drug-metabolizing 
enzymes»
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Fig. 4.2. Effect of different periods of p-ionone pretreatment 
on the hepatic cytochrome P-450 concentration and 
biphenyl-4-hydroxylase activity in rats.
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Fig.4.3. Effect of different periods of safrole pretreatment 
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5- Comparison of induction by p-ionone, safrole, 
phenobarbitone and 3-raethylcholanthrene
Inducers of drug-met abolozing enzymes are of at least two types, 
exemplified by phenobarbital and 3-methylcholanthrene (Conney, 1967)# 
Many compounds are similar to phenobarbital in stimulating varied 
pathways of metabolism by liver microsomes, including oxidation and 
reduction reaction's, glucuronide formation, and de-esterification.
In contrast, polycyclic aromatic hydrocarbons typified by 3-methyl­
cholanthrene and 3,4-benzpyrene, stimulate a more limited group of 
reactions. The differences between phenobarbital and polycyclic 
hydrocarbons have helped in the identification of several hydroxylating 
enzyme systems in liver microsomes (Conney et al,•1959; Conney et a l , 
I960). In rats or mice, 3,4-benzpyrene stimulates the 2-hydroxylation 
of biphenyl but not its 4-hydroxylation, whereas phenobarbital causes 
a large increase in the 4-hydroxylation but no increase in the
2-hydroxylation (Creaven and Parke, 1966). These findings suggest 
that separate enzyme systems catalyze the hydroxylation of biphenyl in; 
the 2— and 4-positions and that the syntheses of the two enzyme systems 
are under separate control, or that two different conformations of the 
same enzyme system are involved.
It is now established that p-ionone, safrole and iso-safrole 
(see Tables 3.1 and 3.7) are inducers of some drugpmetabolizing 
enzymes. It was, therefore, thought desirable to compare their 
stimulating effects qualitatively and quantitatively with those of
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phenobarbitone and 3-methylcholanthrene. Since p-ionone was found 
to induce 4-hydroxylation of biphenyl and not the 2-hydroxylation, 
the.pattern of change in hepatic microsomal bipheny1-4-hydroxylase, 
p—nitrobenzoic acid reductase, 4-methylumbelliferone (4-MU) glucuronosyl 
transferase activities, cytochrome P-450 and protein content after 
pretreatment of rats for 28 consecutive days with p-ionone and ' 
phenobarbitone were observed. As administration of safrole and
iso-safrole induced both 2- and 4-hydroxylation of biphenyl the
effects of chronic administration (15 consecutive days) of one of 
them, i.e. safrole, on the 2-hydroxylation of biphenyl, in addition 
to all the above liver parameters, were observed and compared with the 
effects of chronic administration of 3-methylcholanthrene.
a) Comparison of P-ionone with phenobarbitone 
EXPERIMENTAL:
For these experiments 96 black-hooded male rats (l00-125g.) were 
selected, randomly separated into four groups, kept 12 in a cage and
were allowed normal food and water ad libitum. The rats of one group
were treated with p-ionone at a dose of 150 mg./kg, body weight, 
intraperitoneally once every morning. Another group was given i.p., 
injection of phenobarbital sodium at a dose level of 50 mg./kg. body 
weight and the other two groups received separately the vehicles (ethyl 
oleate and isotonic saline), each for 28 consecutive days. After 1, 2,
168
3, 4, 7, 10, 14, 21 and 28 days of treatment two rats from each group 
were killed, livers were taken out and weighed, microsomal preparations 
were made and drug-metabolizing enzymes were determined as described 
earlier-in Chapter II (Materials and Methods).
EES TILTS: •
The results are presented in Figures 4.4 - 4.6 details of
which are given in Tables A.69 - A.80 in the Appendix. Although
hypertrophy of liver occurs and microsomal protein is increased after 
pretreatment with p-ionone the extent is much lower than is caused by 
phenobarbitone (see Figure 4.4). Hypertrophy after p-ionone 
administration increases slowly (10$) in 3-4 days and remains at the 
same level even after chronic pretreatment; phenobarbitone causes 
rapid liver hypertrophy which continues to increase slowly.on chronic 
administration. Increase in microsomal protein content in both cases 
is comparatively greater than the respective increases in liver size.
Biphenyl-4-hydroxylase activity (see Figure 4.5) is increased 
more than 60$ within one day after p-ionone administration. This 
activity fluctuates, increasing gradually to about 100$ above normal 
after 20 days and then slowly declines. After phenobarbitone (see 
Figure 4.5) this enzyme activity increases by 80$ within one day, 
fluctuates, and then remains constant at that level in spite of 
further treatment. Cytochrome P-450 (see Figure 4.5), however, is
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increased to the extent of 200$ within four days after pretreatment 
with phenobarbitone and then gradually declines in spite of continued 
treatment. With p-ionone the level of cytochrome P-450 increases 
(see Figure 4.5) slowly by some 80-90$, and remains more or less 
constant over 28 days.
* *
Although nitro-reductase is considerably induced at the initial 
stage of phenobarbital treatment (see Figure 4.6) this effect gradually 
decreases even after continued treatment. The induction of this 
enzyme after p-ionone treatment is of the order of 4-0-50$ for the 
first seven days increasing to more than 100$ at 25 days, after which 
it again decreases (see Figure 4.6). Glucuronyl transferase activity 
(see Figure 4.6) is induced more by p-ionone than by phenobarbital 
pretreatment.
b) Comparison of safrole with 3-methylcholanthrene 
EXPERIMENTAL:
For these experiments 36 black-hooded rats (100-115 g.) were 
selected, randomly separated into 3-groups of 12, kept in separate 
cages and were allowed normal food and w-ater ad libitum. One group 
was treated intraperitoneally with safrole at a dose level of 125 mg./kg. 
body weight once every day consecutively for 14 days. Another group 
was treated in a similar manner with 3-methylcholanthrene at a dose 
level of 20 mg./kg, body weight and the third group received the vehicle
173
(ethyl oleate) in a similar manner for the same period. After 1,3,
5, 7 and 14 days of treatment two rats of each group were killed, 
livers were removed and weighed, microsomal preparations were made 
and drug-metabolizing enzymes were determined as described in Chapter 
II (Materials and Methods).
RESULTS:
The results are presented in Figures 4.7 - 4.10 and the details 
are given in Tables A.81 - A.87 of the Appendix.
It has been observed that within one day after safrole treatment 
liver hypertrophy (25-30$) occurs, which after a fall during the 
next 2.-3 days, again increases to some 25$ above normal at seven days 
and thereafter gradually decreases (see Figure 4.7). After
3-methylcholanthrene treatment liver size increases during the first 
5-6 days reaching 25$ above controls and then gradually declines (see 
Figure 4.7) even after continued dosage. The microsomal protein (see 
Figure 4.7) after safrole treatment increases (20$) rapidly within 24 
hours and then slowly declines to some 15$ above normal after fourteen 
days continuous treatment. After 3-methylcholanthrene there is a very 
slow increase in microsomal protein reaching about 10$ above the 
normal in 5 days and thereafter remains constant despite further 
treatment (see Figure 4.7).
174
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Cytochrome P-450 (see Figure 4.8) after safrole treatment 
increases by some 100$ within the first two or three days and thereafter 
decreases to about 80$ above normal at 14 days. After 3-methylcholanthrene 
treatment cytochrome P-450 (see Figure 4.8) increases continuously to 
a level of 180$ above normal by the seventh day after which it gradually 
falls similar to the fall in liver weight, reaching 80$ above normal 
after 14 days.
Biphenyl-4-hydroxylase activity (see Figure 4.8) after 3-methyl- 
cholanthrene treatment remains unchanged for the first two days after 
which it is increased only slightly and after seven days again 
diminishes to the normal value. Hence the induction of this activity 
by 3-methylcholanthrene, even on continuous administration, is almost 
insignificant in comparison with the induction of cytochrome P-450 (see 
Figure 4.8). Safrole treatment on the other hand causes a gradual 
increase in biphenyl-4-hydroxylase activity (see Figure 4.8) which 
after 5 days closely parallels the increase in cytochrome P-450.
Biphenyl-2-hydroxylase activity (see Figure 4.9) is increased 
fifteen to twenty-fold within one day after treatment with 3-metliyl- 
cholanthrene, and after a temporary depression for 3-4 days rapidly 
increases again with continuous dosage (see Figure 4.9). Safrole 
treatment also causes an immediate increase (about ten-fold) of this 
enzyme but even after repeated dosage this enhanced activity gradually
decreases (see Figure 4.9). As stated above, although cytochrome P-450 
is greatly increased by 3-methylcholanthrene, biphenyl-4-hydroxylase 
activity is only slightly increased. Hydroxylation at the 2-position, 
however, is enormously increased and remains high in spite of the 
gradual decrease in cytochrome P-450 that occurs after seven days. 
Furthermore, although cytochrome P-450 is not increased to the .same 
extent by safrole treatment as it is by 3-methylcholanthrene, the
4-hydroxylation of biphenyl is increased more by safrole than by 
methylcholanthrene. Also the 2-hydroxylation is less induced by 
safrole than methylcholanthrene but in the case of safrole is comparable 
to the level of induction of cytochrome P-450.
Both p-nitrobenzoic acid reductase and 4-methylumbelliferone 
glucuronyl transferase activities are gradually increased by treatment 
with safrole or 3-methylcholanthrene, reaching peak values in 3-7 days 
and remain high during the whole period (14 days) of treatment (see 
Figure 4. 10).
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Fig. 4.9. Effect of safrole and 3-methylcholanthrene
treatment on the hepatic biphenyl-2-hydroxylase 
activity'of rats..
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Chronic administration of coumarin
Feuer and Goldberg (1967) found that coumarin administration does 
not change the capacity for hydroxylation of nitroanisole, hexobarbitone, 
butylated hydroxy toluene and biphenyl although certain coumarin 
derivatives such as 6-methyl coumarin, 7-ethoxycoumarin-4-carboxylic 
acid and 6-acetyl-7-hydroxy-4-8-dimethylcoumarin strikingly induce the 
above enzyme activities. While carrying out these present experiments 
it was observed that after treatment of rats with coumarin for a short 
period of 3 days although the liver weight and nitro-reductase activity 
is increased, the cytochrome P-450 is decreased markedly (see Table 
3.5). It was therefore desirable to investigate the effects after 
treatment for longer periods.
EXPERIMENTAL:
For these experiments six hooded male rats (130-150 gm.) were 
selected, kept three in each cage and were allowed normal food and 
water ad libitum. One group was given i.p. injections of coumarin at 
a dose level of 150 mg./kg. body weight once every day consecutively 
for 15 days. The control animals received the vehicle in a similar i
manner. Twenty-four hours after the last dose the animals were killed, 
liver weight was recorded and drug-metabolizing emzymes were determined 
as described in Materials and Methods (Chapter II).
RESULTS:
The results (see Table 4,10) show that although liver weight did not
further change there was inhibition rather than induction of nitro­
reductase, a decrease in protein content (lO/), a marked inhibition 
of biphenyl-4-hydroxylase (more than 30^) and a further decrease in 
cytochrome P-450 content (,60ft) while glucuronyl transferase only 
was unaltered.
Table 4.10.
J
Effect of chronic pretreatment' of rats Tyith coumarin on the 
different liver parameters
Parameter Controls Pretreated
ft
Change
Liver weight (gm.) 5.5 + 0.1 (3) 6.1 + 0 (3) + 11
Bi ph e ny 1-4-hy dr oxy 1 as e 
pnoles/gm./hr. 4.2 + 0.1 (3) 2.8 + 0 . 3  (3) - 33
p-Nitrobenzoic acid 
reductase 
pmoles/gm./hr.
1.3 + 0.1 (3) 0.8 + 0.1 (3) - 38
4-MU-glucuronyl 
transferase 
pmoles/gm. /hr.
4 2 + 3  ■ (3) 45 + 3  (3) n.s.
Cytochrome P-450 
mpmoles/gni. liver 2 8 + 3  (3) 11 + 2 (3) - 61
Microsomal protein 
mg./gm. liver 31 + 1 (3) 2 8 + 2  (3) - 10
n.s. is written where the percentage change is'less than the 
limits of significance.
/ Period of treatment was 15 days.
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7. Effect of nutritional status on induction 
by g-ionone and safrole
It is well known that dietary conditions have a great influence 
on drug metabolism. It is also known that starvation depresses hepatic 
microsomal drug metabolism both in vivo and in vitro, and it is the 
oxidative pathways which are mainly affected. According to Dixon 
£t a l . (i960), there is an actual loss of microsomal enzyme protein 
during food deprivation. However, the picture has been complicated 
by the findings of Kato and Gillette (1965a; 1965b) who showed that 
in rats the effects of starvation depend on the sex of the animal j 
and on the drug substrate. Males show impairment of certain microsomal 
enzymes during starvation, while females show the opposite effect#
During the course of this work it has been observed that the capacity 
for metabolizing drugs is lower in females than in males, but the 
induction effect of J3-ionone on the oxidative pathway of drug metabolism 
is higher in the female than in the male (see Table 4.5). All these 
observations and findings led me to investigate the influence of 
starvation on the normal activity of aromatic hydroxylase, nitro­
reductase, glucuronyl transferase and on the concentration of hepatic 
microsomal hemoproteinsj, cytochrome P-450 and cytochrome bg, and 
microsomal protein in the male and female rat. In addition the 
inductive effect of (3-ionone in starving male and female rats and that 
of safrole in starving male rats were also studied.
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EXPERIMENTAL: .
In the experiments concerning p-ionone induction, black-hooded 
male and female 45 day-old rats were used and in the other set of 
experiments concerning safrole induction 40 day-old male rats were 
used. The animals were maintained as described for other experiments. 
For p-ionone treatment, both male and female rats were separated into 
four groups each and their 'initial body weight was noted. Two male 
and female groups each were allowed normal food and water ad libitum, 
and the other two groups each were allowed no food but water only for 
72 hours. One group each of male and female well-fed and fasted rats 
were treated by intraperitoneal injection with p-ionone at a dose 
level of 150 mg./kg. body weight once a day consecutively for three 
days starting simultaneously with the onset of the dietary regulation. 
The other four groups received the vehicle in a similar manner.
For safrole treatment, the rats were separated into four groups 
of which two each were subjected to food deprivation and the remaining 
two were well fed. One group each of the different dietary conditions 
were treated with safrole at a dose level of 125 mg./kg. body weight. 
The period and manner of dietary regulation and pretreatment were the 
same as described in the case of p-ionone treatment above.
Before the animals were sacrificed 24 hours after the last dose, 
their final body weights were noted. After killing^the animals’ livers
184
were removed, weights were noted, microsomal preparations were made 
and drug-metabolizing enzymes were determined as described in Materials 
and Methods (Chapter II)
RESULTS:
The results concerning p-ionone treatment in starvation are 
presented in Tables 4.11 and 4.12 in this chapter and the details are 
given in Tables A.88 - A.91 of the Appendix; and the results concerning 
safrole treatment in starvation are presented in Tables 4.13 and 4.14 
the details of which are given in Tables A.92 - A.94 of the Appendix.
It is obvious that both the body weight and liver weight are 
markedly diminished in starvation. Food deprivation also causes 
increase in specific activity of aromatic hydroxylase and the 
concentrations of cytochrome P-450, cytochrome bg and microsomal 
protein per gram of liver, while the specific activity of nitro­
reductase is markedly reduced and that of glucuronyl transferase is 
not significantly changed in either sex; (see Tables 4.11 and 4.13).
With the total activities, nitro-reductase is decreased, glucuronyl 
transferase, cytochrome P-450, cytochrome bg and microsomal protein 
are also decreased, but there is no, significant change in the total 
activity of aromatic hydroxylase in either male or female rats (see 
Tables 4.12 and 4.14). It has been observed and shown before in
various experiments that p-ionone and safrole treatment of rats 
fed normally, cause induction of all the liver parameters studied 
(see Tables 3.1 and 3.7 in Chapter III). Treatment of the starved 
rats, however, with either compound prevents the extensive decrease 
in liver weight observed in untreated starved rats and caused more 
increase in the specific activities of aromatic hydroxylase and 
glucuronyl transferase and the concentration of cytochrome P-450, 
cytochrome bg and microsomal protein per gram of liver (see Tables 
4.11 and 4.13). However, the total activities of these parameters 
are proportionately less increased than in normal fed rats (see 
Tables 4.12 and 4,13).
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Some General Metabolic Effects
1, Stimulatory effect of P-ionone and safrole on 
carbohydrate metabolism
NADFH-dependent enzymes in liver microsomes metabolise not only 
drugs but also a variety of normal body substrates (Conney, 1967). 
Treatment of rats with polycyclic hydrocarbons, barbiturates and 
various other drugs, with completely unrelated chemical and 
pharmacological properties, which stimulate the hepatic drug- 
metabolizing enzymes also enhances the metabolism of glucose and 
galactose via the glucuronic acid pathway (hongeneeker et al, 1940; 
Conney and Burns, 1959; Burns ejfc ad, 1960; Conney et al, 1961a).
Larger amounts of D-glucuronic, L-gulonic and L-ascorbic acids are 
formed and ascorbic acid excretion in urine is commonly used as an 
index of this induction.
In view of the fact that p-ionone and safrole treatment cause 
induction of all the NADPH-dependent drug-metabolizing enzymes studied 
(see Chapter III) , these compounds might also have influence on the 
metabolism of glucose and galactose enhancing the excretion of ascorbic 
acid in urine.
EXPERIMENTAL:
To investigate any such effect, black-hooded male rats (140-155 g.) 
were maintained individually in metabolic cages and were allowed normal
191
food and water ad libitum* Urine was collected daily into 10 ml. 
of 12fo w/v metaphosphoric acid solution, made up to standard volume 
and assayed for ascorbic acid by the 2 ,6-dichlorophenol~indophenol 
titration method as described in Materials and Methods (Chapter II)• 
For three consecutive days the normal excretion of ascorbic acid by 
the rats was "ascertained after which the rats were treated separately 
with p-ionone (150 mg./kg.) or safrole (125 mg./kg.) by intraperitoneal 
injection once daily for three days. Urine was collected and ascorbic 
acid was assayed as stated above.
' ’ x
HESULTS:
The results (see Table 4.15) show that both p-ionone and safrole 
enhance the excretion of ascorbic acid markedly, which indicates that 
these two compounds also stimulate the metabolism of glucose and 
galactose through glucuronic acid pathway as do the barbiturates and 
polycyclic hydrocarbons.
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2. Hepatic changes induced by 3-ionone, safrole, iso-safrole 
phenobarbitone and 3-methylcholanthrene 
Phenobarbital, polycyclic hydrocarbons and a number of other drugs
and foreign chemicals which increase the liver microsomal enzyme levels
also stimulate the liver growth (Conney, 1967). There are, however,
chemicals such as chloroform and halothane which increase liver growth
without markedly enhancing liver microsomal enzyme activity (Kunte
ejfc al, 1966). It has been shown that a number of drugs including
phenobarbital increase liver growth in rats by stimulating liver
mitosis and cell division. The present work has shown (see Chapter h i )
that p-ionone, safrole and iso—safrole treatment cause enlargement of
the liver to the order of 10, 15 and 20 percent respectively above the
normal. For elucidation of the nature of this enlargement a comparative
study has been made with regard to the changes in whole liver protein,
microsomal protein, cytochrome P-450 and cytochrome b^ concentration
in rats treated with p-ionone, safrole or iso-safrole and rats treated
with phenobarbital or 3-methylcholanthrene.
EXPERIMENTAL:
For these experiments black-hooded rats (125-155 gm.) were used. 
Animals were maintained as described previously for other experiments. 
Groups of animals were treated with p-ionone, safrole, iso-safrole, 
phenobarbital and.3-methylcholanthrene at dose levels as indicated in 
the Tables 4.16 and 4.17 once a day consecutively for three days. 
Twenty-four hours ?»fter the last dose all the rats were killed and the
194
different liver parameters were determined as described in Materials 
and Methods (Chapter II).
RESULTS:
The results are presented in Tables 4.16 anc^ 4.17 ■ and-the details 
are given in Tables A.95 - A.98 of the Appendix. It shows (see Table 
4.16) that whole liver protein, microsomal protein, and the hemoproteins 
- cytochrome P-450 and cytochrome bg content expressed as per gram 
of liver, are all increased to varying extents in the case of each 
treatment, whereas the DNA content was rather lower than the normal 
except with p-ionone. When however expressed as ’per 100 g. body weight1 
(see Table 4. 17) the DNA content showed an increase in all the cas'es 
of treatment, the highest being with phenobarbitone. The increases 
in other parameters were proportional to liver enlargement in each 
case.
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o
3. Effect of 3-ionone, safrole, phenobarbitone and 5-methyl-
cholanthrene on the pharmacological activity 
of hexobarbitone
So far, with the exception of the investigation of the influence 
of (3-ionone and safrole on ascorbic acid excretion, all the studies 
have been concerned with the effect of these compounds on drug 
metabolism at the molecular level. It is obviously desirable to 
investigate these effects in the intact animals as well, and this 
has been done by studying the duration of pharmacological action of 
hexobarbitone.
The duration of narcosis following administration of hexobarbitone 
affords a convenient in vivo measure of hepatic microsomal enzyme 
function since the duration of action is primarily dependent on the 
rate of microsomal detoxication of the drug in the liver (Conney, 1967)#
The duration of action of hexobarbitone is much longer in adult 
female rats than in adult males (Quinn et al, 1958), a difference that 
only becomes apparent at the age of five to six weeks, when there is an 
abrupt decrease in the action of the drug in male rats due to increased 
activity of the hexobarbitone-metabolizing enzyme(s). It was therefore 
suggested that the male hormones were responsible for this change at 
puberty.
On the other hand, in the course of this work it has been observed 
that p-ionone treatment of rats and mice induces the aromatic hydroxylation
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(see Tables 4.5 and 4.6) more in the female than in the male. It has 
further been observed that continuous p-ionone treatment for longer 
periods causes a gradual increase in the induction of the aromatic 
hydroxylase activity in rats (see Figure 4.5). Besides this it has 
been observed that treatment of rats with safrole, a methylenedioxyphenyl 
compound, causes induction of aromatic hydroxy 1 at ion both at the 4- and
2-positions of biphenyl.
It was therefore of special interest to investigate the effect of 
treatment of male and female rats with p-ionone on the hexobarbitone- 
induced sleeping time. The effects of safrole, and of chronic treatment 
with p-ionone., phenobarbitone and 3-methylcholanthrene, on the hexo- 
barbitone-induced sleeping time were also investigated.
EXPERIMENTAL:
For these experiments black-hooded male rats were used. Sex, age 
and body weight of the animals are indicated in the respective tables 
of results. Animals were maintained throughout the course of treatment 
as described previously for other experiments. Treatment of groups of 
animals by intraperitoneal injection of solutions of p-ionone or safrole 
in ethyloleate was given once daily for three consecutive days. Chronic 
treatment with p~ionone, phenobarbitone and 3-methylcholanthrene was 
continued for 28 days. The dose levels of p-ionone, safrole, phenobarbitone 
and 3-methylcholanthrene used are indicated in the respective tables.
The control animals received only the vehicle. Hexobarbitone was
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administered as a solution of the sodium salt in water, prepared by 
dissolving hexobarbitone base (May and Baker) in an equivalent amount 
of sodium hydroxide solution freshly prepared for each experiment.
The duration of action of hexobarbitone, otherwise known as 
hexobarbitone sleeping time, was determined as follows. Bats were 
weighed immediately before dosing and given a dose (200 mg./kg.)' of 
hexobarbitone by intraperitoneal injection. In one experiment, however, 
the female rats were given a dose of 100 mg./kg. The time of injection 
was taken as the start of the sleeping time, although this was not 
strictly correct as the animal did not lose righting reflex until some 
two or three minutes later; However, it was impractical, especially 
when injecting large numbers of animals, to determine the point of 
loss of righting reflex accurately. Once the animal lost consciousness 
it was laid on its back on the bench under an electric lamp to keep warm. 
Buring the period of anaesthesia the tail of each animal was pinched every 
3-5 minutes until the righting reflex was restored# The righting reflex 
was considered to be restored when the animal could "right" itself
immediately three consecutive times after being laid on its back. The
■ /
difference between the time of injection and this time was taken as the 
hexobarbitone sleeping time. Hexobarbitone injection was given twenty- 
four hours after the last dose of J3-ionone, safrole, phenobarbitone and
3-methylcholanthrene.
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KESUI1TS:
It is observed that with a similar or even half the dose of 
hexobarbitone, sleeping time is more prolonged in the female than in 
the male (see Tables 4.18-4*20) which proably is due to the fact that 
the enzyme which metabolizes this drug is less active in females than 
in males as explained by Quinn al (1958). It is of course well 
known that the duration and intensity of drug action is often greater 
in the adult female rat than in the adult male (Poe at al, 1936;
Hoick etal_, 1937; Hoick, 1949).
It has been further observed that the duration and intensity of 
hypnotic action of hexobarbitone varies with age and in both male and 
female rats is greater in older rats than in young ones (see Table
4.19). This indicates that the hexobarbitone-metabolizing enzyme 
activity also decreases with increase of age, post-maturity, as has 
been observed with aromatic hydroxylase (see Table 4.5).
After p-ionone treatment of rats the hexobarbital-induced sleeping 
time is shortened both in the male and the female (see Tables 4.18 and
4.19). It indicates that the metabolism of hexobarbitone is induced 
as p-ionone has been found to induce several other drug-metabolizing 
enzymes (see Table 3.1). Furthermore, p-ionone treatment causes a 
greater decrease in the sleeping time in the female than in the male 
(see Tables 4.18 and 4.19) , irrespective of age. This again means that 
metabolism of hexobarbitone is induced more in the female than in the
201
male after p-ionone treatment. In other words p-ionone induces 
N-demethylation and hydroxylation of the cyclohexene ring - as well 
as aromatic hydroxylation (biphenyl) - at a higher rate in female than 
in male (see Table 4.5).
Safrole treatment on the other hand does not shorten the hexobarbital 
induced sleeping time at all in the male and not significantly in the 
female either (see Table 4.20) which shows that the hexobarbitone- 
metabolizing enzymes are not induced by safrole although this compound 
markedly induces aromatic hydroxylation (see Table 3.7). 3-Methylchol-
f
anthrene, a carcinogenic polycyclic hydrocarbon also does not shorten 
.the hexobarbital—induced sleeping time and after chronic treatment with 
the compound sleeping time is actually greatly prolonged (see Table 4.2l). 
This indicates that hexobarbitone metabolism is inhibited by chronic 
pretreatment with 3-methylcholanthrene although this carcinogen induces 
aromatic hydroxylation and many other enzymes studied (see Figures 4.8 
- 4.10). It has been found by Fine and Molloy (1964) that a number of 
methylenedioxyphenyl compounds inhibit the hypnotic action of barbiturates. 
It is also known that the methylenedioxyphenyl compounds act as co­
carcinogens and that safrole is a low grade hepatic carcinogen (Long 
et al, 1963; Hagan et^  al_, 1965). Hence the carcinogenicity may be 
somehow related to the inhibition of the metabolism of hexobarbitone.
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Hexobarbitone-induced sleeping time is comparatively more 
shortened by chronic treatment of p-ionone (see Table 4.21) than 
by treatment for shorter periods (see Tables4.18 and 4.19) which 
indicates that on continuous treatment with p-ionone the hexobarbital— 
metabolizing enzyme is gradually induced. This inductive effect 
is comparable to the inductive effect of chronic treatment with 
phenobarbitone on the hexobarbitone—induced sleeping time (see 
Table 4.21).
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Table 4*19.
Effect of pretreatment of male and female old and young rats with 
P-ionone on the hexobarbital ^ -induced sleeping time
Age
(days)
Sex
and
body weight 
(gnu)
4
Treatment7
Dose of 
hexobarbitone 
mg./kg. 
body weight*
Sleeping time 
(minutes)
$
control
47
male
150-185
Control 200 2 7 + 2  (4)+
P-ionone 
(150 mg./kg.
200 2 1 + 3  (3) 771*
female
120-140
Control 200 115 + 16 (5)
P-ionone 
'150 mg#/kgv
200 32 + 7 (5) to 00
152
male
400-460
Control 200 6 9 + 6  (3)
P-i onone 
'150 mg./kg)
200 5 6 + 5  (3) 81 $
female
250-290
Control 200 294 + 25 (3)
p-ionone 
[150 mg./kg.,
200 6 6 + 7  (3) 22fo
* Dose of hexobarbital was 200 mg./kg. body weight for both males and 
females.
/ Dose of p-ionone was 150 mg./kg. body weight, 
t Figures in parentheses indicate number of animals used.
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Investigation of Mechanisms
1. Effect of g-ionone, safrole and iso-safrole 
on the NAPPH^,- generating system
It is generally accepted that the drug-oxidizing enzymes in the 
hepatic endoplasmic reticulum require for their normal functioning 
the reduced coenzyme NADPH^j the NADP 
"being present in the soluble fraction. Thus, any alteration in the 
rate of production of this reduced coenzyme might be one of the factors 
responsible for an increase or decrease in activity of the drug- 
metabolizing enzymes after pretreatment of animals with different 
drugs and chemicals.
It was therefore thought desirable to investigate whether p-ionone, 
safrole and iso-safrole, which have been found to have an induction 
effect on aromatic hydroxylases (see Chater III) , have any influence on 
the production of NALPHg*
This was investigated by determining the enzyme activities after 
an interchange of the treated and untreated liver microsomes with the 
corresponding supernatant fractions, as follows*
EXPERIMENTAL;
Groups of rats were treated by intraperitoneal injection of p-ionone 
(150 mg./kg.), safrole (125 mg./leg.) and iso-safrole (125 mg./kg.) once
— >NADPIL generating system
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a day consecutively for three days while the ‘control groups received 
only the vehicle. Twenty-four hours after the last dose all the animals 
were killed, livers were removed, homogenized in three volumes of 1.15 
KC1 f/v). The liver homogenates of three each of J3-ionone», safrole- 
and iso-safrole—treated and control animals were pooled and centrifuged 
at 10,000 x g. for ten minutes. The supernatant obtained after similar 
centrifugation has so far been used in all the experiments for enzyme 
assay, but for this experiment the supernatant was further centrifuged 
at 100,000 x g. for one hour in order to separate the soluble fraction 
from the microsomes. The microsomes were then resuspended in the 
soluble fractions, the resultant constitution being as follows:
a) microsomes (treated} + soluble fraction (treated)
b) microsomes (control) + soluble fraction (control)
c) microsomes (treated) + soluble fraction (control)
d) microsomes (control) + soluble fraction (treated)
The temperature throughout was maintained at 0-5°« Biphenyl-4- 
and 2-hydroxylase activities were assayed with the reconstituted 
suspensions, the methods being as described in Materials and. Methods 
(Chapter II).
RESULTS:
Induction of the aromatic hydroxylases (see Table 4.22} were . 
observed with reconstituted suspensions consisting of p-ionone-safrole-7 
or iso-safrole-tre ted liver microsomes plus supernatant fractions of
the same livers, as has heen previously shown using the 10,000 x g. 
supernatants, but there was no induction with control rat liver 
microsomes plus p-ionone-, safrole- or iso-safrole-treated soluble 
fractions (see Table 4.22). On the other hand induction was observed 
with p-ionone-, safrole- or iso-safrole-treated liver microsomes plus 
the control soluble fraction (see Table 4.22), and the level of increased 
enzyme activity was similar to that of the treated microsomes plus 
treated supernatant.
These findings indicate that none of the drug-metabolizing 
inducers namely, p-ionone, safrole or iso-safrole, has any influence 
on the rate of production of NADPE^, since had there been any such 
effect the enzyme activity of the resuspension of control microsomes. 
plus treated soluble fraction should have been increased. The reasons 
for the slight increase in enzyme activity of the resuspension of 
P-ionone, safrole or iso-safrole-treated microsomes plus the control 
soluble fraction over that of the microsomes plus soluble fraction from « 
the same treated liver, could be due to the fact that control supernatant 
would not contain any p-ionone, safrole or iso-safrole wherease there 
might still be traces of these compounds present in the soluble fraction 
from the treated rats which would have some inhibitory effect on the 
enzymes.
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Table 4.22.
Effect of interchange of the supernatant and microsomal fractions of 
control rat liver with those of g-ionone, safrole and iso-safrole 
treated ones, on the aromatic hydroxylation of biphenyl*
Composition of Incubation 
Mixture*
Enzyme activity (pmoles/gm.liver/hr.
Biphenyl-4-
hydroxylase $change
Biphenyl-2-
hydroxylase
"t
change
Soluble (c) + Microsomes (c) 4*2 0.10
Soluble (b ) + Microsomes (b ) 5.8 + 38 0.10 0
Soluble (s) + Microsomes (s) 5.8 + 38 0.61 +510
Soluble (i) + Microsomes (i) 5.6 + 33 0.80 + 700
Soluble (C) + Microsomes (b ) 6.2 + 48 0.11 +10
Soluble (C) + Microsomes (s) 6.1 +- 45 0.75 + 650
Soluble (c) + Microsomes (i) 6.4 + 52 0.86 +760
Soluble (b ) + Microsomes (c) 4.0 - 5 0.10 0
Soluble (s) + Microsomes (c) 4.2 0 0.10 0
Soluble (i) + Microsomes (c) 3.9 - :j 0.06 , -4°
* The letters in parenthese indicate pretreatment with p-ionone (B]>, 
safrole (s), iso-safrole (i) and control (c).
The other components of the incubation mixture are as given in Chapter II*
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2. Effect of carbon monoxide on induction by B-ionone, 
safrole and iso-safrole
It is already known that carbon monoxide inhibits the metabolism
of drugs by microsomes of various species by forming a ligand with the
cytochrome P-450 and hence blocking the enzyme site# For example, it
inhibits the rat liver microsomal enzymes that catalyze the N-demethyl-
ation of 3-me thy 1-4-monomethyl—azobenzene (Conney? et al, 1957$ ,
aminopyrine (Orrenius et al, 1964), and monomethyl-4-aminoantipyrine,
the O-demethylation of codeine, and the hydroxylation of acetanilide
(Cooperr et al, 1965). It also inhibits the enzymes in rabbit liver
which catalyze the hydroxylation of aniline and N-dealkylation of
N-ethylaniline, hut not the enzyme which catalyzes N-hydroxylation of
aniline and N-ethylaniline (Kampffmeyer and Kiese, 1965; RLese, 1965).
/>ee~ GiC'lte.tte,
Gillette and Sasame (jl967} have found that carbon monoxide inhibits 
the microsomal enzymes in mouse liver which catalyze N-demethylation, 
O-demethylation, S-demethylation, aromatic hydroxylation and aliphatic 
hydroxylation reactions, but not the sulphoxidation of diaminophenyl- 
sulphide.
Biphenyl is oxidized by liver microsomes of rat, rabbit and mouse 
etc., both at the 4— and 2-positions (Creaven et al, 1965b) and these 
oxidation systems are induced by the administration of phenobarbitone 
and polycyclic hydrocarbons (Creaven and Parke, 1966), confirmed during 
the course of this work (Chapter III). It has further been observed
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that administration of p-ionone (a terpenoid.) stimulates hydroxylation 
of biphenyl only at the 4-position while safrole and iso-safrole 
(methylenedioxyphenyl compounds) induce hydroxylation at both the 4- 
and 2-positions (see Tables: 3.1 and 3.7). Moreover, all these three 
compounds have been found to have inductive effects on p-nitrobenzoic 
acid reductase (see Tables 3.1 and 3.7).
In view of the above observations on biphenyl hydroxylation it 
was considered desirable to investigate whether these oxidation systems 
and/or nitro reductive activity are inhibited by carbon monoxide as 
many other oxidation reactions have been found in different laboratories 
to be inhibited.
EXPERIMENTAL;
Groups of black-hooded rats (125-150 g.) were treated by intra- 
peritoneal injection of p-ionone (150 mg./kg.) safrole and iso-safrole 
(125 mg./kg.) in ethyl oleate once a day consecutively for three days. 
The control animals received only the vehicle . Twenty-four hours after 
the last dose the animals were killed, the livers removed, homogenized 
in three volumes of -1.15$ KC1 (W/v ) and centrifuged at 10,000 x g. for? 
ten minutes. The supernatant thus obtained was used for enzyme assay, 
the methods being the same as described in Materials and Methods 
(Chapter II) with the exception that incubation was carried out in 
various gaseous environments.as follows. To observe the effects of
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carbon monoxide on biphenyl^- and 2-hydroxylations enzyme substrate 
mixtures prepared from 10,000 g. supernatant liver homogenates from 
p-ionone-, safrole- and iso-safrole-treated and control rats were 
flushed with oxygen only prior to and during incubation# Another 
series were prepared which were similarly flushed with oxygen and 
carbon monoxide (50:50) and a third series with carbon monoxide (99fo) 
only. In the case of nitro-reductase activity, one series of each 
were flushed with nitrogen only, one with nitrogen and carbon monoxide 
(50:50) and a third with carbon monoxide only.
RESULTS:
The results are presented in Table 4.23 and the details are
given in Tables A. 99 - A.101 of the Appendix.
Hydroxylation of biphenyl both at the 4- and 2-positions are
markedly inhibited (see Table 4.23) by carbon monoxide even in the.
presence of oxygen. Nitro-reductase on the other hand is only very 
slightly inhibited by carbon monoxide (see Table 4.23)# These findings 
agree with those obtained by Cooper et al^ , (1965) who showed that carbon 
monoxide had an inhibitory effect on the metabolism of codeine, 
monomethyl-4-aminoantipyrine, and acetanilide which was reversed by 
exposing to light at 450 nm thus indicating that cytochrome P-450 plays 
a major role in the oxidation of these drugs. The present results 
do not show any significant- effect of carbon monoxide on the enzyme
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Table 4.23.
Effect of carbon monoxide on the aromatic hydroxylase and nitro 
reductase activities of liver microsomes of normal and P-ionone, 
safrole, and iso-safrole treated rats
Enzyme Gaseous
environment
Control*
After pretreatment with*
p-Ionone Safrole Iso-safrole
Biphenyl
-4-
hydroxylase
°2
4.3 7.0 5.8 5.2
50$ CO 0.5 1.7 1.3 0.8
99$ CO 0.2 1.3 1.2 0.6
Biphenyl
-2-
. hydroxylase
°2
0.11 0.11 0.62 0.61
50$ CO 0.11 0.08 0.25 0.17
99$ CO 0.06 0.07 0.23 0.17
p-Nitro-
benzoic
acid
reductase
N2
1.6 2.3 3.4 2.8
50$ CO 1.4 2.0 2.6
j
2.7 L
99$ CO 1.2 2.0 2.6 2.4
* Enzyme activities are expressed as ymoles product/gm.liver/hour.
See Appendix (Tables A.99 - A.IOl) for S.D. values and further details.
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nitro-reductase, and are in disagreement with the observations of , 
Gillette and associates (1968)#
It should be noted that whereas the 4~hydroxylation of biphenyl 
was inhibited by carbon monoxide to the extent of > 96$ in the control 
preparations, inhibition in the pretreated preparations was of the 
order of 80-90$; in the 2-hydroxylation of biphenyl carbon monoxide 
inhibited the reaction by < 50$ in the controls and by 4*0-70$ in the 
pretreated preparations#
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3. Effect of actinomycin D on the inductive effects of g-ionone 
and safrole on drug-metabolizing enzymes
In mammalian tissue the messenger ENA (m-RNA) template for protein 
synthesis has been found to be fairly stable in contrast to that in 
unicellular micro-organisms (Levinthal e_t al^ , 1962; Nathans at al, 1962 
and Guidice and Novelli, 1963). An average half life of 2 hours, was 
demonstrated for the liver m-ENA in steady state conditions (Trakatellis 
et^  al^ , 1964). Study of the cessation of protein synthesis after 
treatment with actinomycin D, however, showed variable results. Even 
a very large dose of actinomycin did not affect the protein synthesis 
of the liver slices iii vitro in contrast to the pronounced inhibitory 
effect in vivo (Revel et al, 1964). Actinomycin D binds to DNA and 
blocks DNA directed synthesis of nuclear ENA required for protein 
synthesis (Reich et_ al, 1961; Tamaoki and Mueller, 1962), and it has 
been found that actinomycin D prevents the induction by 3-methylchol- 
anthrene or phenobarbital of all microsomal enzymes studied, for 
example, benzpyrene hydroxylase (Gelboin and Blackburn, 1964), amino-
pyrine, O-demethylase (Orrenius e_t al, 1965) and aminoazo dye N-demethylases:
\
(Conney, 1965; Jervell jet^  al_, 1965; Conney, 1967). These findings, 
however, contrast with the actinomycin D insensitive induction of • 
tryptophan pyrrolase in rat liver (Greengard et^  aJ, 1963) by tryptophan. 
This insensitivity was shown to be caused by tryptophan stabilization 
of the enzyme tryptophan pyrrolase, which has a rapid turnover rate
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(Berlin and Schimke, 1965), rather than by inducing de novo synthesis 
of the enzyme.
In view of the above facts it was of interest to investigate the 
effect of actinomycin D on the induction by p-ionone and safrole of 
aromatic hydroxylases (ortho and para), nitro-reductase, glucuronyl 
transferase, cytochrome P-450 and microsomal protein which has been 
observed during the course of this work (see Tables 3.1 and 3.7).
EXPERIMENTAL:
Five sets of experiments were carried out separately with p-ionone 
and safrole witi different time courses of treatment. One each with 
P-ionone and safrole was of 24 hours treatment the results.* of which 
are given in Table 4.24, the details being in Tables A. 102 and A. 103 
(for p-ionone) and A.106 and A.107 (for safrole) of the Appendix. The 
other three sets of experiments were of 48 and 72 hours treatment with 
safrole and 48 hours with p-ionone. The results are given in the Appendix 
only (see Tables A.104 and A. 105 for p—ionone and Tables A.108 - A,111 for 
safrole.
For the 24-hour treatment experiments with black-hooded male rats (100 
125 g.) were used. The animals were maintained as described for other 
experiments previously. Groups of animals were treated by intraperitoneal 
injection with actinomycin D, p-ionone or safrole and the vehicles (isotoni 
saline and ethyl oleate) as detailed below.
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Group of Treatment
rats
- lhr. Ohr. 3hr« 7hr. 12hr. 24hr«
Group I B.S.* Eth.01. B.S. B.S. B.S. Killed
Group II Act.D Erh.01. Act • D Act.D Act.D Killed
Group III B.S. I.A, B.S. B.S. B.S. Killed
Group IV Act,,D I.A. Act ,D Act. D Act.D Killed
* Abbreviations: B.S., buffered saline (0.15M sodium chloride - 0.04M
sodium phosphate buffer pH, 7.4); Eth.01., ethyl oleate; Act.D.,
actinomycin D; I.A., inducing agent (p-ionone or safrole).
' •
Thus the control animals (Group I) received only saline (0.2 ml./
100 g.) five times, Group II animals received actinomycin D (80 (ig./kg./ 
dose) four doses, and ethyl oleate once. Group III received a single dose 
of the inducer p—ionone (150 mg./kg.) or safrole (125 mg./kg.) at 0 hr. 
and four times buffered saline. Group IV animals received a single dose 
of p-ionone (150 mg./kg.) or safrole (125 mg./kg.) and four doses of 
actinomycin D (80 pg./kg.dose). Actinomycin D and p-ionone/saf role were 
given in buffered saline and ethyl oleate (0.2 ml./lOO gm.) respectively. 
All the animals were killed 24 hours after dosing with the inducer, 
livers were removed and the drug-metabolizing enzymes were determined as 
described earlier in Materials and Methods (Chapter II).
RESULTS:
Actinomycin D administration in the normal (untreated) animals
causes variable inhibition (5-50$) of the different parameters studied
(see Table 4.24). p-Ionone or safrole administration on the other
hand induce these parameters. When actinomycin D and .p-ionone are 
«
simultaneously administered the enlargement of liver is prevented and 
the inductive effects of p-ionone on hipheny1-4-hydroxylase, nitro­
reductase, glucuronyl transferase, cytochrome P-450 and microsomal 
protein are almost completely annulled; on simultaneous administration 
of safrole and actinomycin D, the safrole induction of all these 
parameters was similarly inhibited (see Table 4.24), but the overall 
picture of enzyme activities particularly in respect of aromatic - 
hydroxylase activities was slightly different. The induction of 
biphenyl-4-hydroxylase activity is not only prevented but the enzymic 
activity is suppressed to the extent of 50-60$ of the control level- 
(see Table 4.24). This is probably due to the fact that immediately 
after administration of safrole this enzyme activity is inhibited (see 
Figure 4.3) to the extent of 70-80$ probably by competition for the 
enzyme site. The enzyme activity then slowly increases with time 
reaching the normal level after 18 hours or so and then increases by 
a further 10-20$ above the normal level (see Figure 4.3). Actinomycin 
D administered even one hour before safrole might thus enhance the
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inhibitory effect of safrole and/or decrease the rate of regaining 
normal activity so that even after twenty-four hours the activity 
remains at a lower value than the normal level. For p. similar 
reason cytochrome P-450 also might have been below the normal level 
(see Table 4.24). A  similar picture of enzyme inhibition is shown 
by glucuronyl transferase, after simultaneous administration of r 
actinomycin D and safrole or p-ionone. It is possible that the 
activity of this enzyme also suffers an initial inhibitory phase 
following the administration of an inducer similar to that seen with 
cytdchrome P-450 and biphenyl-4-hydroxylase. The safrole-induced 
increase in bipheny1-2-hydroxylase, on the other hand, is only partially 
prevented by concurrent administration of actinomycin D (see Table 4.24) 
Similar results were obtained (see Tables A. 104 and A.105 and A # 108 —
A.Ill in the Appendix) in other experiments where animals were treated 
by two or three intraperitoneal injections with p-ionone (150 mg./kg.) 
or safrole (125 mg./leg.) and simultaneous 2 or 3 doses of actinomycin 
D (100 pg*/kg.) in 48 or 72 hours. Hence these findings suggest that 
induction of drug—metabolizing enzymes such as biphenyl-4-hydroxylase, 
nitro-reductase, glucuronyl transferase and cytochrome P-450 is 
probably due to increase in synthesis of enzyme protein dependent on 
nuclear m-ENA so that blockage of DNA directed m-ENA synthesis by 
actinomycin D prevents drug-metabolizirg enzyme protein synthesis, but 
induction of biphenyl-2-hydroxylase may be due only partly to increased 
enzyme synthesis mechanism and partly to some other mechanism.
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4* Effect of actinomycin D  on the 3-methylcholanthrene- 
indueed increase in drug-metabolizing enzymes
3-Ms thyl cholanthrene is a known highly potent inducer of drug- 
metabolizing enzymes including those studied during the course of 
this work, such as biphenyl-4- and 2-hydroxylases, nitro-reductase, 
glucuronyl transferase and cytochrome P-450 (see Figures 4.8 — 4.10). 
Safrole has also been found to produce comparable induction of these 
enzymes with the exception, however, of biphenyl-2-hydroxylase which 
although also induced is increased to a lesser extent with safrole than 
with methylcholanthrene (see Figure 4.9). It has already been reported 
in the previous section of this chapter that the safrole-induction of 
these enzymes is either completely abolished or markedly decreased by 
actinomycin D with the exception of biphenyl-2-hydroxylase which was 
only partially prevented. Hence it was thought necessary to investigate 
whether actinomycin D would have a similar effect on the 3-methylchol- 
anthrene-induction of these enzymes and particularly of biphenyl-2- 
hydroxylase•
' ■
EXPERIMENTAL:
' ’ \ ■ - 1
For this experiment also black-hooded male rats (100-125 g.)
were used. Maintenance of animals and mode of treatment with methyl­
cholanthrene and actinomycin 1) was the same as described in the previous 
section, the dose of 3-methylcholanthrene being 20 mg./kg. body weight.
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RESULTS:
The results (see Table 4.25) of this experiment show that 
similarly to the safrole experiments the 3-methylcholanthrene- 
induction of biphenyl-2-hydroxylase and nitro-reductase is only 
partially prevented by actinomycin D, although induction of biphenyl-
4-hydroxylase and cytochrome P-450 is completely blocked, which 
suggests that the increased activities of biphenyl-2-hydroxylase 
and p-nitrobenzoic acid reductase are at the most, only slightly 
dependent on de novo enzyme synthesis#
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5# Effect of thioacetamide on .induction by 3-ionone,
safrole and iso-safrole
It was recognised early that agents which stimulate increased 
activity of the microsomal enzymes involved in metabolism of drugs can 
be classified into two groups: those which induce the increased metabolism 
of a wide variety of drugs, and those whose inductive effects are 
directed toward a much smaller number of substrates (Conney, 1967).
Both types of inducing agents are, however, thought to produce their 
effects by causing an increase in the synthesis of the microsomal enzymes 
responsible for drug metabolism. This conclusion is based largely Ion 
the observation that inhibitors of protein or nucleic acid synthesis, 
such as ethionine, puromycin and actinomycin D prevent .induction (Conney 
et al, 1956; Conney et^  cQ, 1957a; Conney ejb al, 1960; Orrenius and Ernster, 
1964; Gelboin and Blackburn, 1964; Conney and Gilman, 1963; Conney, 1965 
and Orrenius et a l , 1965). In the previous two sections of this chapter 
results of such study with actinomycin D have been described where 
induction of biphenyl-4-hydroxylase, glucuronyl transferase and cytochrome 
P-450 by p-ionone and safrole were found to be completely blocked by 
actinomycin D; induction of nitro-reductase was less affected and that 
of biphenyl-2-hydroxylase was only partially prevented. The work of 
Laird (1953) and of Adams and Busch (1963) suggested that thioacetamide 
might also be used to block induction. They found that thioacetamide 
caused a marked decrease in microsomal protein and ENA. At the same
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time ENA accumulated in the nucleus, and it was proposed that the decrease
in protein and ENA in the microsomes was due to suppression of the release
of ENA from the nucleus# Support for this proposal was provided by
Stttcker and Yokoyama (1966), who reported that thioacetamide inhibited
3
the migration of ENA labelled with H-cytidine from the nucleus to the
. . e
cytoplasm. Thioacetamide was therefore employed in the current studies 
to verify the results obtained with actinomycin D as to the mechanism of 
stimulation by p-ionone and safrole of bipheny1-4-hydroxylase, glucuronyl 
transferase, cytochrome P-450, nitro-reductase and biphenyl-2-hydroxylase 
in particular.
EXPERIMENTAL:
Three sets of experiments were done separately with p-ionone, safrole 
and iso-safrole treatment. The results of all three sets of experiments 
are jointly presented in Table 4.26, the details of which are given 
separately in Tables A.114 and A.115 (for p-ionone), A,116 and A. 117 
(for safrole), and A.118 and A.119 (for iso-safrole) of the Appendix.
For these experiments black-hooded male rats (100-125 g.)-were selected, 
randomly separated into four groups and maintained with normal food and 
water ad libitum and were used as described previously. The four groups 
of animals in each experiment were treated with one of the inducers ‘ 
(p-ionone, safrole or iso-safrole), thioacetamide and the vehicles as 
detailed below.
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Gro?P f  Treatment
animal ___
-lhr. Ohr. 23hr. 24hr. 47hr. 48hr # 7-2hr.
Group I(control) S. Eth.01. S# Eth.01. S# Eth.01# Killed
Group II T.A. Eth.01. T.A. Eth.01. T.A. Eth.01. Killed
Group III S. I.A. S. I.A. S# I.A. Killed
Group IV T.A. I.A. T.A. I.A. T.A. I.A. Killed
Abbreviations: T.A., thioacetamide;;Eth#01., ethyl oleate; S., 0.9$
saline; I.A. , inducing agent (p-ionone, safrole or iso-safrole)#
i  ■ -/ ! 
P-Ionone was given as 7.5$ solution in ethyl oleate, safrole and
iso-safrole as 6«25$ solution in ethyl oleate and thioaietamide as 1$
solution in 0.9$ NaCl. The dose levels were p-ionone 150 mg./kg.,
safrole and iso-safrole 125 mg./kg. and thioacetamide 50 mg./kg. body
weight.
RESULTS:
Thioacetamide alone (see Table 4.26) causes an increase in liver 
weight of 10-30$ in three days#' The levels of the drug-metabolizing 
enzymes, including biphenyl-4- and 2-hydrosylases, glucuronyl transferase, 
cytochrome P-450, together with cytochrome bg and microsomal protein are 
however decreased by 10-70$. On the other hand, nitro-reductase is 
increased by 10-30$ similar to the increase in liver weight. There wq,s 
no increase in the body weight of the thioacetamide treated animals,
probably due to rejection of food, for the control animals gained 12-15g./ 
100 g. body weight in three days# The condition of the animals otherwise 
was good in marked contrast to animals treated with actinomycin D, 
which caused marked deterioration# It is known that thioacetamide is 
carcinogenic and it is possible that the increase in liver weight is due 
to an hypertrophy associated with the subsequent hepatocarcinogenic 
activity of this compound. On the other hand, the increase in liver size 
is paralleled by an increase in one of the enzymes: namely, nitro­
reductase. This finding again raises a question how one particular 
enzyme may be induced by, the same compound which inhibits all other enizymes 
studied.
While thioacetamide and p-ionone were concurrently administered the 
effect on liver size was additive (see Table 4.26). The p-ionone 
induced increases in biphenyl-4-hydroxylase, cytochrome P-450, cytochrome 
bg and microsomal protein levels were not only abolished by thioacetamide 
but were suppressed below the normal levels; the induction of glucuronyl 
transferase was inhibited but the activity was still above that of the 
controls. Nitro-reductase activity was increased still further by 
thioacetamide plus p-ionone and the effect was additive (see Table 4.26)
Similar additive effects on liver size were obtained when thioacetamide 
and safrole or iso-safrole were concurrently administered. The effects
229
of thioacetamide on the safrole and iso-safrole induction of the above 
enzymes were similar to those observed with p-ionone induction,(see 
Table 4.26). The induction of biphenyl-2-hydroxylase, which is induced 
only by safrole and iso-safrole and not by p-ionone, is only partially 
prevented by thioacetamide (see Table 4.26). . . *
These findings suggest that the mechanisms of induction of nitro­
reductase by p-ionone, safrole or iso-safrole, and that of biphe.nyl-2— 
hydroxylase by safrole and iso-safrole, differ from the induction of 
biphenyl-4-hydroxylase, glucuronyl transferase, cytochrome P-450, 
cytochrome bg and microsomal protein by any of these compounds#
Sladek and Mannering (1969a) observed that although thioacetamide
blocked the phenobarbital - induced increase in 3-methyl-4-methy1amino-
/
azobenzene N-demethylase, it had no effect on the 3-methylcholanthrene- 
induced increase of the same enzyme. No such difference was found in 
the effect of thioacetamide on the induction of drug-metabolizing enzymes 
by p-ionone and safrole, but whereas thioacetamide blocked 70$ of the 
bipheny1-2-hydroxylase activity induced by iso-safrole it blocked only 
30$ of the enzyme activity induced by safrole.
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6* Effect of 3-amino-l,2,4-triazoIe on the induction of
hepatic microsomal drug-metabolizing enzymes produced 
by p-ionone, safrole and iso-safrole
Although the exact mechanism by which drugs and other chemicals 
lead to the induction of drug-metabolizing enzymes remains to be 
elucidiated, stimulation of both haeme synthesis and protein synthesis 
are undoubtedly essential to the induction processsince these drugs 
that stimulate liver microsomal enzyme activity also increase (Conney, 
1967) the amount of cytochrome P-450, a haemoprotein pigment of liver 
microsomes. Granick and Urata (1963), and Granick (1966) found that 
the administration of many drugs, including phenobarbital, markedly 
increased the activity of ^-aminolevulinic acid synthetase which is the 
initial and rate—limiting factor in hepatic haeme synthesis. It has 
been suggested (Baron and Tephly, 1969a) that phenobarbitone might exert 
its stimulatory effect on drug-metabolism by increasing the rate of 
hepatic haeme synthesis which directs the increased synthesis of 
cytochrome P-450.
The herbicide 3-amino-l ,2,4-triazole is known to inhibit hepatic 
^-aminolevulinic acid dehydratase (EC 4.21.24), the enzyme mediating 
the next step of haeme biosynthesis (Tsehudy and Collins, 1957).
Although inhibition of the second and presumably non-rate-limiting 
step seemed to be a rather insufficient method of inhibiting haeme
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biosynthesis, the fact that aminotriazole could be employed in very 
high doses in the animal organism presented an opportunity of inhibiting 
the dehydratase to such an extent that it could assume a rate-controlling 
function (Baron and Tephly, 1969a).
Kato (1967), and Baron and Tephly (1969a and 1969b) reported that 
administration of aminotriazole to rats markedly decreased the normal 
activities of drug-metabolizing enzymes and the content of cytochrome 
P-450 in'hepatic microsomes. Aminotriazole also inhibited the induction 
of cytochrome P-450 and of certain drug-metabolizing enzymes by 
phenobarbital (Kato, 1967; and Baron and Tephly, 1969a) and 3,4-benz- 
pyrene (Baron and Tephly, 1969b).
Since pretreatment of rats with p-ionone, safrole or iso-safrole . 
causes induction (see Tables 3.1 and 3.7 in Chapter III) of hepatic 
microsomal drug-metabolizing enzymes and cytochrome P-450 as well, it 
was of interest to investigate whether there is any correlation between 
the induction of cytochrome P—450 and haeme synthesis and the induction 
of the drug-metabolizing enzymes.
EXPERIMENTAL:
For investigation three sets of experiments were‘ done separately 
with p-ionone, safrole and iso-safrole. In the case of p-ionone and 
safrole, treatment was for 72 hours and iso-safrole treatment for 24 hours.
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For these experiments Wistar albino male rats (100-125) were used. 
The animals were allowed normal food and water ad libitum and were 
maintained as described earlier for other experiments. Groups of 
animals were treated intraperi tone ally for three days with p-ionone 
(150 mg./kg.) and safrole (125 mg./kg.) in ethyl oleate and 3-amino-l,
2,4-triazole (3g./kg.) in raline as follows:
Group of
animal Treatment
-lhr. Ohr. 23hr. 24hr • 47hr • 48hr. 72hr •
Group l(control) S. Eth.01. s ' Eth.01. s. Eth.01. Killed
Group II A .T. Eth.01. A.T. Eth.01. A.T. Eth.01. Killed
Group III S. I.A. & I .A. S. I.A. Killed
Group IV A.T. I.A. A.T. I.A. A.T. I.A. Killed
Abbreviations: S., 0.9$ saline; Ebh.01., ethyl oleate; A.T., 3-amino-
1,2,4-triazole; I.A., inducing agent (p-ionone or safrole).
In the case of iso-safrole, thioacetamide was given as a single dose 
(50 mg./kg.) at — lhr. and iso-safrole was also given as a single dose 
(125 mg./kg.) at Ohr. The control groups received the vehicle only. 
Twenty-four hours after the last dose the animals were killed, the livers 
were removed and drug-metabolizing enzymes were determined as described 
earlier in Materials and Methods (Chapter II).
RESULTS:
The results for p-ionone and safrole are jointly presented in 
Tables 4.27 - 4.29 and the details are given in Tables A . 120 - A.122 
(for p -ionone) and A.123 — A. 125 (for safrole) in the Appendix. The 
results for iso-safrole are given in Table 4.29, the details being in 
Tables A. 126 and A. 127 of the Appendix.
Aminotriazole alone (see Tables 4.27 and 4,28) causes a slight 
increase (10*) in liver size, but the oxidative enzymes such as 
biphenyl-4- and 2-hydroxylases, and the hepatic microsomal cytochrome 
P-450 are inhibited by 20-30$, while nitro-reductase is increased by
N
about 40$. Glucuronyl transferase activity, liver UNA. and protein are 
unaffected by amino-triazole while microsomal protein and cytochrome bg 
are slightly decreased (by 5-10$).
The concurrent administration (see Table 4.27 and 4.28) of amino­
triazole and p-ionone or safrole causes further increase in liver size. 
The inductive effects of p-ionone or safrole on biphenyl-4-hydroxylase 
activity and cytochrome P—450 are markedly decreased by aminotriazole; 
the induction of biphenyl-2-hyd.roxylase is inhibited by only 30$; and the 
levels of cytochrome bg, and protein, are reduced by about 50$. The 
induction of glucuronyl transferase activity is unaffected by amino­
triazole while the induction of nitro-reductase is further enhanced,
(see Table 4.27) . Kato (1967) however, reported that nitro-reductase
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activity is inhibited in the normal animal, and its induction by 
phenobarbital pretreatment is prevented by aminotriazole. Further, 
he showed that in both normal and phenobarbital-induced animals the 
cytochrome bg is unaffected by aminotriazole. The present work does 
however agree with his findings that cytochrome P-4-50 and aromatic 
hydroxylation are inhibited by aminotriazole. In his experiment, 
however, treatment was only for a short period of 24 hours whereas 
the present animals were pretreated for 3 days. A  later experiment, 
to test this point, in which animals received only a single dose 
(3 g./kg.) of aminotriazole plus iso-safrole (125 mg./kg.), 
confirmed the previous findings of three-day pretreatment (see Table 
4.29).
These findings suggest that of the enzymes studied only the 
induction of biphenyl-4-hydroxylase may be partly due to simultaneous 
induction of cytochrome P-450 by synthesis of haeme,
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7. Effect of P-ionone, safrole, iso--safrole and phenobarbitone 
on the turnover rate of liver protein
Most proteins in mammalian liver have a half-life of a few days
or less (Buch .anan, 1961; Schimke, 1964) and an accumulation of liver
protein could result from an increased rate of synthesis or a decreased
rate of breakdown. Examples of both mechanisms have been described
by Schimke (1964) and by Schimke at al, (1965) •
Kato et al , (l965<^f ound that in rats that had been treated for 42
hours with phenobarbitone there was an increase of about 30$ in the
14 | '
incorporation in vivo of L-Leucme- C into microsomal protein#
Increased amino acid incorporation by liver microsomes in vitro from
rats trea/fced with phenobarbital have also been reported (Kato ejb al,
1966), The induction of microsomal enzymes by phenobarbital can be
prevented by treatment with puromycin and actinomycin D (Conney and
Gilman, 1963), and these results seem to indicate that phenobarbital
treatment increased the rate of synthesis of microsomal proteins. The
!
rate of protein breakdown is, however, also decreased by treatment with 
phenobarbitone (Shuster and Jick, 1966).
p-Ionone, safrole and iso-safrole treatment of rats produces 
substantial increase in liver weight, microsomal protein and the activity 
of many microsomal enzymes (see Tables 3.1 and 3.7 in Chapter III), and 
this induction is prevented by inhibitors of protein synthesis, namely 
actinomycin D and thioacetamide. It was therefore of interest to
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investigate whether the increased protein and enzyme levels induced by 
P-ionone, safrole and iso-safrole were due, in any extent, to a decrease 
in the turnover of liver proteins* For this investigation two sets of 
experiments were performed as follows:-
a) Loss of radioactivity from pre-labelled liver proteins 
EXPERIMENTAL:«
For this set of experiments 64 black-hooded male rats (100-130 g.)
were selected* All the rats were given subcutaneous injections of 10 pc 
3
of L-leucine H (1*0 Ci/nM.). After 24 hours 4 rats were killed, livers 
removed, weights noted and subcellular fractions were prepared and 
determined by the initial level of incorporation as described in 
Materials and Methods (Chapter II)• The remaining sixty rats were • 
randomly separated into five groups. The different groups of rats were 
treated intraperitoneally with p-ionone (150 mg./kg.), safrole (125 mg./kg.) 
iso-safrole (125 mg,/kg.) and phenobarbitone (50 mg./leg.) once a day 
consecutively for three days, the control group received ethyl oleate 
(vehicle). The animals were allowed normal food and water ad libitum 
throughout the entire period of the experiment. .Three rats from each 
group were sacrificed every alternate day and the levels of radioactivity 
in the different sub-cellular fractions were determined as described in 
Materials and Methods (Chapter II).
RESULTS:
As we are primarily concerned with induction of microsomal enzymes,
. 241
the observations with the microsomal fractions only are presented in 
Table 4*30 and Figures 4.11 - 4.14 of this chapter and the detailed 
results ar.e given in. Tables A. 128 - A.135 in the Appendix; the results 
obtained for the other subcellular fractions are given only in the 
Appendix (Tables A. 128 - A.135).
The rate of loss of radioactivity from the pre-labelled liver 
microsomes, in both treated as well as non-treated animals, was more 
rapid during the first 48 hours than thereafter. If the loss of 
radioactivity is expressed as per ’gm. of liver weight1 no significant
i
difference is observed between the microsomes of pretreated and untreated'
animals. The pretreatment with p-ionone, safrole and iso-safrole is'
known to result in an increased synthesis of enzyme protein, particularly
of the microsomal fraction. This increased rate of synthesis following
3
the labelling with leucine- H would itself result in a decrease of 
radioactivity per unit weight, so that any decrease in the rate of 
catabolism of the prelabelled protein may not become apparent. If the 
loss of radioactivity is expressed per unit of body weight or per whole 
liver this problem is of less consequence, since the total amount of 
isotope in the liver and the body would not be greatly affected by the 
increased rate of protein synthesis. When expressed as rate of loss of 
radioactivity per 100 g. body weight the prelabelled liver microsomes 
showed a lower rate of protein catabolism after pretreatment of the
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Fig. 4.11. Effect of p-ionone pretreatment of rats on the
loss of radioactivity from the rat liver
microsomal protein prelabelled with 3ll-leucine
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Fig. 4.12. Effect of safrole pretreatment on the loss of
radioactivity from the rat liver microsomal
protein prelabelled with 3n_leucine.
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Fig.4.13. Effect of iso-safrole pretreatment on the loss of
radioactivity from the rat liver* microsomal protein
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animals with p-ionone, safrole, iso-safrole or phenobarbitone. The
i
greatest effect was obtained with phenobarbitone (a decrease of rate 
of turnover of 38$) with lesser effects with iso-safrole (24$), safrole 
(19$) and {3—i on one (18£).
These findings suggest that the rate of catabolism of microsomal
protein is decreased by these hepatic microsomal enzyme stimulators* :
3
b) Incorporation in vivo of H-leucine into subcellular liver fractions
EXPERIMENTAL; ' ' |
For this set of experiments 15 black-hooded male rats (115-145 g.)
vrere used. The animals were divided into five equal groups, kept j
separately in different cages and were allowed normal food and water
ad libitum. The different groups of rats were treated intrap eri tone ally \
with p-ionone (150 mg./kg.), safrole (125 mg,/kg.), iso-safrole (125 mg./kg.),
and phenobarbitone (50 mg./kg.) once a day consecutively for 4 days.
The control group received ethyl oleate (vehicle). Twenty-four hours
after the last dose all the animals were given subcutaneous injections
3
of 10 |ic of L-leucine- H (l.O Ci/nM.) per 100 g. body weight. The rats 
were killed after 90 minutes, livers removed, weights noted, subcellular 
fractions were prepared and their protein content and radioactivity were 
determined as described in Materials and Methods (Chapter II).
RESULTS:
The results concerning incorporation of L-leucine are presented in
*
table 4.31 and th se concerning the protein content of subcellular fractions in
Tables 4.32 and 4.33 of this chapter. Details have been given in 
Tables A. 136 to A.139 in the Appendix. When expressed in terms of 
unit weight of liver the specific radioactivity was greater in the 
microsomal fractions of the untreated than of the pretreated animals 
(see Table A.136 in the Appendix). If however the results are expressed 
as total incorporation of radioactivity per 100 g. body weight the 
greatest effect was obtained with phenobarbitone (an increase in 
incorporation of radioactivity by 24$) and lesselr effect with iso-safrole 
(21$), safrole (14$) and p-ionone (8$). There is a greater incorporation 
of L-leucine in the treated than in the untreated liver, particularly 
in the microsomal fraction (see Table 4.3l). Thereason for this is 
the hypertrophy of the liver resulting from the pretreatment, and 
expression of results in terms of unit body weight minimises this source 
of difficulty and error. The results therefore confirm that the 
inductions of hepatic microsomal drug-metabolizing enzymes by p-iorione* 
safrole, iso-safrole and phenobarbitone are associated with increased ■ 
synthesis of microsomal protein.
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8. Effect of (3-ionone and safrole on adonyl cyclase
It is proposed (Sutherland and Robinson, 1966) that the catecholamine
hormones (adrenaline and noradrenaline) in particular owe their metabolic
ability to their interaction with the membrane-bound enzyme adenyl
cyclase* The enzyme is present in all animal cells examined with the
exception of enucleated erythrocytes. ATP is the substrate for this
. 2+
reaction, and in the presence of Mg the enzyme catalyzes the formation 
of cyclic 3',5’-AMP and inorganic phosphate. The biological effects 
of the hormones are said to be caused by the direct action of the cyclic 
AMP on some active protein or enzyme system# '
In liver, adrenaline reacts with the membrane aden/1 cyclase system 
and leads to an elevation of the intracellular concentration of cyclic 
3 ’,5’-AMP. This in turn results in an increase in the amount of the 
phosphorylated or active form of phosphorylase, which in the liver is the 
rate limiting enzyme in the conversion of glycogen to glucose.
It has been shown (Pouts and Adamson, 1959; Adamson and Fouts, 1961; 
Dixon et al, 1961) that changes in smooth endoplasmic reticulum (SER) 
structure and microsomal drug-metabolizing activity are generally 
accompanied by changes in hepatic glycogen content.
The present work was done in an attempt to correlate changes in 
hepatic glycogen concentration with increase in activity of drug- 
metabolizing enzymes produced by p~ionone and safrole administratibn
253
and to ascertain whether cyclic AMP is involved in the mechanism of 
enzyme induction hy (3-ionone and safrole.
EXPERIMENTAL:
For these experiments black-hooded male rats (120-160 g.) were 
used. Animals were allowed normal food and water ad libitum and were 
maintained as described earlier. Groups of animals were treated 
intraperitoneally with J3-ionone (150 mg./kg.), safrole (125 mg./kg.) 
or noradrenaline bitartrate (l mg./kg. calculated as free bases) for 
different periods as indicated in Table 4.34. The animals were killed, 
the livers removed and then glycogen content was determined as described 
in Materials and Methods (Qhapter II),
RESULTS:
The results (see Table 4.34) show that liver glycogen is decreased 
markedly (40-70J®) by noradrenaline and by 1 5 - 3 0 by p~ionone and safrole. 
This would suggest that the inductive effects of [3-ionone and safrole 
might be at least in part, mediated through cyclic AMP, but treatment 
with different doses of noradrenaline (l-4 mg./kg.) for different 
periods (1-24 hours) have been found to have no stimulating effect on 
biphenyl hydroxylases. This would however be expected if the only effect 
of noradrenaline was the activation of phosphorylase with the associated 
increased concentration of NADPHg, for it is known that the levels of 
this coenzyme are adequate for the amount of enzyme protein present.
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9• Effect of in vitro treatment with 3-ionone and 
safrole on drug-metabolizing enzymes
Since it was found that after pretreatment of rats with p-ionone and
safrole the hepatic drug-metabolizing enzymes such as aromatic hydroxylase
and nitro-reductase were increased (see Tables 3.1 and 3.7 of Chapter III),
it was thought desirable to investigate whether this inductive effect was 
*
due to any conformational change. This was studied by adding different 
concentrations of p-ionone and safrole to the enzyme substrate mixture 
before incubation for the enzyme assay.
EXPERIMENTAL:
For this experiment normal (untreated) rat liver 10,000 x g» 
supernatant was used for enzyme assay, methods being as described in 
Materials and Methods (Chapter II).
RESULTS: ■
The results (see Tables 4.35 and 4.36) show that presence of these
compounds inhibits rather than increases the activity of the enzymes, I
namely biphenyl-4-hydroxylase and. p-nitrobenzoic acid reductase. This
suggests that induction of these drug-metabolizing enzymes by p-ionone
and safrole is not due to any simple conformational change effected in vitro.
However, with the enzyme biphenyl-2-hydroxylase a different picture is i
presented. The presence of these inducing agents (p-ionone and safrole) •
—3
at 10 M decreases the activity of this enzyme, but at concentrations of 
—5
10 M this enzyme activity is increased (see Table 4.35). This indicates
256
—3
that at 10 M  concentration of {3-ionone or safrole, which is comparable
in order of magnitude to the substrate concentration, competitive
-4
inhibition of this enzyme occurs. At a concentration of 10 M, which
is approximately equal to the concentration expected to occur in the
liver 24 hours after pretreatment with these compounds- increased enzyme 
*
activity results, due probably to the physico-chemical effects of
these compounds on the integrity of these membrane-bound enzymes, or
their associated membranes i.e., the membrane environment of the enzyme. 
—5
At 10 M this physico-chemical effect is still apparent but with further
6
lowering of concentration '(10.-M) the effect disappears.
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10« Effect of g-ionone, safrole,iso-safrole .pheriobarbitone and 
3-meth.ylcholanthrene on hemoproteins 
in rat liver microsomes
The microsomal hemoprotein in the reduced form, combines with CO
to give a characteristic spectral peak at 450 mp and has been called
o~
cytochrome P-450 or the CO binding pigment (Omura and Sato, 196dj)# 
Treatment of rats with phenobarbital or the polycyclic hydrocarbon,.
3-methylcholanthrene, increases the apparent concentration of the 
cytochrome P-450 present in liver microsomes (Remmer and Merker, 1965; 
Gram et_ al, 1967< )* Recent studies have indicated that the hemoprotein 
increased by phenobarbital is not the same as that found in liver
v
microsomes after 3-methylcholanthrene treatment (Sladek and Mannering,
a '
1966; Alvares at al, 1967j\ Kuntzman et al, 1968; Hildebrandt et_ al, 1968)
Carbon monoxide interacts with reduced microsomal hemoprotein obtained
from 3-methylcholanthrene treated rats as expected, but the maximum
absorption of this complex was found at 448 nm , instead of at 450 nm
which is the maximum for the hemoprotein from microsomes of normal or
cl
phenobarbital treated rats (Alvares et^  a l , 1967/; Kuntzman et^  al, 1968) . 
Studies which show that prior treatment of rats with either ethionine 
or actinomycin D prevented the spectral changes in microsomal hemoprotein 
caused by 3-methylcholanthrene treatment, suggested that this hydrocarbon 
caused the synthesis of a new hemoprotein or a different form of the 
original hemoprotein (Alvares et al, 1967; Kuntzman et al, 1968).
260
Some similarities (see Figures 4*7 - 4.10) have been observed 
between safrole and 3-methylcholanthrene as to the mode of their 
stimulating effect on drug-metabolizing enzymes particularly that of 
biphenyl-4 and 2-hydroxylases. Biphenyl-2-hydroxylase is highly 
induced by both safrole.and 3-methylcholanthrene while 4-hydroxylation 
is very slightly induced by these agents. On the other hand, {3-ionone 
or phenobarbitone do not induce 2—hydroxylation at all but induce
4-hydroxylation markedly,(see Figure 4.5)# Because of these observations 
it was thought that like 3-methylcholanthrene, treatment with safrole 
might also cause synthesis of a new hemoprotein which could be indicated 
by any such peak shift of cytochrome P-450.
EXPERIMENTAL:
To examine this, groups of black-hooded male rats were treated 
intraperitoneally .-with safrole or iso-safrole (125 mg/kg), 3-methylcholanthrene 
(20 mg,/kg.), phenobarbitone (50 mg,/kg.), p-ionone (150 mg./kg.) and. 
ethyl oleate (0.2 ml./lOO g.) once daily for three days. Animals were 
killed 24 hours after the last dose, livers were removed, microsomal 
pellets were prepared and resuspended and the absorption spectra of CO-binding 
reduced cytochrome P-450 was traced.in a Unicam SP800 Spectrophotometer 
as described in Methods and Materials (Chapter II).
RESULTS:
It shows (see Figure 4.15) that the absorption peak of only the 
3-methylcholanthrene treated microsomes causes shifting of the 
absorption peak from 450 nm to 448 nm; safrole-, iso-safrole- 
P-ionone- or phenobarbitone-treated microsomes do not. This indicates 
that none of these compounds except 3-methylcholanthrene is involved 
in synthesis of any hemoprotein other than cytochrome P-450.
Phenob a rb i tone
3-Methylcholanthrene 
Iso-safrole
0.8
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o 0.6
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Fig. k.15# Effect of p-ionone, safrole, iso-safrole,
3-methylcholanthrene.and phenobarbitone treatment 
‘ on the absorption spectra of the reduced carbon 
.monoxide binding pigment (cytochrome P-450).
11, Detection of a new hemoprotein
Recent studies have established the operation in liver microsomes 
of a unique electron-transfer system characterised by two hemoproteins, 
that is, cytochrome hg (Stritfmatter and Ball, 1954) and P-450 (Qmura 
and Sato, 1964a and 1964b). This system consists of two interconnected 
chains, each containing one of the two hemoproteins (Sato, 1965 and 
Estabrook, 1967). While NADH is the major source of reducing equivalent 
for the chain involving cytochrome b g ,  P-450 is reduced by electrons 
derived mainly from NADPH.
It is now well known that P-450 acts as the oxygen activating
enzyme (Estabrook £t al_, 1963; Cooper et al, 1965; Omura _et al, 1965)
<v
as well as the site of substrate interaction (imai and Sato, 1966J;
Imai and Sato, 1967 and Remmer et al, 1967), for oxidative transformation 
of various lipophilic foreign compounds and possibly also of steroids.
The function of cytochrome bg, on the other hand, had remained unclarified 
except that Oshino et al, (1967) suggested a role for this cytochrome in 
oxidative desaturation of fatty acids. In that view cytochrome bg seems 
to serve as a relay station where electrons from NADH, NADPH and ascorbate 
are passed to an unidentified cyanide sensitive factor, which probably^ 
activates oxygen for the desaturation process.
Since {3-ionoiie, safrole and iso-safrole were found to induce various 
hepatic microsomal drug-metabolizing enzymes and the hemoprotein
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cytochrome P-450 as well (see Tables 3.1 and 3.7), it became of interest
to examine their effect on the other hemoprotein cytochrome bg of the'
liver microsomes. Consequently cytochrome br was determined as described
o
in Materials and Methods (Chapter II) after pretreatment of rats with 
p-ionone, safrole and iso-safrole and was found to be induced although 
not to the same extent that cytochrome P-450 was induced (see Table 4.16)« 
On the other hand the "oxidation-reduction difference absorption spectra” 
of safrole and iso-safrole treated rat liver microsomes have been found 
to have two absorption peaks , one at 455 nm and one at 425 nm , the latter 
being due to cytochrome bg. The "oxidation-reduction difference, 
absorption spectra" of untreated control rat-liver micrjsomes, like that 
of p-ionone-, phenobarbitone- or 3-methylcholanthrene-treated rat liver 
microsomes show only an absorption peak at 425 nm > due to cytochrome bg* 
(see Figures 4.16a - 16f.). Reduction of safrole or iso-safrole treated 
microsomes with NADPH or NagS^O^ instead of NADH also produced a similar 
absorption peak at 455 nm (see Figure-4.17). This peak at 455nm was' 
found to increase with continuation of treatment (see Figure 4.18), and 
at its maximum exceeds the peak due to cytochrome bg. When safrole— 
or iso-safrole-treated microsomes were treated with 0.5$ deoxycholate 
(DOC) or Triton X— 100 and centrifuged (100,000 x g. for 1 hour) the 
oxidation-reduction difference absorption spectrum of the deposit showed 
a considerable reduction in the peaks at both 455 nm and 425 nm (see 
Figure 4.19). On treatment with 1$ DOC or Triton X-100 the "oxidation—
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reduction difference absorption spectrum" of the centrifuged deposit 
at both wavelengths was completely abolished (see Figure 4.20), but ' 
the absorption spectrum of the supernatant obtained after centrifugation 
exhibited both absorption maxima of 455 nm and 425 nm (see Figure 4.21). 
The CO-difference spectrum of the above reduced supernatant gives an 
absorption peak at 420 nm indicating that cytochrome P-450 has also 
been solubilized (see Figure 4.22). These show that cytochrome bg 
and the newly found hemoprotein are dissolved by DOC and Triton X-100 
and that cytochrome P-450 is converted to cytochrome P-420.
Induction by safrole or iso-safrole of hepatic microsomal 
cytochrome bg,and the newly detected substance as well^is diminished 
when thioacetamide also is administered with the inducing agent (see 
Figure 4.23). A  similar decrease of these two parameters occurs when
3-amino-l,2,4-triazole and safrole or iso-safrole are administered 
concurrently (see Figure 4.23). These last two observations show that 
the newly detected substance is a hemoprotein.
These findings suggest that cytochrome bg and the newly found 
hemoprotein may have some role on the metabolism of drugs.
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1. Induction of drug metabolism by substrate
Of the considerable number of naturally-occurring anutrient compounds, 
of different chemical structures, such as terpenoids, alkaloids, flavonoids, 
esters, ethers and methylenedioxyphenyl compounds which were studied, only 
{3-ionone (terpenoid) and safrole and its isomer iso-safrole (methylene­
dioxyphenyl compounds) were found to markedly increase the activity of the 
hepatic microsomal drug-metabolizing enzyme systems. Other compounds 
produced minor changes in one or more of the enzyme parameters measured, 
while others produced no significant change in any parameter. It must, 
however, be remembered that all of these compounds were administered for 
relatively shorb periods (3 days) only, and that certain known inducers, 
e.g. DDT, take a considerably longer period ('3 weeks) to manifest their 
enzyme-stimulating effects.
These current observations raise the question as to the physico­
chemical criteria necessary for compounds to be inducers of the drug- 
metabolizing enzymes. It is known that lipid solubility of a compound 
at physiological pH is important, and inducing ability often parallels 
the lipid solubility of the inducing compounds. Terpenoids, the components 
of essential oils, are readily lipid-soluble. In the course of this work, 
the partition coefficients of a number of terpenoids between chloroform, 
or heptane, and water has shown that they are all lipid soluble with 
similar partition coefficients. Hence if lipid solubility was the only 
factor necessary iir a compound to be an.inducing agent, all the terpenoids
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should have induced the drug-metabolizing enzymes to the same extent 
that p-ionone did.
Another criterion for induction, which may be considered here, 
is the mode of bio-transformation of the inducing compound and the rate 
of its metabolism, both of which would be dependent on the structure of 
the compound. ionone is a cyclic terpenoid with a keto group in the 
side-chain and may undergo both hydroxylation and oxidation-reduction 
(Parke, 1967<$ as follows
.OENCH.CO.CH,
Hydroxylati on
P~ionone
Reduction
,CH=CHC0CH,
Oxidation
‘CH.
0
OH
4—hydroxy-p-ionone 4-oxo-p—i onone 
Reduction
!H=CH. CH0H-. CH0
Hydroxylation
CH
X / c,=CH.CHOH.CH
Oxidation
CH,
p-ionol
OH
4-hydroxy-p-ionol •
H=CII.CH0H.
CEn
4-oxo-p-ionol
In addition to hydroxylation, and oxidation-reduction, the hydroxylated 
product can further undergo conjugation reactions particularly the formation 
of glucuronides. Thus p-ionone is metabolized by all three possible major 
pathways of metabolism of foreign compounds (hydroxylation, oxidation-
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reduction, conjugation) which satisfies the suggested criterion that 
for a compound to be an inducer of a particular enzyme it needs to be ‘a 
substrate of that enzyme. P-Ionone induces the hepatic drug-metabolizing 
enzymes that are responsible for hydroxylation, oxidation-reduction and 
glucuronide conjugation, and it is significant that these three types 
of enzyme reaction are all involved in the metabolism of this compound.
It is well appreciated that these hepatic enzymes invariably have 
a high degree of specificity with regard to both substrate and reaction, 
and hence it is perhaps presumptuous to assert that the enzyme activities 
measured in this work, and shown to be induced, are precisely those 
involved in the metabolism of the inducer. For example, the hydroxylation 
measured was aromatic hydroxylation - namely the 4-hydroxylation of 
biphenyl, whereas that required for the hydroxylation of [3-ionone would 
be an alicyclic hydroxylase, similar to that involved in the metabolism 
of hexobarbitone♦ However, it is acknowledged that both activities are 
mediated through cytochrome P-450 and therefore must have much in common. 
Again, the oxido-reductase activity measured was nitro-reductase 
(microsomal) whereas that required for the reduction of j3-ionone is 
probably an alcohol dehydrogenase (soluble and microsomal), but both 
are likely to involve a common electron transport pathway at least, and 
may involve a common terminal flavoprotein enzyme. Similarly, it is 
known that there are many (substrate-specific) glucuronyl transferases, 
but most recent work (Mulder, 1970) is leading to the belief that these
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are merely different conformational expressions of the same membrane bound 
enzyme protein* Where enzyme induction is due to the synthesis of a new. 
enzyme protein, the conf ormationally-induced substrate-specificity of that 
protein is not of major importance, and does not invalidate the conclusions 
that have been drawn from the use of model enzyme systems (bipheny 1-hydroxylase, 
p-nitrobenzoic acid reductase, umbelliferone glucuronyl transferase)• Where, 
on the other hand, enzyme induction is due to changes of enzyme conformation 
— as is believed to occur with safrole — these models may show no induction
s
and other models (e.g. 2-hydroxylation of biphenyl) may have to be devised.
Safrole, which has been found to be another inducer of biphenyl j
1
' j
hydroxylases, nitro-reductase and glucuronyl transferase is metabolized by: ;
a) methylenedioxy ring scission; b) modification of the ring substituents;
c) introduction of an additional group (hydroxyl) into the phenyl ring :
(Casida et al, 1966), which may be represented as follows
HCOHCH. 0-C-H OH
.OH
Microsomal
NADFH2
+ HCHO
CH CH=i CH„CH=i
Safrole
CHCH,CH, 00H
COOH
110
COOH
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The oxidation products thus formed are also likely to undergo 
conjugation, and the double bond in the side chain (allyl group) 
probably undergoes reduction. Hence the metabolic reactions which 
this compound undergoes also satisfy the criterion that a compound 
may induce enzymes for which it is a substrate. Probably iso-safrole, 
an isomer of safrole is albo metabolized in a similar fashion and 
hence is also capable of inducing the same enzyme# -
2. Potency of inductive effects of ft-ionone 
safrole and iso-safrole
The inductive potencies of p-ionone and safrole may not be as great 
as those of phenobarbitone or 3-methylcholanthrene, the recognised 
representatives of the two groups of inducing agents (Conney, 1967) ■, 
but the maximal levels of induction produced by J3-ionone and safrole 
are quite comparable with those produced by phenobarbitone and
3-methylcholanthrene, although the dosages required are greater. The
t
liver weights, microsomal protein and cytochrome P-450 contents are not 
elevated by (3-ionone to the extent that they are by phenobarbitone, but
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all three enzymes measured, namely, bipheny1-4-hydroxylase, p-nitrobenzoic 
acid reductase and glucuronyl transferase are induced to similar levels 
by these two inducers (see Figures 4.4 - 4.6). The increased microsomal 
protein is no doubt enzyme proteins, since it has been shown by many 
(Conney et al, 1956; Conney et al, 1960; Conney et a l 1961; Remmer and 
Merker, 1963; Hart and Fouts, 1965a) that induction of drug-metabolizing 
enzymes is accompanied by liver growth and protein synthesis. The 
question, however, arises how (3-ionone induces the above enzymes to the 
same extent as phenobarbitone but without an equivalent increase in 
microsomal protein. The same question is also applicable to the 
improportionate increase by p-ionone and phenobarbitone of cytochrome P-450 
which is thought to be the factor controlling hydroxylation (Ernster and 
Orrenius, 1965; Remmer and Merker, 1965b; Kato, 1966), This may, however, 
be a case when cytochrome P-450 does not parallel hydroxylation as Griem 
and Remmer (1966) and Kato et_al_ (1968a) found. These findings suggest 
that although increased enzyme protein synthesis and carbon monoxide- 
binding hemoprotein (cytochrome P-450) content are the primary factors 
in induction of the microsomal drug metabolizing enzymes, possibly 
cytochrome P-450 reductase or some other enzyme, unknown as yet, may also 
determine this enzyme induction.  ^ .
In spite of a comparable increase in liver weight after treatment 
with 3-methylcholanthrene or phenobarbitone the microsomal protein content 
is increased by phenobarbitone only (Conney and Gilman, 1963). This
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finding has been confirmed during the course of this work (see Figures 
4.4 and 4.7), and the increase in microsomal protein following methyl-* 
cholanthrene is less than even after {3-ionone and safrole pretreatment. 
Induction of cytochrome P-450 by 3-methylcholanthrene is also comparable 
to that following phenobarbitone treatment (see Figures 4.5 and 4.8), but 
nevertheless the increases in enzyme activities produced by these two . 
inducers vary both in nature and in amount. The present work has further 
confirmed that phenobarbitone induces hydroxylation of biphenyl only at 
the 4-position whereas 3-methylcholanthrene induces hydroxylation of the
j
same compound predominantly at 2-position. Creaven and Parke (1966), 
however, found no increase of hydroxylation at the 4-position after 
treatment with 3-methylcholanthrene. This difference in findings is 
probably due to the lesser amount of the cofactor NADP which these authors 
used in their experiments; other factors may be the length of duration of 
pretreatment and the species of animals used (Creaven and Parke gave 
methylcholanthrene for one day to mice, whereas in the present work the 
maximum effect on biphenyl-4-hydroxylase activity was found only after 
seven days continuous treatment of rats with the polycyclic hydrocarbon). 
The other two enzymes namely, p-nitrobenzoic acid reductase and glucuronyl 
transferase are induced more by 3-methylcholanthrene than phenobarbitone.
The question thus arises concerning the qualitative differences of 
the inducing effects of 3-methylcholanthrene and phenobarbitone on the
hydroxylation of "biphenyl; why and how does one compound induce
4— hydroxylation only whereas the other compound induces preferentially 
2-hydroxylation. Recent studies have indicated that cytochrome P-450, 
which is considered to be the enzyme responsible for drug hydroxylation7 
when increased by 3-methylcholanthrene is not the same as when increased 
by phenobarbitone (Sladek and Mannering, 1966; Alvares et al, 1967&; 
Kuntzman et al, 1968; Alvares et a4, 1968). This has also been 
confirmed in the present work (see Figure 4.15). Either cytochrome 
P-450 is changed, by association with the carcinogen, to a hemoprotein 
complex with an absorption maximum at 448 run, or a new hemoprotein with 
maximum absorption at 448 my, is synthesized after 3-methylcholanthrene 
treatment. Possibly the increased hydroxylation of biphenyl at the 
2-position is due to this new or changed hemoprotein. Furthermore, 
there may be some parallelism or relationship between the carcinogenicity 
of a compound and its ability to induce the 2-hydroxylation of biphenyl, 
since the enzyme was found to be induced only by the carcinogenic 
polycyclic hydrocarbons such as 3,4-benzpyrene, 1 ,2 ,5,6-benzanthracene 
and 3-methylcholanthrene, whereas non-carcinogenic hydrocarbons do not 
induce the hydroxylation of biphenyl at any position (Creaven and 
Parke, 1966 ) .
Induction by safrole, another naturally occurring anutrient which 
has been shown in the course of this work to be a potent enzyme inducer 
(see Table 3.7), may be closely correlated with 3-methylcholanthrene
283
both qualitatively and quantitatively, with the exception of the effects 
on microsomal protein and cytochrome P-450. Microsomal protein is 
increased more by safrole than by 3-methylcholanthrene, whereas 
cytochrome P-450 is induced more by 3-methylcholanthrene than by safrole 
- despite comparable liver hypertrophy produced by both of these two 
compounds. Both safrole and 3-methylcholanthrene induce hydroxylation 
of biphenyl at the 4- and 2-positions; safrole induces the 4-hydroxylation 
more, and the 2—hydroxylation less, than does 3-methylcholanthrene.
The other two enzymes, namely, p-nitrobenzoic acid reductase and 
glucuronyl transferase, are induced to similar extents by both safrole 
and methylcholanthrene. Again, the question arises as to how and why 
safrole induces the hydroxylation of biphenyl at the 2-poisition whereas 
P-ionone does not. Although 3-methylcholanthrene causes the formation 
of a new hemoprotein (cytochrome P-448) no such effect is produced by 
safrole which produces a similar induction pattern, or for that matter 
by p-ionone (see Figure 4.15). So it would not be justified to say that 
the cytochrome P—448 is responsible for the hydroxylation of biphenyl at
■ * ' S
the 2~position. Since safrole is also known to be carcinogenic (Long 
jrfc al , 1963), this property of carcinogenesis may possibly be related 
to a specific mode of enzyme induction which, fortuitously, is measured 
by an increase in the 2-hydroxylation of biphenyl. It would therefore 
appear that the 2-hydroxylation of biphenyl may present a model enzyme 
system which mirrors some enzymic parameter concerned in carcinogenesis.
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3. Physiological factors affecting the induction effects 
of [3-ionone, safrole and iso-safrole
a) Age:
With regard to the influence of age on the drug-metabolizing enzymes, 
it is known-that in neonates the enzyme activities are either absent or 
very low and progressively increase, reaching the adult level at 4-6 weeks
' I .
after'birth# Kato et al_ (1964^ showed that for a number of hepatic- drug- 
metabolizing enzymes the activities gradually increase after birth reaching 
adult level in 4— 6 weeks, but thereafter decrease with age# Tn the course 
of this work it has been found that p-nitrobenzoic acid reductase activity 
in rats gradually increases with age attaining the maximum activity in
s' .
about 35 days but thereafter remains almost constant, even up to 334 days, 
(see Table 4.2). On the other hand biphenyl-4-hydroxylase activity is 
low at birth, increases progressively up to the third week or so and then
b
gradually decreases, as was found by Kato^(19641 for other hepatic enzymes.
In contrast, the biphenyl-2-hydroxylase activity is low at birth, but 
progressively decreases until at eight to nine weeks it is barely detectable. 
Cytochrome P-450 gradually increases after birth up to 5-6 weeks and then 
remains at that level without any further change# Considering these 
various enzymes it is apparent that although there is a general increase 
of the hepatic drug-metabolizing enzymes after birth, followed by a 
subsequent decline, there is a considerable variation among them in the 
pattern of development and degeneration#
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It has also keen observed that {3-ionone-induction of p-nitroreductase 
activity is more pronounced in immature (< 4 weeks) rats than in the 
mature ones and that the inductive effect gradually declines with age. 
{3-Ionone~inducti©n of biphenyl-4-hydroxylase activity is, however, less 
pronounced in the immature rat than in the mature ones and with the 
increase of age the effect again gradually declines. The induction of 
cytochrome P-450 is also less pronounced in immature rats than in mature 
ones. Induction of nitro-reductase by safrole like {3-ionone is more 
pronounced in immature rats. However, the inductions of biphenyl-4- 
and 2-hydroxylase activities by safrole give altogether a different 
picture; there is no significant increase in biphenyl-4j-hydroxylase 
activity in immature rats, a slight increase at age 5 weeks, and 
inhibition rather than induction in rats older than 8 weeks; on the 
other hand bipheny 1-2-hydroxylase activity is induced only slightly in 
immature animals, highly at age 5 weeks and at 8 weeks this activity is
' ‘ ' ' I
increased from zero to the level found in untreated 5 week-old animals 
(see Table 4.2 and 4.4). Safrole induction of cytochrome P-450 is almost 
of the same order in immature rats and in 5 week-old rats, but induction 
falls markedly with further increase of age. In summary, the effects 
of {3-ionone and safrole in inducing different drug-metabolizing enzymes 
are not the same with respect to the age of the animal.
In accordance with the prevailing consensus of opinion the 
concentration of cytochrome P-450 parallels the hydroxylation of drugs.
It does not, however, seem to parallel the hydroxylation of biphenyl at either 
the 4- or 2-positions, since cytochrome P-450 concentration remains high 
in old, untreated animals whereas biphenyl-4-hydroxylase activity falls 
with increase of age, and biphenyl-2-hydroxylase activity not only decreases 
but disappears completely within eight weeks of birth. Although the 
increase in activity of biphenyl-4-hydroxylase after safrole administration 
at different ages may be correlated with the increase in cytochrome P-450 
concentration, it is, however, very difficult to explain how in the older
rats biphenyl-^hydroxylase activity could be inhibited by safrole while
ii
cytochrome P-450 concentration is increased. So, it seems unlikely that 
hydroxylation of biphenyl at either 2- or 4-position is.solely dependent 
on the concentration of cytochrome P-450* In contrast, there does appear 
to be a closer correlation between cytochrome P-450 and bipheny1-4-hydroxylase 
activity when {3-ionone is administered to animals of different ages.
b) Species and sex:
That the amount of cytochrome P-450 alone is not the sole factor
responsible for controlling the activity of biphenyl hydroxylation is
also evident from the species and sex-dependent differences in the
activity of these enzymes after {3-ionone or safrole administration.
by io'fro't*-
In female rats (see Table 4.5) cytochrome P-450 is induced £to an extent 
only about 50$ of that shown by the males; whereas biphenyl-4-hydroxylase, 
is induced in the female nearly twice as much as in the male. In the 
case of mice (see Table 4.6) although cytochrome P-450 is extensively
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induced (120$) in the female after {3-ionone administration, the 
increase in biphenyl-4-hydroxylase activity is only about one third of 
the induction of cytochrome P-450. In these animals, both male and 
female, although safrole induces cytochrome P-450 to the extent of 
30-40$, biphenyl-4-hydroxylase activity is inhibited. This reverse 
effect is more pronounced rn the iso-safrole-treated mice in which 
cytochrome P-450 is induced by 115$ in the male and 165$ in the female 
and whereas biphenyl-2-hydroxylase is induced to the extent of 65$ in 
both sexes the biphenyl-4-hydroxylase is, on the contrary, inhibited 
to an extent of 20-40$ (see Table 4,6). In the male rabbit a similar 
picture is obtained; cytochrome P-450 is extensively induced (more than 
100$) after safrole administration, whereas biphenyl hydroxylation, both 
at the 2- and 4—positions, are inhibited rather than induced (see Tables 
3.1$ and 3,14)# Phenobarbitone(see Figures 4,4 and 4.5) induces 
cytochrome P-450 in rats about two-fold whereas biphenyl-4-hydroxylase 
is induced by about only 70$. Had the cytochrome P-450 concentration 
been the only controlling factor for the drug-metabolizing enzyme 
acitivities, the increase in concentration of this hemoprotein in the 
rat, mouse or rabbit by {3-ionone, safrole or phenobarbitone should have 
paralleled the increase in biphenyl-hydroxylase activity. As they did 
not, other factors must be involved.
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c) Duration of dosage
The initial inhibition of biphenyl hydroxylase during the first
few hours after f3—ionone or safrole administration (see Figures 4.2 and
4.3) is probably due to competition of the inducer with the substrate at
the binding site of ' the enzyme. Soon after [3-ionone administration 
*
cytochrome P-450 also is inhibited although to a lesser extent and 
recovers from the inhibitory.phase within six hours while the biphenyl-
4-hydroxylase activity still suffers inhibition (see Figure 4.2). If 
the cytochrome P—450 would be the sole factor concerned in the drug- 
metabolizing enzyme activity one would expect that biphenyl-4-hydroxylase 
activity would be increased after {3-ionone administration to a similar 
extent as P-450. It is true, however, that this enzyme activity has 
recovered considerably from the initial phase of inhibition from 55$ 
to 20$ (see Figure 4.2). Again the question arises how, at twelve hours 
after [3-ionone administration, the increase in activity of biphenyl-4- 
hydroxylase surpasses the increase in concentration of cytochrome P-450 
and also reaches a maximum (see Figure 4.2) despite further continuous 
dosage with {3—ionone (Figure 4.5), whereas cytochrome P-450 continues 
to increase with the continued treatment eventually reaching a maximum 
after about 24;, days. - .
The initial degrees of inhibition (see Figure 4.3) of biphenyl-4- 
hydroxylase and cytochrome P-450 during the first twelve to eighteen 
hours after safrole administration approximately parallel each other
and are greater than are observed after {3-ionone, probably due to a 
greater competition with'the substrate for the enzyme. Following this 
inhibition, the extent of induction of these two parameters thereafter 
varies widely and cytochrome P-450 is induced 2-3 times more than the 
biphenyl-4-hydroxylase,(see Figures 4.3 and 4.8). On the other hand 
biphenyl-2-hydroxylase, which suffers inhibition only during the first 
3 houps, by 24 hours and thereafter is induced several times more than 
cytochrome P-450 (see Figures 4.3, 4.8 and 4,9). This leads one to 
assume that even if cytochrome P-450 is a determining factor for 
biphenyl-4- and -2-hydroxylases, inducing agents like safrole modify 
the role of cytochrome P-450 either by changing the rate of its 
reduction, which is now thought to be more important foi* hydroxylation 
reactions than the amount of cytochrome P-450 (Remmer et al, 1966), or 
by changing its conformation and hence its ability to react with the 
substrate
d) Starvation
The increases in the specific activities of biphenyl hydroxylases 
produced by {3-ionone and safrole during starvation (see Tables 4.11 and 
4.13)are probably only apparent increases due to depletion of liver 
glycogen stores and the consequent marked decrease in liver weight, 
since the total activities are not significantly changed in this 
condition (see Tables 4.12 and 4.14). Moreover, although the microsomal 
protein per gram of liver is increased (see Tables 4.11 and 4.13), the 
total microsomal protein per 100 gm body weight is decreased (see Tables
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4.12 and 4.14-) , which means that there is an actual loss of microsomal 
protein, as found by Dixon et_ ad (i960). The observations that the 
sex-dependent differences in the hydroxylation of drugs disappears
Cu
during starvation of rats (Kato and Gillette, 1965j) has also been 
confirmed by this work. . Although the specific activity of biphenyl- 
4-hydroxylase is comparatively greater in well-fed males than in well-fed 
female rats (see Table' A.89), the relative increase in the specific 
activity of this enzyme after starvation is greater in females than 
in males (see Table 4.11). This difference in the increase in enzyme 
activity in starved male and female rats is substantiated by the greater 
increase of cytochrome P-450 and microsomal protein in the female rats 
(see Table 4.1l). As regards the enzyme, glucuronyl transferase, although 
its specific activity is not changed by starvation (see Table 4.1l), the 
total activity is significantly decreased in both males and females (see 
Table 4.12). These reduced enzymic activities may be due, in addition 
to deficiency of enzyme proteins, to an insufficiency of liver glycogen 
which is required for the regeneration of NADH^ and NADPH^ which are 
needed for the formation of UDPGA and for hydroxylation, respectively.
On the other hand (3-glucuronidase activity is higher in tthe liver of 
fasted than of well-fed animals and this may affect the overall measurement 
of glucuronyl transferase activity (Miettinen and Leakinen, 1963). A  
somewhat different picture has been obtained for p-nitrobenzoic acid 
reductase in the starved rat, as the specific activity of this enzyme was 
decreased by 15-45$ (see Tables 4.11 and 4.13) wjp\VI& the total activity
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also decreased 40-100^ (see Tables 4.12 and 4.14). These results 
however do not agree with the observation of either Kato ejfc al (1965^ 
who found that the specific activity of p-nitrobenzoic acid reductase 
is significantly increased in starved female rats although not in 
male rats, nor of Dixon et al (i960) who showed that starvation 
of mice impairs the oxidation of hexobarbital, chloropromazine, 
aminopyrine and acetanilide but not the reduction of p-nitrobenzoic 
acid or prontosil. It is somewhat surprising that in spite of the 
increase in microsomal protein per gram of liver in fasted rats, 
the specific activity of p-nitrobenzoic acid reductase is decreased. 
This loss of activity, however, is evident even after administration 
of enzyme inducers such as {3-ionone or safrole. For although both the 
specific activity and the total activity of this enzyme are increased 
in the starved rat by any of the above inducers, the enzyme is not 
induced to the same extent as is observed in well-fed rats. On the 
other hand, the specific activities of biphenyl-4-hydroxylase^ 
cytochrome P-450, cytochrome b^ and the microsomal protein (see Tables 
4.11 and 4.13) after {3-ionone and safrole administration are increased 
more in starved than in normal rats, but the total activities are 
approximately the same in both cases. This would suggest that whereas 
starvation for 72 hours does not deprive the animal of the ability to 
synthesize new microsomal enzyme proteins it may deprive them of the 
energy reserves necessary for the proper functioning of some of these 
enzymes.
P-Ionone induces a greater increase in the specific and total 
activities of biphenyl-4—hydroxylase in the normal female rat than in 
the normal male, but following starvation the induced levels in the 
male rat are almost as high as those of the female (see Tables 4.11 
and 4.12). This would suggest that some factor which seems to limit 
the induction of bipheny1-4-hydroxylase by {3-ionone in the normal male 
rat is lessened or removed by starvation.
4. Relationship between intermediary metabolism 
and drug-metabolism
After {3-ionone or safrole administration, ascorbic acid excretion is 
also enhanced (see Table 4.15) which shows that these naturally occurring 
anutrients can affect not only the metabolism of drugs but also the 
metabolism of some nutrients such as carbohydrates. Possibly similar 
factors, such as location of the enzymes on the hepatic endoplasmic 
reticulum are involved in the induction of the metabolism of drugs and 
the induction of the metabolism of carbohydrates to ascorbic acid via 
the glucuronic acid pathway (Conney etr ad^ , 1956; Conney and Burns, 1959), 
The extent of induction of these enzymic reactions of intermediaiy 
metabolism shown by {3-ionone and safrole parallel their induction of the 
microsomal drug metabolizing enzymes, for {3-ionone, which is the less 
potent inducer of the drug^etabolizing enzymes, also causes less 
increase in the excretion of ascorbic acid (see Table 4.15). It has 
also been shown that vitamin C-deficient animals are more sensitive
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to various drugs (Richards et al, 194-1; Richards, 1947; Axelrod et al, 
1954*; Conney et a l , 1961a) from which it may be inferred that the 
metabolism of some drugs is dependent on ascorbic acid#
5# Liver parameters associated with induction 
of drug metabolism
{3-Ionone, safrole and iso-safrole not only stimulate drug-metabolism 
but also increase liver size, liver protein content, microsomal protein, 
cytochrome P—450 and cytochrome bg (see Tables 4#16 and 4.17), which 
indicates a relationship between these liver parameters and the metabolism 
of drugs. Of more interest, however, is the induction of cytochrome bg 
by safrole and iso-safrole. With most potent inducers such as phenobarbitone 
and 3-methylcholanthrene, it is found (see Tables 4.16 and 4.17) that the 
induction of other enzymes and liver parameters are comparable to the extent 
of induction of cytochrome bg, but with safrole and iso-safrole the induction 
of cytochrome b is much greater than the induction of the other liver 
enzymes and proteins# This suggests the possibility of a special role 
of cytochrome bK in the-metabolism of drugs, or of safrole and iso-safrole, 
at least# It could be postulated that the preferential induction by safrole 
and iso-safrole of hydroxylation at the 2-position rather than 4-position 
of biphenyl may be correlated with induction of cytochrome bg. However, 
since 3-methylcholanthrene which also preferentially induces hydroxylation 
of biphenyl at the 2-position, does not have any unusual effect on the 
induction of cytoviirome bg, this role for cytochrome b^in the preferential
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induction of 2-hydroxylation is unlikely.
Another important factor to he considered is the content of 
DNA present in the liver. Although the DNA content per gram of liver 
is not increased hy any of the enzyme inducers studied, the total
quantity per 100 gram body weight is increased hy all of them, the
highest value being with phenoharhitone. This shows that the liver 
enlargement produced by {3-ionone , safrole and iso-safrole involves 
mitosis and cell division, as has heen previously shown in the case
of phenobarbitone (Conney, 1967), or polyploidy.
6. Effects of inducing agents on hexoharhitone anaesthesia
The hexobarbital-induced sleeping time is decreased hy {3-ionone to 
an extent comparable to that produced hy phenoharhitone pretreatment 
(see Table 4.21) , hut is not decreased by safrole (see Table 4.20).
This indicates that the metabolism of hexoharhital is increased hy 
{3-ionone hut not hy safrole although both of them induce the metabolism 
of biphenyl (aromatic hydroxylation), p-nitrobenzoic acid (nitro-reductase) , 
4-methylumhelliferone (glucuronyl transferase) and a number of other liver 
enzyme parameters, associated with drug metabolism. The inability of 
safrole to induce the metabolism of hexoharhital and hence decrease its 
pharmacological, activity may possibly he associated with its carcinogenicity, 
since other methylenedioxyphenyl compounds possessing carcinogenic 
properties have heen shorn to have inhibitory effects on hexoharhital
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metabolism with an increase in sleeping times (Fine and Molloy, 1964). 
Furthermore, in the course of this work the carcinogen 3-methylcholanthrene 
in spite of being a potent inducer of many drug-metabolizing enzymes has 
also been found to increase the pharmacological activity of hexoharhital 
(see Table 4.2l). The more pronounced effect of [3-ionone on the 
hexoharhital sleeping time in the females (see Tables 4.18 and 4.19) 
further indicates that the mechanism of induction by this compound is 
different from that by phenobarbitone.
7, Mechanisms of induction
a) Role of cofactor
The levels of the biphenyl-4- and -2-hydroxylase activities of 
reconstituted mixtures of liver microsomes and soluble fractions 
obtained from animals treated with [3-ionone, safrole, or iso-safrole 
and controls (see Table 4.22) indicates that the induction of these 
two enzymes is due to increased activity of the enzyme protein and not 
to an increased contribution of any factor, such as the NADPH^-generating 
system, present in the soluble fraction.
b) Role of carbon monoxide and cytochrome P-450
The inhibition by carbon monoxide of the activities of biphenyl—4- 
and -2-hydroxylase in normal animals and of these enzymes induced by 
p-ionone, safrole and iso-safrole (see Table 4.23) suggests that 
cytochrome P-450, which is inactivated by carbon monoxide, plays an 
important role in both the 2- and the 4-hydroxylation of biphenyl, as it
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does in the hydroxylation of many other drugs. Nevertheless, the 
present work has confirmed previous observations (Greim and Remmer, 1966; 
Kato et al, 1968^ that although induction of the hepatic microsomal 
drug-metabolizing enzymes, by various inducing agents, produces in 
many cases, a simultaneous increase in the concentration of cytochrome 
P-450, this does not always parallel the increase in microsomal 
hydroxylation. The minor inhibition by carbon monoxide of the 
p-nitrobenzoic acid reductase activity of rat liver microsomes (see 
Table 4,23), is less than has been previously observed with mouse liver 
preparations (Gillette £t al,1968) which indicates that carbon monoxide 
may affect p-nitrobenzoic acid reductase activity to different extents 
in different species, and consequently the role of cytochrome P-450 in 
the reduction of nitro groups may also vary with species.
c) Role of new enzyme protein synthesis
Treatment with actinomycin D or thioacetamide completely blocks the 
induction of biphenyl-4-hydroxylase, glucuronyl transferase and cytochrome 
P-450, and partially blocks that of bipheny1-2-hydroxylase (see Tables 
4.24 and 4.26). This suggests that most of the induction of the first 
three of these enzymes, and part of the induction of biphenyl-2-hydroxylase, 
involves the synthesis of new enzyme protein, since actinomycin D (Reich 
et al , 1961) and thioacetamide (Laird, 1953; Adams and Busch, 1963) 
inhibit this process by blocking respectively the synthesis of, and the 
release of, the messenger RNA required for protein synthesis. As the
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induction of "biphenyl-2-hydroxylase by safrole, iso-safrole and 3-methyl- 
cholanthrene are only partially inhibited by actinonryrcin D and thioacetamide 
(see Tables 4.24 and 4,26) the mechanism of induction of this enzyme by 
these inducers must involve another mechanism or mechanisms apart from new 
m-ENA-directed protein synthesis. The partial blocking by actinomycin D 
of the induction of p-nitrobenzoic acid reductase (see Table 4.24), and 
the absence of any effect of thioacetamide on the induction of this 
enzyme (see Table 4.26), suggests that for nitro-reductase the synthesis 
of new enzyme protein is a minor factor in induction, even if it is 
involved at all,
d) Role of haeme synthesis ;
The herbicide 3-amino-l,2 ,4-triazole, which prevents the biosynthesis 
of haeme, results in an increase in liver size but inhibits the activities 
of biphenyl-4- and -2-hydroxylases, and decreases the concentration of 
microsomal protein, cytochrome P-450 and cytochrome bg in normal, as well 
as (3-ionone- and safrole-treated rats (see Tables 4,27 and 4.28), It does 
not, however, have any effect on glucuronyl transferase, and actually 
increases the activity of nitrobenzoic acid reductase in both normal and 
pretreated rats, This indicates the extent to which the drug-metabolizing 
enzymes are dependent upon haeme synthesis, and shows that both 2- and 
4-hydroxylation in normal and pretreated animals are dependent on the 
biosynthesis of haeme, probably for the formation of cytochrome P-450, 
whereas glucuronyl transferase, as would be expected, shows no such
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dependence. Forthermore, with regard to p-nitrobenzoic acid reductase, 
the aminotriazole experiments substantiate the previous studies using 
thioacetamide and carbon monoxide, and it may now be said with more 
certainty that p~nitrobenzoic acid reductase of rat liver cannot be 
related to the concentration of cytochrome P-450. In other words, the 
reduction of p-nitrobenzoate by an. NADPHg-dependent enzyme in liver 
microsomes is not mediated via cytochrome P-450, nor probably by any 
haeme protein. This view, however, is in contrast to that of Sasame 
and Gillette (1969) who suggested, on the basis of their kinetic studies, 
that the activity of p-nitrobenzoate reductase in mouse liver is mediated 
by cytochrome P-450
e) Turnover rate of microsomal protein
It has been found (see Table 4.31) that pretreatment with various
inducing substances gives rise to a considerable increase in liver weight,
amounting after four days pretreatment to maxima of 15$ with {3-ionone,
15$ with safrole, 22$ with iso-safrole and 26$ with phenobarbitone.
3
However, the rate of incorporation of H-leucine into rat liver protein
in the case of every form of pretreatment, is less than the control when
considered on the basis of unit weight of liver tissue. When, however,
the results are expressed in terms of the bodyweight, there is an overall
3
increase in the rate of II-leucine incorporation into the different sub­
fractions of the liver, which is greatest in the microsomal fractions.
This therefore confirms that there is an increased rate of synthesis of
the microsomal protein. However, it is debatable as to which is the
appropriate basis for consideration of these figures, that is, per unit
weight of liver or per unit bodyweight. The increased liver weight that
accompanies pretreatment is associated with an increase in the size
(weight) of each hepatic cell, and also to an increase in the number of
cells, as there is an increase of total DNA. Even if one uses the unit
liver cell as a basis for calculations it then seems that there is still
3
a slight increase in the rate of H-leucine incorporation into the
microsomal protein:
3
Increased H-leucine Increased ENA
incorporation
P-Ionone + 8  + 6
Safrole + 1 4  + 1 0
Iso-safrole + 2 1  + 8
Phenobarbitone * + 2 4  + 1 8
In determination of the turnover rates of intracellular proteins 
(see Figures 4.11—4.14)', the inducing compounds were given daily for 
3 days. The alteration in the rate of turnover of labelled proteins 
would therefore be maximal on the 2nd and 3rd days, after which time 
the rates would be expected to return to normal. The percentage decrease 
in the rate of turnover of labelled proteins at 48 hr., the time of 
maximum effect, is greatest for the proteins of the microsomal fraction;
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the order of this effect heing phenobarbitone > iso-safrole > safrole > 
p-ionone. A  similar effect is also observed with the soluble protein 
fraction, and is of the order: phenobarbitone > safrole, iso-safrole > 
p-ionone. These decreased rates of turnover of microsomal protein would 
be comparable with increases in the enzyme activities of the order of 15$ 
in the case of p-ionone, 20-25$ in the case of safrole and iso—safrole, 
and 35$ in the case of phenobarbitone# The decreased rate of turnover 
of soluble proteins may also imply an increased activity of certain 
soluble.enzymes#
f) Conformational change
Although p-ionone and safrole administered ijn vivo induce the 
activity of biphenyl-4-hydroxylase and p-nitrobenzoic acid reductase, 
both of these enzymes are inhibited rather than induced by p-ionone 
or safrole added directly to the hepatic microsomal preparation in vitro 
(see Tables 4#35 and 4.36). -
This indicates that induction of these drug-metabolizing enzymes 
by p-ionone or safrole is unlikely to be due to any direct conformational 
change of the enzymes or to any similar change of this membrane 
environment.
Both p-ionone and safrole, however, at a certain concentration 
in vitro, increase the activity of biphenyl-2-hydroxylase. This is
rather surprising for although safrole induces this enzyme markedly 
in vivo p-ionone does not. However, these observations together with 
other findings described previously suggest that the increased activity 
of biphenyl-2-hydroxylase may be due to certain changes in the 
conformation of the enzyme or in its structural relationships within 
the membrane of the endoplasmic reticulum.
8 . New Hemoprotein (?)
A  possible new cytochrome has been detected, which has an 
oxidation-reduction difference spectrum with an absorption maximum at 
455 nm (see Figure 4.16). This new substance appears only after 
pretreatment of animals with safrole or iso-safrole, and these two 
inducing agents have been found to progressively increase the 
concentration of this new component on continued dosage (see Figure 4.18). 
Neither p-ionone, phenobarbitone nor 3-methylcholanthrene give rise to 
the appearance of this new substance. This compound is associated with
y *
the particular microsomal fraction deposited by centrifugation at 
100,000 x g, and its appearance is inhibited by pretreatment with 
thioacetamide or aminotriazole (see Figure 4.23), which suggests that 
it is protein in association with a haeme.
It may be solubilized by treatment with sodium deoxycholate or 
triton X-100 with no change of its light-absorption characteristics —
unlike cytochrome P-450, which when solubilized by these detergents 
is converted into cytochrome P-420. No function has been ascribed to 
this new substance, and although it might possibly be associated with the 
preferential induction of biphenyl-2-hydroxylase, shown by safrole and 
iso-safrole, this is unlikely since 3-methylcholanthrene shows a 
similar preferential induction of this enzyme but does not similarly 
induce this new cytochrome.
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9# Conclusi on
These experimental results have thus shown that:
1. Certain naturally occurring anutrient substances present in foods 
can induce the hepatic microsomal drug-metabolizing enzymes. This, to 
some extent, substantiates the thesis that these enzymes are concerned 
with the metabolism of anutrients present in the diet, and that their 
induction is in the nature of substrate-induction.
2. The mode of action of these various inducers may differ - as 
shown by the different effects on various enzyme parameters, species 
and strain difference and difference of age and sex, and also by the 
investigations of the molecular mechanism.
3. Whereas p-l'onone, like phenobarbitone, results in an induction of 
enzymes which may be largely attributed to the synthesis of new enzyme 
proteins, safrole and iso-safrole like 3-methylcholanthrene give rise 
to an induction which may be attributed only in part to new enzyme 
proteins. These latter inducing agents are capable of producing 
induction of certain enzymes in a much shorter period of time than is 
usual for protein synthesis, and it is suggested that this may be due 
to a change in the conformation of the enzyme or to an alteration of 
its membrane environment which results in the manifestation of a much 
greater activity of the enzyme in question.
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Table A.I.
Effect on the liver weight of the pretreatment of rats 
with different terpenoids
Terpenoids 
'150 mg/kgkbody wt,)
Liver weight x 10Q 
Body weight
1o
changeControls Pretreated
Gitral 4,7 + 0.7 (8) 4.6 + 0.5 (8) n.s.
Bomeol 4,8 + 0,4 (9) 5.0 + 0.3 (9) n.s.
Terpineol 4.9 + 0 . 3  (6) 5.0 + 0.8 (6) ; n.s.
Nerolidol 4.6 + 0.3 (3) 4.9 + 0.3 (3) n.s.
Linalool 4.6 +  0.3 (3) 4.9 + 0.7 (3) n.s.
Limon.ene 4,9 + 0 . 3  (6) 5.2 + 0.2 (6) n.s.
Carvone 4,8 + 0.2 (6) 4.5 + 0.5 (6) n.s.
p-Ionone 4.9 + 0.4 (15) 5.6 + 0.3 (15) + 15
Squalene 4.9 + 0.1 (3) 4.9 + 0.1 (3) n.s.
n.s. is written where the percentage change is less than the limits of
significance.
329
.> Table A.2.
Effect of pretreatment of rats with different terpenoids on the
4-hydroxylation of biphenyl by liver microsomal preparation
Terpenoids 
(150 mg/kg,body wt.)
Enzyme activity 
(pmoles product/gm.liver/hour)
$
changeControis Pretreated
Citral 5.0 + 0.7 (3) 5.5 + 0.1 (3) n.s.
Borneol 4.5 + 0.3 (6) 5.7 + 0.3 (6) + 25
Terpineol 4.4 + 0.5 (9)' 5.3 + 0 . 3  (9) + 20
Nerolidol 4.1 + 0.1 (3) 4.0 + 0.1 (3) n.s.
Linalool 4.6 + 0.1 (3) 4.5 + 0.2 (3) n.s.
Limonene 4.7 + 0.2 (6) 5.7 + 0.3 (6) + 20
Carvone 4.4 + 0.5 (9) 4.7 + 0.5 (9) n.s.
P-Ionone 4.6 + 0.5 (14) 7.0 + 0.5 (14) + 55
Squalene 4.00 + 0.1 (3) 3.6 + 0.1 (3) - 10
n.s. is written where the percentage change is less than the limits of
significance.
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Table A.3.
Effect of pretreatment of rats with different terpenoids on the
reduction of n-nitrobenzoic acid by liver microsomal preparation
Terpenoids 
'150 mg/kg,body ■ wt.)
Enzyme activity 
(jjmoles product/gm.liver/hour)
1o
changeControls Pretreated
Citral 1.2 + 0.1 (3) 1.2 + 0.1 (3) n.s •
Bomeol 1.3 + 0.2 (6) 1.3 + 0.3 (6) n.s.
Terpineol 1.1 + 0.2 (6) , 1.3 + 0.2 (6) n.s.
Nerolidol 0.9 + 0 . 1  (3) 1.3 + 0.2 (3) + 40
Linalool 1.2 + 0.2 (3) 1.8 + 0.2 (3) + 50
Idmonene 1.3 + 0.2 (6) 1.7 + 0.5 (6) n.s.
Carvone 1.2 + 0.2 (9) 1.4 + 0.1 (9) n.s.
P-Ionone 1.3 + 0.3 (14) 2.4 + 0.5 (14) + 85
Squalene - -
n.s. is written where the percentage change is less than the limits of
significance.
Table A.4.
Effect of pretreatment of rats with different terpenoids on the
conjugation of glucuronic acid with 4~methylumbelliferone by
liver microsomal preparation
Terpenoids 
(150 mg/kg, body wt*
Enzyme activity 
(pmoles product/gm,liver/hour)
1o
changeControls Pretreated
Citral 48 + 4 (3) 4 7 + 7  (3) n.s.
Borneol 4 9 + 7  (6) 5 3 + 4  (6) n.s.
Terpineol 52 + 6 (6)* 5 3 + 5  (6) n.s.
Nerolidol 5 6 + 3  (3) 59 + 12 (3) n.s.
Linalool 5 1 + 5  (3) 5 6 + 2  (3) n.s, i
• I
Limonene 49 + 4 (6) 5 6 + 8  (6) n.s.
Carvone 5 0 + 6  (9) 5 1 + 7  (9) n.s.
(3-Ionone
'
5 0 + 7  (11) 73 + 11 (11) + 45
Squalene 49 + 5 (3) 41 + 4 (3) n.s.
n.s#;', is'written where the percentage change is less than the limits of
significance.
Table A.5.
Effect of pretreatment of rats with different terpenoids on the content
of cytochrome P-450 in liver microsome
Terpenoids 
(150 mg/kg, body wt)
Cytochrome P-450 
(mpmoles/gm. liver)
1o
changeControls Pretreated
Citral 18 + 2 (3) 16 + 2 (3) n.s,
Borneal 22 + 4 (6) 26 + 3 (6) n.s.
Terpineol 22 + 3 (9)‘ 2 5 + 2  (9) n.s.
Nerolidol 2 6 + 3  (3) 2 7 + 5  (3) n.s.
Linalool 21 + 2 (3) 20 + 3 (3) n.s.
Limonene 2 3 + 4  (6)
i
2 6 + 3  (6) n.s.
Carvone 22 + 4  (9) 27 + 4 (9) n.s •
P-Ionone 2 2 + 4  (14) 34 + 5 (13) + 55
Squalene 20 + 2 (3) 18 + 2 (3) n.s.
n.s. is written where the percentage change is less than the limits of
significance.
Table A. 6.
Changes in liver weight after pretreatment jaf rats with
different alkaloids
Alkaloid
Dose 
mg/kg, 
body wt.
Liver weight x m  
Body weight
f
changeControls
%
Pretreated
Caffeine 100 4.8 + 0.4 (9) 4.7 + 0.5 (9) n.s.
Tyramine 100 4.3 + 0 . 6  (3)
\
4.7 + 0.1 (3) n.s.
Tryptamine 25 4.8 + 0.1 (3) 4.5 + 0.1 (3) - 5 ft
Gramine 50 4.3 + 0.2 (3) 4.9 + 0.3 (3) + 1 5  $
Arecoline 1* 4.6 + 0.2 (3)^ 4.7 + 0.4 (3) n.s.
Piperine 10 4.8 + 0.2 (3) 4.7 + 0.3 (3) n.s •
n.s. is written where the percentage change is less than the 
limits of significance,
* A  higher dose was not possible because of the high toxicity,of 
arecoline. i
Table A.7.
Effect of pretreatment of rats with different alkaloids on the
4-hydroxylation of biphenyl by liver microsomal preparation
Alkaloid
Dose 
'mg/kg, 
body wt.
Enzyme activity 
(pmoles product/gm.liver/hour)
$
change ■Controls Pretreated
Caffeine 100 4.3 + 0.3 (10) 6.2 + 0.7 (10) + 45 $
Tyramine 100 4.4 + 0.1 (3) 3.9 + 0.1 (3) - 10$
Tryptamine 25 5.0 + 0.2 (3) 5.2 + 0.2 (3) n.s.
Gramine 50 4.7 + 0.1 (3) 4.7 + 0 . 7 ( 3 ) n.s.
Arecoline 1 4.5 + 0.1 (3) 3.8 + 0.3 (3) - 15$
Piperine 10 4-.1 + 0.1 (3) 4.0 + 0.2 (3) n.s.
n.s. is written where the percentage change is less than
the limits of significance.
Table A.8..
Effect of pretreatment of rats with different alkaloids on the
reduction of p-nitrobenzoic acid by liver microsomal preparation
Alkaloid
Dose 
mg/kg. 
body wt.
Enzyme activity 
(jimoles product/gm.liver/hour)
$
changeControls
. %
Pretreated
Caffeine 100 1.4 £  0.6 (6) 1.4 £  0.1 (6) n.s.
Tyramine 100 , 1.3 £  0.2 (3) 1.3 + 0 . 1  (3) n.s.
Tryptamine 25 0.9 + 0.2 (3) 1.0 + 0 . 1  (3) n.s.
Gramine 50 1.2 £  0.2 (3) 1.2 + 0.1 (3) n.s.
Arecoline 1 1.6 £  0.1 (3) 1.5 + 0 . 3  (3) n.s •
Piperine 10 1*1 £ 0 * 1  (3) 1.1 £  0.1 (3) n.s •
n.s. is written where the percentage change is less
than the limit of significance.
Table A. 9.
Effect of pretreatment of rats with different alkaloids on the
conjugation of glucuronic acid with 4—methylumbelliferone by
liver microsomal preparation
Alkaloid
Dose 
mg/kg, 
body wt.
Enzyme activity 
(pmoles product/gm.liver/hour)
$
changeControls
*
Pretreated
Caffeine 100 53 + 10 (7) 4 9 + 7  (7) n.s.
Tyramine - - - ■
Tryptamine 25 4 1 + 4  (3) 4 5 + 3  (3) U.S.
Gramine 50 45 + 1 (3) 4 8 + 4  (3) n.s.
Arecoline 1 • 56 + 4 (3) 54 + 3 (3) n.s.
Piperihe 10 -
n.s. is written where the percentage change is
less than the limit of significance.
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Table A.10.
Effect of pretreatment of rats with different alkaloids on the 
cytochrome P-450 content in liver microsome
Alkaloid
Dose 
.mg/kg, 
body wt.
Cytochrome P-450 
(miimoles/gm. liver)
1°
changeControls
» ■
Pretreated
Caffeine 100 2 5 + 1  (9)v 27 + 5 (9) n.s.
Tyramine 100 2 4 + 1  (3) 23 + 1 (3) n.s.
Tryptamine 25 19 + 0 (3) 20 + 1 (3) n.s.
Gramine 50 25 + 0  (3) 23 + 1 (3) n.s.
Arecolin 1 2 6 + 3  (3) 2 5 + 1  (3) n.s.
Pi peri ne 10 2 5 + 2  (3) 25 + 3 (3) n.s.
n.s. is written where the percentage change is
less than the limit of significance
• Table A. 11.
Changes in liver weight after pretreatment of rats with different
flavonoids
Flavonoid
Dose 
mg./kg. 
.body wt.
Liypr. "'eight x 10Q
Body weight
1o
changeControls Pretreated
Quercetin ' 150 4.7 + 0.4 (3) 4.8 + 0.1 (3) n.s.
Rutin 150 4.7 + 0.0 (3) 4.4 + 0 . 3  (3) n.s.
Hesperetine 25 4.3 + 0.0 (3) 4.8 + 0.2 (3) +10
Hesperidin 150 4.8 + 0.2 (3) 4.7 + 0.4 (3) n.s.
n.s. is written-where :the percentage change is less than the limits
of significance. « ,
A.12.
Effect of pretreatment of rats with different flavonoids on the 
hydroxylation of biphenyl hy liver microsomal preparation
Flavonoid
Dose
3ng*/kg. 
body wt.
Enzyme activity 
(Jmoles product/gm,liver/hour
fo
changeControls Pretreated
Quercetin 150 4 . 4 +  0.3 (6) 3.9 + 0.2 (6) n.s.
Rutin 150 4.5 + 0,5 (3) 4.1 + 0.2 (3) n.s •
Hesperetine 25 4.4 + 0.2 (3) 5.3 + 0.4 (3) +20
Hesperidin 150 4.9 + 0.6 (3) 4.8 + 0 . 1  (3) n.s.
n.s. is written where the percentage change is less than the limits
of significance ,
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Table A.13.
Effect of pretreatment of rats with different flavonoids on 
reduction of p-nitrobenzoic acid by liver 
microsomal preparation
Elavonoid
Dose
m g ‘/kg* v 
body wt.
Enzyme activity 
pmoles product/gm. liver/hour.
1*
changeControls Pretreated
Quercetin 150 1.5 + 0.3 (6) 1.3 + 0 . 1  (6) n.s.
Rutin 150 1.5 + 0.4 (3) 0.9 + 0.2 (3) n.s.
Hesperetine 25 1.5 + 0.2 (3) 1.7 + 0.1 (3) n.s.
Hesperidin 150 1.3 + 0.4 (3) 1.0 + 0.2 (3) n.s.
n.s. is written where the percentage change is less than the limits
of significance
Table A. 14.
Effect of prebreatment of rats with different flavonoids on the
conjugation of glucuronic acid with 4-methylumbelliferone by 
liver microsomal preparation
Flavonoid
Dose 
mg./kg. 
body wt.
Enzyme activity 
[jmoles product/gm.liver/hour
1°
changeControls Pretreated
Quercetin 150 48 + 4 (6) 4 3 + 5  (6) n.s.
Rutin 150 47 + 4 (3) 4 0 + 2  (3) - 15$
Hesperetine 25 48 + 3 (3) 5 0 + 4  (3) n.s.
Hesperidin 150 4 7 + 1  (3) 40 + 13 (3) n.s.
n.s. is written where the percentage change is less than the limits
of significance
342
Table A.15.
Effect of pretreatment of rats with different flavonoids on 
the cytochrome P-450 content of liver microsome
Flavonoid
Dose 
mg./kg. 
body wt.
Cytochrome P-450 
(mpmoles/gm. liver)
'fo
changeControls Pretreated
Quercetin 150 25 + 2 (6) 2 0 + 3  (6) n.s •
Rutin 150
*
26 + 3  (3) 16 + 3 (3) -40
Hesperetine 25 28 + 2 (3) 2 2 + 1  (3) -20
Hesperidin 150 2 1 + 3  (3) 14 + 7 (3) n.s.
n.s. is written where the percentage change is less than the limits
of significance
Table A.16.
Changes in liver weight after pretreatment of rats with
some esters
Ester
Dose 
mg/kg 
body wt.
Liver weight . n 
Body weight
changeControls Pretreated
Ethyl
Benzoate 150 4.9 + 0.1 (3) 4.7 + 0.1 (3) n.s.
Ethyl
Cinnamate IjffO 5.1 + 0.5 (3) 4.7 + 0.2 (3) - 10
Chlorogenic
Acid 150 5.1 + 0.4 (3) 5.4 + 0 . 5  (3) n.s.
Table A.17*
Effect of pretreatment of rats with some esters on the 
hydroxylation of biphenyl by liver microsomal preparation
Ester
Dose 
mg/kg 
body wt.
Enzyme activity 
(pmoles product/gm.liver/hr.)
j
j '
* ■
changeControls Pretreated
Ethyl
Benzoate 150 4.0 + 0 . 1  (3) 4.0 + 0.2 (3) n.s. 1
Ethyl
Cinnamate iffo 4.2 + 0.3 (3) 4.2 + 0.2 (3) n.s.
Chlorogenic
iicid 150 4.4 + 0 . 3  (3) 4.4 + 0.3 (3) n.s,.
n.s. is written where the percentage change is less than the limits of
significance.
Table A.18.
Effect of pretreatment of rats with some esters on the reduction
of p^nitrobenzoic acid by liver microsomal preparation
Ester
Dosg 
mg./kg. 
body wt.
Enzyme activity 
(pmoles product/gm.liver/hr.)
*
change
Controls Pretreated
Ethyl
benzoate
1 ■. \
-
S'
Ethyl
cinnamate 1*)0 1.12 + 0.2 (3) 1.2 + 0.1 (3) n.s.
Chlorogenic
acid 150 1.6 + 0.2 (3) 1.7 + 0 . 1 n.s.
Table A. 19.
Effect of pretreatment of rats with some esters on the conjugation of 
glucuronic acid with 4-methylumbelliferone by the liver
microsomal preparation
Ester
Dose 
mg./kg. 
body wt.
Enzyme activity 
(pmoles product/gm.liver/hr.)
: $
changeControls Pre treated
Ethyl
benzoate 150 49 + 4 (3) 4 3 + 5  (3) n.s.
Ethyl
cinnamate 1150 5 3 + 3  (3) 5 0 + 4  (3) n.s.
Chlorogenic
acid - -
n.s. is written wTrre the percentage change is less than the limits of
significance.
Table A.20.
Effect of pretreatment of rats with,some esters on the
cytochrome P-450 content of liver microsomes
Ester
Dose 
mg./kg. 
body .wt#
Cytochrome P-450 
(mymoles/gm. liver)
%
change
Controls Pretreated
Ethyl
benzoate 150 2 0 + 3  (3) 1 8 + 2  (3) n.s#
Ethyl
cinnamate 1#0 2 6 + 2  (3) 2 5 + 2  (3) n.s.
Chlorogenic 
acid . 150 1 9 + 3  (3) 19 + 4 (3) n.s •
Table A.21.
Changes in liver weight after pretreatment of rats 
with some ethers
Ether
(150 mg./kg. 
body weight)
Dose 
mg./kg. 
body wt.
Liver weight M  
Body weight
1o
changeControls Pretreated
Vanillin 150 4.7 + 0.5 (6) 4.9 + 0.4 (6) n.s.
Coumarin 150 5.2 + 0.4 (3) 5.8 + 0.4 (3) n.s.
n.s. is written.where the percentage change is less than the limits of
significance.
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Table A.22.
Effect of pretreatment of rats with some ethers on the 4~hydroxylation
of biphenyl by liver microsomal preparation
Ether
(150 mg./kg. 
body weight)
Dose 
mg./kg. 
body wt.
Enzyme activity 
([Jtmoles product/gm. liver)
f
changeControls Pretreated
Vanillin 150 4.4 + 0.3 (3) 5.4 + 0 . 2  (3) + 25
Coumarin 150 4.7 + 0 . 3  (3) 4.7 + 0.1 (3) n.s.
Table A.23. '
Effect of pretreatment of rats with some ethers on the reduction of 
p-nitrobenzoic acid by liver microsomal preparation
Ether
(150 mg./kg. 
body weight)
Dose 
mg./kg. 
body wt.
Enzyme activity 
(pmoles product/gm.liver/hr.)
changeControls Pretreated
Vanillin
---  . — --■ ;
;
150 1.5 + 0.2 (3) 
“.
1.8 + 0.1 (3) n.s.
Coumarin
■ ' i '
150 ii 0.9 + 0.2 (3)
i;
i
1.3 + 0.2 (3) n.s •
n.s. is written where the percentage change is less than the limits
of significance.
Table A. 24.
Effect of pretreatment of rats with some ethers on the conjugation
of glucuronic acid with 4-methylumbelliferone by liver microsomal
preparation
Ether 
(150 mg/kg 
body weight)
Enzyme activity 
(ymoles product/gm.liver/hr*)
' $ 
changeControls Pretreated
Vanillin 4 8 + 3  (3) 4 9 + 4  (3) n#s.
Coumarin 40 + 9. (3) 4 4 + 6  (3) n.s •
Table A.25.
Effect of pretreatment of rats with some ethers on the cytochrome 
P—450 content of liver microsomes
Ether 
(150 mg/kg 
body weight)
Cytochrome P-450 
mpmoles/gm,liver
$
change1Controls Pretreated
Vanillin 2 8 + 2  (3) 2 6 + 1  (3) n.s •
Coumarin 1 7 + 3  (3) 11.0 + 2 (3) -35
n.s. is written where the percentage change is less than the limits
of significance.
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Table A,26.
Effect of pretroatment of rats with some t'erpenes after oral
adniini strati on in food on the liver weight
Terpene
(150 mg/kg.body wt.)
liver weight ~ |nn 
Body weight
1o
changeControls Pretreated
Citral 5,2 + 0.2 (3) 5.3 + 0.1 (3) n.s.
Borneol 4.6 + 0.2 (6) 4.6 + 0,2 (6) n.s.
Terpineol 5.1 + 0.2 (6) 5.5 + 0.2 (6) n.s.
Limonene 4.4 + 0.5 (3)
\
4.6 + 0.4 (3) . n.s.
Carvone ! 4.9 + 0.1 (6) 5.3 + 0 . 2  (6) +10
P-Ionone 4.2 + 0.4 (3) 5.5 + 0.5 (3) +30
n.s. is written-where the percentage change is lower than the limits
of significance.
Table A,27.
Effect of pretreatment of rats with some terpenoids after oral
administration in food on the 4—hydroxylation of biphenyl by-
liver microsomal preparation
Terpene 
(150 mg./kg.body wt.)
En2yme activity . 
pmoles product/gm.liver/hour
*
changeControls Pretreated
Citral 4.3 + 0 . 1  (3) 4.4 + 0.3 (3) n.s.
Borneol 4.4 + 0 . 5  (6) 4.9 + 0 . 8  (6) n.s.
Terpineol 4.4 + 0.4 (9) 5.5 + 0.4 (9) +25
Limonene . 4.1 + 0.2 (3) 4.0 + 0.0 (3) n.s.
Carvone 4.5 + 0.4 (9) 5.8 + 0.7 (9) +30
p-Ionone 4.2 + 0.2 (3) 6.7 + 0.3 (3) +6GV
j
n.s. is written where the percentage change is lower than the limits 
of significance.
Table A.28.
Effect of pretreatment of rats with some terpenoids after oral
administration in food on the reduction of n-nitrobenzoic acid 
by liver microsomal preparation
Terpene 
(150 mg/kg. body wt.)
Enzyme activity 
pmoles product/gm.liver/hour.
fo
changeControls Pretreated
Citral 4.3 + 0 . 3  (3) 1.6 + 0.2 (3) n.s.
Borneol 1.5 + 0.4 (6) 1.7 + 0.7 (6) n.s.
Terpineol 1.2 + 0.1 (9) 1.3 0.3 (9) n.s.
Limonene 1.6 + 0.3 (3)
\
2.1 + 0.1 (3) +20
Carvone ' 1.2 + 0.1 (9) 1.3 + 0.1 (9) n.s.
p-Ionone 1.3 + 0.1 (3) 2.1 + 0.3 (3) +80
i
n.s. is written wbere the percentage change is lower than the limits
of significance.
Table A.29.
Effect of pretreatment of rats with some terpenoids after oral
administration in food on the conjugation of glucuronic acid
with 4—Methylumbelliferone by liver microsomal preparation
Terpene 
(150 mg/kg. body wt.)
Enzyme activity 
pmoles product/gm,liver/hour
1°
changeControls Pretreated
Citral 5 3 + 5 ( 3 ) 54 + 1 2 ( 3 ) .n.s.
Borneol 5 0 + 3 (6) 5 1 + 6 (6) n.s.
Terpineol 53 + 6 ( 9 ) 54 + 3 ( 9 ) n.s.
Limonene 50 + 4 
\
( 3 ) 51 + 2 ( 3 ) n.s.
Carvone ' 53 + 6 ( 9 ) 5 7 + 8 (9) n.s.
{3-1 on one 50 ±_ 6 ( 3 ) 85 + 6 ( 3 )
i
+ 70 |
n.s. is written where the percentage change is lower than the limits
of significance. .
Effect of pretreatment of rats with some terpenoids after oral
administration with food on the cytochrome P-450 content of
liver microsome
Terpene 
(150 mg/kg. body wt.)
Cytochrome P-450 
mpmoles/gm. liver
1o
changeControls Pretreated
Citral 19 + 2 (3) 2 4 + 2  (3) + 25
Borneol 27 + 4 (6) 27 + 2 (6)
>
n.s •
Terpineol 2 4 + 3  (9) 3 3 + 4  (9)
i
35
Limonsne 2 0 + 2  (3) 
\
23 + 4 (3) n.s.
(
Carvone 2 5 + 6  (9) 2 7 + 5  (9) n.s.
p-Ionone 2 6 + 3  (3) 39 + 4 (3) + 501
n.s. is written where the percentage change is lower than the limits
of significance.
Table A *31*
Changes in liver weight after parenteral treatment of 
rats with methylenedihydroxyphenyl and related compounds
Compound Dose 
mg/kg•
body wt.
.Liver weight 
Body weight
%
changeControl Pretreated
Safrole 125 4*6 +_ 0*4 (9) 5.4 +_ 0.3 (9) + 20
Iso— safrole 125 4.8 +_ 0#3 (5) 5.9 + 0.2 (5) + 25
Piperonal 150 5.0 + 0.4 (3) 4.8 + 0.2 (3) n.s.
Piperonyl
alcohol 150 5.0 + 0.3 (3) 5.1 + 0.2 (3)' n.s.
Piperonylic acid , 150 4.9 + 0.1 (3) 5.1 + 0.8 (3) n.s.
Piperonyl 
acrylic acid 150 5.0 + 0.2 (3) 5.4 + 0.3 (3) n.s.
Piperine 150 5.0 + 0.1 (3) 5.5 + 0.0 (3) + 10
Eugenol 150 5.0 + 0 . 2 (3) 5.0 + 0.2 (3) n.s •
* 100 5.4 + 0.1 (2) 5.0 + 0.3 (2) n.s.
Allyl benzene
150 5.4 +. 0.1 (2) 5.1 + 0.1 (2) n.s •
3,4—Di hydroxy 
benzoic acid 150 5.0 + 0.3 (3) 5.0 + 0.8 (3) n.s.
n.s# is written where the percentage change is lower than the limits of
significance.
Table A. 32.
Effect of parenteral treatment of rats with some methylenedioxyphenyl
and related compounds on the biphenyl~4~hydroxylase activity of
liver microsomal preparation
Compound
Dose
mg/kg.
body wt.
Enzyme activity 
pmoles product/gm.liver/hour
1°
change
Controls Pretreatment
Safrole 125 4.3 + 0.4 (9) 5.6 + 0.4 (9) + 30
Iso-safrole 125 4.2 + 0.2 (5) 6.6 + 0 . 4  (5) • + 55
Piperonal 150 4.1 + 0.1 (3) 4.6 + 0.2 (3) + 10
Piperonyl
alcohol 150 4.7 + 0.4 (3) 4.8 + 0.6 (3) n.s.
Piperonylic
acid 150 4.4 + 0.2 (3) 4.3 + 0.4 (3) n.s.
Piperonyl 
acrylic acid 150 4.2 + 0.2 (3) 4.7 + 0.3 (3) n.s,
i
Piperine 150 4.3 + 0 . 2  (3) 4.4 + 0.3 (3)
I
l
n.s.
Eugenol 150 4.3 + 0.3 (3) 4.0 + 0.2 (3) n.s.
Allylbenzene
100 3.9 ±. 0.0 (2) 4.1 ± 0.2 (2) n.s.
150 3.9 + 0.0 (2) 4.2 + 0.0 (2) n.s.
3 ,4— Dihydroxy 
benzoic acid 150 4.2 + 0.2 (3) 4.3 + 0.1 (3) n.s.
n.s. is written where the percentage change is lower than the limits of
significance-
Table A,33.
Effect of parenteral treatment of rats with some methylenedioxyphenyl
and related compounds on the biphenyl~2~hydroxylase activity of
liver microsomal preparation
Compound
Dose
mg/kg,
body wt.
Enzyme activity 
mpmolesproduct/gm.liver/hour
1o
Controls Pretreated
change
Safrole 125 0*14.+ 0*03 (9) 0.95 + 0.21 (9) + 600
Iso-safrole 125 0.20 + 0.02 (5) 1.30 + 0.04 (5; + 550
Piperonal 150 0.08 + 0.02 (3) 0 . 0 9 + 0 . 0 3  (3; n.s.
j
Piperonyl
alcohol 150 0.20 + 0.01 (3) 0.18 4 0.01 (3; n.s •
Piperonyl acid 150 0.14 + 0.04 (3) 0.16 + 0.04 (3; n.s.
Piperonyl 
acrylic acid 150 0.19 + 0.03 (3) 0.21 + 0.07 (3' n.s.
Piperine 150 0.16 + 0.01 (3) 0.15 + 0.03 (3; n.s.
Eugenol 150 0.12 + 0.02 (3) 0.12 + 0.03 (3 n.s •
100 0.09 + 0.01 (2) 0.08 + 0.01 (2 n.s.
Allylbenzene
150 0.09 + 0.01 (2) 0.09 + 0.02 (2 n.s.
3 ,4— Di hydroxy 
benzoic acid 150 0.19 + 0.01 (3) 0.18 + 0.02 (3 n.s.
n.s. is written where the percentage change is lower than the limits of
significance. .
Table A.34.
Effect of parenteral treatment of rats with some methylenedioxyphenyl
and related compounds on the reduction of p-nitrobenzoic acid by
liver mi cro s omal preparati on
Compound
Dose 
mg/kg, 
body wt.
Enzyme activity
pmoles product/gm.liver/hour
1*
change
Controls Pretreated
Safrole 125 1.2 + 0.2 (9) 2.5 + 0.4 (9> + 110
Iso-safrole 125 1.4 + 0.2 (5) 2.7 + 0.5 (5)- + 100
Piperonal 150 1.4 + 0.1 (3) 1.4 + 0.1 (3) n.s.
Piperonyl
alcohol 150 1.6 + 0 . 2  (3) 1.8 + 0.2 (3) n.s.
Piperonylic
acid 150 1.4 + 0.1 (3) 1.8 + 0 . 4  (3) n.s.
Piperonyl 
acrylic acid 150 1.3 + 0.3 (3) 1.9 + 0.1 (3) + 45
Piperine 150 1.4 + 0.1 (3) 1.8 + 0.2 (3) + 30
Eugenol 150 1.4 + 0 . 1  (3) 1.7 + 0.1 (3) + 20
Allylbenzene
100 1.4 + 0.1 (3) 1.8 + 0 . 1  (2) + 30
150 1.4 + 0.1 (3) 1.9 + 0.1 (2) + 35
3,4-Dihydroxy 
benzoic acid 150 1.3 + 0.3 (3) 1.4 + 0.3 (3) n.s.
n.s. is written where the percentage change is lower than the limits
of significance.
Table A,35.
Effect of parenteral treatment of rats with some methylenedioxyphenyl
and related compounds on conjugation of 4-methylumbelliferone -with
glucuronic acid by liver microsomal preparation
Compound
Dose 
mg/kg, 
body wt.
Enzyme activity 
pmoles product/gm.liver/b our
*
change
Controls Pretreated
Safrole 125 5 0 + 6 (9) 89 + 13 ( 9 ) . + 80
Iso-safrole 125 47,+ 5 ( 3 ) 7 3 + 2 (3) ■ + 55
Piperonal 150 4 5 + 2 (3) 4 3 + 3 (3) n.s.
Piperonyl
alcohol 150 46 + 2 (3) 4 9 + 1 (3) n.s.
Piperonylic
acid
150 4 5 + 5 (3) 48 +_ 4 (3) n.s •
Piperonyl 
acrylic acid 150 49 + 5 (3) 4 5 + 3 (3) n.s.
Piperine 150 45 + 4 ( 3 ) 6 1 + 5 (3)
i
1
+ 135
Eugenol 150 4 5 + 3 ( 3 ) 45 + 2 (3) n.s.
Allylbenzene - -
3,4-Di hydro xy 
benzoic acid 150 4 8 + 5 (3) 46 + 4 (3) • n,s.
n.s. is written when the percentage change is lower than the limits of
significance,
Table A*36.
Effect of parenteral pretreatment of rats with some methylenedioxyphenyl
and related compounds on the cytochrome P-450 content of liver microspme
Compound Dose 
mg/kg. 
body wt.
Cytochrome
mpmoles/gm.
‘ P-450 
liver
1"
Controls Pretreated
change
Safrole 125 21 + 2 (9) 4 3 + 3 ( 9 ) + 105
Iso-safrole 125 2 3 + 2  (4) 51 + 4 ( 4 ) + 120
Piperonal 150 22 + 3 (3) 22 + 4 ( 3 ) n.s.
i
i
Piperonyl
alcohol 150 2 2 + 1  (3) 23 + 1 ( 3 ) n.s.
Piperonylic
acid
150 19 + 1 (3) 2 0 + 2 ( 3 ) n.s; *
Piperonyl 
acrylic acid 150 2 3 + 1  (3)' 2 3 + 2 ( 3 ) n.s.
Piperine 150 22 + 3 (3) 2 0 + 3 ( 3 ) n.s.
j
Eugenol 150 2 2 + 3  (3) 2 1 + 3 ( 3 ) n.s.
Allylbenzene
100 2 7 + 3  (2) 31 + 2 (2) n.s.
150 27 + 3 (2) 34 + 1 ( 2 ) + 25
3,4-Dihydroxy 
benzoic acid
150 2 3 + 1  (3) 24 + 2 ( 3 ) n.s.
n.s. is written where the percentage change is lower than the limits of
significance. '
Table A, 37.
Effect of parenteral pretreatment of rats with some methylenedioxyphenyl
and related* compounds on the protein content of liver microsome
Compound
Dose 
mg/gm. 
body wt.
Enzyme activity 
pmoles product/gm.liver/hour
5‘
changeControls Pretreated
Safrole 125 3 0 + 2 (9) 3 8 + 3 ( 9 ) + 25 .
Iso-safrole 125 3 0 + 3 (4) 3 8 + 1 (4) + 25
Piperonal 150 30 + 1 ( 3 ) 32 + 0 ( 3 ) n.s.
Piperonyl
alcohol 150 28 + 1 ( 3 ) 29 + 2 ( 3 ) n.s.
Piperonylic
acid
150 3 2 + 3 ( 3 ) 32 + 4 ( 3 ) n.s.
Piperonyl 
acrylic acid 150 2 8 + 4 ( 3 ) 2 8 + 2 ( 3 ) n.s.
Piperine 150 32 + 2 ( 3 ) 3 1 + 2 ( 3 ) n.s.
Eugenol 150 32 + 2 ( 3 ) 32 + 2 ( 3 ) n.s.
Allylbenzene
100 3 2 + 1 (2) 37 + 2 (2) + 15
150 3 2 + 1 (2) 3 8 + 0 (2) + 20
3,4-Dihydroxy 
benzoic acid 150 28 + 4 ( 3 ) 29 + 1 ( 3 ) n.s.
n.s. is written vdiere the percentage change is lower than the limits of
significance.
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Table A.40.
Change in liver weight after pretreatmeht of Wistar 
albino male rats of different ages with B-ionone
Age
(days)
Liver .weight 
(gm*)
Liver weight „ 10Q 
Body weight
f
changeControl Pretreated
22 43 + 5 (4) 4.0 + 0.1 (2) 4.7 + 0,2 (2) + 18
35 1 2 3 + 8  (4) 4.4 + 0.2 (2) 5 . 1 + 0  (2) + 16
64 292 + 19 (4) 4.3 + 0.4 (2) 4.6 + 0.2 (2) n.s.
132 4-24 + 28 (4) 3.2 + 0.0 (2) 3 . 4 +  0.1 (2) n.s.
160 451 + 20 (4) 3.2 + 0 . 3  (2) 3.3 + 0.1 (2) n.s,
334 564 + 55 (4) 2.8 + 0.1 (2) 3.0 + 0.1 (2) n.s.
Table A.41.
Effect of pretreatment of rats of different ages with 3-ionone on
the hepatic microsomal biphenyl hydroxylase activity
Age
(days)
*
Body weight 
(gm.)
Enzyme activity 
ymoles product/gm.liver/hour
■f
change
Control Pretreated
22 4 3 + 5  (4) 5.8 + 0.1 (2) 6.0 + 0.2 (2) n.s.
35 123 + 8 (4) 4.2 + 0.0 (2), 6.5 + 0.1 (2) + 55
64 292 +-19'(4) 3.1 + 0.0 (2) 4.7 + 0.0 (2) + 52
132 424 + 28 (4) 2.9 + 0 . 0  (2) 4.2 + 0.1 (2) +• 45
160 451 + 20 (4) 2.8 + 0.1 (2) 3.8 + 0.0 (2) +- 36 .
334 564 + 55 (4) 2.9 + 0.2 (2) 3.8 + 0.3 (2) + 31
Table A.42.
Effect of pretreatment of rats of different ages with g-ionone on
the reduction of p-nitrobenzoic acid by liver microsomal preparation
Age
(days)
Body weight 
(gm.)
Enzyme Activity 
pinoles product/gm .liver/hour
Control Pretreated
1o
change
22 4 3 + 5  (4) 0.8 + 0.1 (2) 2.3 + 0.2 (2) +  187
35 123 + 8 (4) 1.5 + 0.1 (2) 2.6 + 0.0 (2) + 73
64 292 + 19 (4) 1.5 + 0.2 (2) 2.6 + 0.5 (2) + 73
132 424 + 28 (4) 1.3 + 0 . 2  (2) 1.9 + 0.1 (2) + 46
160 451 + 20 (4) 1.2 + 0.0 (2) 1.5 + 0.2 (2) / + 25
334 ' 564 + 55 (4) 1.3 + 0.2 (2) 1.7 + 0.2 (2) + 31
Table A«43,
Effect of pretreatment of rats of different ages with 3-ionone on
the hepatic microsomal cytochrome P-450 content
i
{
Cytochrome P-450 
mymoles/gm. liver
Age
(days)
Body weight 
(gm*) Control Pretreated
%
change
22 4 3 + 5  (4) 17 + 1 (2)
*
20 + 2 (2) +- 18
| 35 123 + 8  (4) 21 +',3 (2) 36 + 3  (2) + 71
64 292 + 19 (4) 2 5 + 3  (2) 42 + 2 (2) + 68
132 424 + 28 (4) 2 5 + 0  (2) 43 + 4 (2) + 72
160 451 + 20 (4) 28 + 0 (2) 4-3 + 4 (2) + 55
334 564 + 55 (4) 2 7 + 3  (2) 4 1 + 2  (2) + 52
Table A.44,
Effect of pretreatment of rats of different ages with 3-ionone on
the hepatic microsomal cytochrome b,g content
Age
(days)
Body weight 
(gm.)
1
<4 ,
Cytochrome 05 
mymoles/gm, liver
1o
changeControl Pretreated
22 43..+ 5 (4) 1 1 + 2  (2) 1 6 + 2  (2) + 45
35 123 + 8 (4) 12 + 1 (2) 16 + 1 (2) + 33
64 299 + 1 9 (4) 1 3 + 1  (2) 1 8 + 0  (2) + 38
132 424 + 28 (4) 14 + 1 (2) 2 0 + 0  (2) + 43
160 451 + 20 (4) 1 4 + 0  (2) 1 9 + 3  (2) + 36
334 564 + 55 (4) 1 3 + 1  (2) 1 8 + 1  (2) + 38
ou i
Table A.45.
Effect of pretreatment of rats of different age with P-ionone on
tbe liver microsomal protein content
Age
(days)
Body weight 
(gnu)
Protein content (mg./gm, liver)
1o
changeControl Pretreated
22 < 4 3 + 5  (4) 3 0 + 1  (2) 32 + 0 (2) + 6
35 , 125 + 8 (4> 3 0 + 1  (2) 3 3 + 1  (2) + 10
64 292 + 19 (4) 27 + 0 (2) 2 9 + 1  (2) + 7
132 424 + 28 (4) 2 8 + 0  (2) 3 0 + 1  (2) + 7
160 451 + 2 0  (4) 27 + 0 (2) 2 8 + 2  (2) n.s#
334- , 564 + 55 (4)
.
2 8 + 2  (2) 30 + 0 (2) n.s#
Table A.46.
Changes in liver weight after pretreatment of rats of different
age with safrole
Age
(days)
Body weight 
(gm.)
l
Liver weight
^— 5---- . g. ■ x 100Body weight
tr
changeControls Pretreated
22 4 1 + 5  (4) 4.0 + 0.1 (2) 4.7 + 0.2 (2) + 18
35 123 + 5  (4) 4.4 + 0 . 2  (2) 5.3 + 0.3 (2)
»
s
+ 20
64 294 + 8 (4) 4.3 + 0 . 4  (2) 4.6 + 0.3 (2) n.s.
132 446 + 16 (4) 3.2 + 0.0 (2) 3.4 + 0.2 (2) n.s.
160 464 + 15 (4) •3.2 + 0.3 (2) 3.3 + 0.2 (2) n.s.
334 514 + 71 (4) 2.8 + 0.1 (2) 3.0 + 0.4 (2) n.s.
Table A.47.
Effect of pretreatment of rats of different age with safrole on
the hepatic microsomal bipheny1-4-hydroxylase activity
Age
(days)
Body weight 
(gm.)
i
I Enzyme activity
(Jmoles product/gm.liver/hr.
*
changeControls
T .
Pretreated
22 4 1 + 5  (4) 5 . V  + 0.1 (2) 6.1 + 0.2 (2) n.s.
35 123 + 5 (4) 4.2 + 0.0 (2) 5.5 + 0.2 (2) + 31
64* 294 + 8  (4) 3.1 + 0.0 (2) 2.4 + 0.0 (2) - 23
132 446 + 16 (4) 2.9 + 0 . 0  (2) 2.3 + 0.1 (2) - 21
160 464 + 15 (4) 2.8 + 0.1 (2) 2.0 + 0.2 (2) - 28
334 541 + 71 (4) 2.9 + 0.2 (2) 1.3 + 0.1 (2) - 55
Table A.48.
Effect of pretreatment of rats of different age with safrole on
the biphenyl--2—hydroxylase activity of the liver
Age
(days)
Body weight 
(gm.)
|
| Enzyme activity 
| pmoles product/gm. liver/hr.
f
changeControl Pretreated
22 4 1 + 5  (4) 0.26 + 0.06(2) 0.73 + 0.24(2) + 181
35 123 + 5 (4) 0.09 + 0.02(2) 0.64 + 0.06(2) + 611
64 294 + 8 (4) < 0.02 0.11 + 0.01(2) -
132 446 + 16 (4) < 0.02 0.13 + 0.02(2) -
160 464 + 15 (4) < 0.02 0.11 + 0 .04(2) -
334 541 + 71 (4^ < 0.02 0.12 + 0.01(2) -
Table A.49.
Effect of pretreatment of rats of different ages' with safrole on
the reduction of p-nitrobenzoic acid by liver microsomal preparation
Age
(days)
Body weight 
(gm.)
'
Enzyme activity 
pinoles product/gm,liver/hour
$
changeControls Pretreated
22 4 1 + 5  (4) 0,8 + 0.1 (2) 2.6 + 0.1 (2) + 225
35 123 £  5 (4) 1.5 + 0,1 (2) 2.9 + 0.5 (2)
■
+ 93
64 294 + 8 (4) 1.5 + 0.2, (2) 2.3 + 0.3 (2) + 53
132 446 .+ 16-(4) 1.3 + 0.2 (2) 2 . 3 +  0.2 (2> + 77
160 464 + 15 (4) ’ 1.2 + 0.0 (2) 1.5 + 0.0 (2) + 25
334 541 + 71 (4) 1.3 + 0.2 (2) 1.8 + 0.1 (2) + 38
Table A.50.
Effect of pretreatment of rats of different ages with safrole on
the hepatic microsomal cytochrome P-450 content
Age
(days)
Body weight 
(gm.)
Cytochrome P-450 content 
(mymoles/gm. liver)
f
changeControls Pretreated
22 4 1 +  5 (4) 1 7 + 1  (2) 3 1 + 3  (2) + 82
35 1 2 3 + 5  (4) 2 1 + 3  (3) 41 + 1 (2) + 97
64 292 + 8 (4) 2 5 + 3  (2) 3 0 + 1  (2) + 20
132 446 + 16 (4) 2 5 + 0  (2) 3 0 + 2  (2) +- 20
160 464 + 15 (4) 28 + 0 (2) 3 3 + 2  (2) + 18
334 ;541 + 71 (4) 
.... . ....
27 + 2 (2) 3 1 + 1  (2) + 15
Table A.51.
Effect of oretreatment of rats of different ages with safrole on
the hepatic microsomal cutochrome ^5 content
Age
(days)
Body weight 
■(gnu)
| Cytochrome b5 content 
mjJmoles/gm. liver
Controls Pretreated
f
Change
!
i
j
| 22 4 7 + 5  (4) 1 1 + 2  (2) 19 + 1 (2) + 73
I*
1
! 35
i
(1
i
i
1 2 3 + 5  (4) 1 2 + 1  (2) 21 + 0 (2) + 75
64 294 + 8 (4) 1 3 + 1  (2) 18 + 1  (2) + 38
132 446 + 16 (4 ) 1 4 + 1  (2) 2 2 + 0  (2) + 57
160 464 + 15 (4) 14 + 0 (2) 22 + 1 (2) + 57
334 5 4 1 + 7 1  (4) 1 3 + 1  (2) 19 + 2 (2). + 46
Table A,52.
Effect of pretreatment of rats of different ages -with safrole on the
liver microsomal protein content
Age
(days)
Body weight 
(gm.)
|
Protein 
1 mg./gm.
content
liver
fo
changeControls Pretreated
22 4 1 + 5  (4) 3 0 + 1  (2) 32 + 0 (2) + 7
35 123 + 5  (4) 3 0 + 1  (2) 3 6 + 1  (.2) +20
64 294 + 8 (4) 2 7 + 1  (2) 3 1 + 2  (2) +15
132 446 + 16 (4) 2 8 + 2  (2) 3 2 + 1  (2) +14
160 464 + 15 (4) 27 + 0 (2) 3 0 + 1  (2) -+11
334 54-1 + 71 (4) 
.
2 | + 2  (2) 3 0 + 1  (2) ■WiS
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Table A.58.
Effect of pretreatment of male and female mice with 3-ionone
on the aromatic hydroxylases and cytochrome P-450 content
of liver microsomal preparation
Sex Parameter Controls Pretreated
1o
change
Cytochrome P-450 
m[jmoles/gm. liver
2 6 + 2  (2) 2 9 + 0  (2) + 12
Male
Bipheny1-4- 
hydroxylase 
jjmo 1 e s/gm. 1 i ver/hr.
8.2 + 0.2 (2) 8.1 + 0.0(2) -*v\ ; £.
. -
Bipheny1-2- 
hydroxylase 
pmoles/gm. liver/hr.
0.55 + 0.02 (2) 0^48 + 0.03 (2) - 1 3
Cytochrome P-450 
|_imole s/gm. liver/hr.
1 7 + 1  (2) 37 + 1  (2) j +118
1
!
Female
Biphenyl-4- 
hydroxylase 
(jmoles/gm. liver/hr.
i
4.5 + 0.3 (2) 6.4 + 0.1 (2) + 42
Bipheny1-2- 
hydroxylase 
(jmoles/gm, liver/hr.
0.51 + 0.05 (2) 0.22 + 0.03 (2) - 57
Table A.59.
Effect of pretreatment of male and female mice with safrole
on the aromatic hydroxylase and cytochrome P-450
content of liver microsomal preparation
Sex Parameter Controls Pretreated
*
change
■
Cytochrome P-450 
mjjmole s/gm. liver
2 6 + 2  (2) 35 + 4 (2) • + 35
Male
Biphenyl-4- 
hydroxylase 
pmoles/gm.liver/hr.
8 . 2 +  0.1 (2) 6.2 + 0.0 (2) ; - 24
Bipheny1-2- 
hydroxylase 
|_imoles/gm. liver/hr.
0.55 ±  0.02 (2)
V
0.68 + 0.00 (2) + 24
Cytochrome P-450 
mpmoles/gm.liver
1 7 + 1  (2) 2 4 + 0  (2) + 41
Female
Bipheny1-4- 
hydroxylase 
(jmoles/gm. liver/hr.
4.5 + 0 . 3  (2) 3.4 + 0.0 (2) - 24
Biphenyl-2- 
hydroxylase 
jjmo le s/gm. liver/hr.
0.51 + 0.05 (2) 0.75 + 0.05 (2) + 47
Table A.60.
Effect of pretreatment of male and female mice with isosafrole
on the aromatic hydroxylation and cytochrome P-450 content
of liver microsomal preparation
Sex Parameter Controls Pretreated
$
change
Cytochrome P-450 
mpmoles/gm. liver
2 6 + 2  (2) 56 ± 5 (2) + 115
Male
Bipheny1-4- 
hydroxylase 
pmoles/gm. liver/hr.
8.2 + 0 . 1  (2) 5.1 + 0.0(2) - 38
Bipheny1-2- 
hydroxylase 
pmo 1e s/gm.1 ive r/hr.
. 0.55 + 0.02 (2) 0.90 + 0.07 (2) + 64
Cytochrome P-450 
mpmoles/gm.liver
1 7 + 1  (2) 45 + 1 (2) + 165
Female
Bipheny1-4- 
hydroxylase 
pmoles/gm. liver/hr.
4.5 + 0.3 (2) 3.7 + 0.3 (2) - 18
Bipheny1-2- 
hydroxylase 
pmo le s/gm. liver/hr.
0.51 + 0.05 (2) 0.84 + 0.05 (2) + 65
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Effect of different doses of P~ionone on the hepatic
drug-metabolizing activities in female rats
Dose of 
{3-ionone 
mg/kg.body wt •
Biphenyl-4- 
hy dr oxy 1 at i on 
[Mole s/gm./hr.
f"
change
.
Cytochrome P-450 
mpmoles/gm. liver
f----- ----
V
t
change
Control 4.0 + 0 . 0  (2) 17 + 0 (2)
10 5.2 + 0.0 (2) +30 1 9 + 2 (2) n.s.
25 6.8 + 0.8 (2) +70 2 0 + 1 (2) +18
50 7.1 + 0.5 (2) +78 20 j^l (2) +18
75 7.8 + 0.3 (2) +95 20 + 2 (2) +18
100 8.5 + 0.5 (2) +113 2 3 + 1 (2) + 35
' f1 '
125 8.6 + 0.8 (2)
t
+115 23 + 1 (2)
1
+35
150 9.6 + 0.3 (2) +138 22 + 2 (2) +29
200 9.6 £  0.5 (2) +138 23 + 2 (2) +35
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Table A#69.
Changes in liver weight after chronic pretreatment of rats with g-ionone
Period of 
pretreatment 
(days)
Liver weight
r— ----- : ' x 100Body weight
Controls Pretreated
jf
change
1 4.7 + 0.0 (2) 5.0 + 0.2 (2) + 6
2 5.2 + 0.0 (2) 5.5 + 0.1 (2) + 6
3 4.9 + 0,0 (2) 5.4 + 0.2 (2) + 10
4 5.2 + 0.2 (2) 5.6 + 0.1 (2) + 8
7 5.0 + 0.0 (2) 5.5 + 0 . 1  (2) + 10
10 5.0 + 0.1 (2} 5.5 + 0.0 (2) + 10
14 5.2 + 0.0 (2) 5.7 + 0.1 (2) + 10
21 5.1 + 0 . 1  (2) 5.5 + 0.1 (2) + 8
28 5.4 + .0.3 (2) 5.9 + 0.1 (2)
i
+ 9
Table A.70#
Effect of chronic pretreatment of rats with g-ionone on the biphenyl-
4-hydroxylase activity of liver microsomal preparations
Period of 
pretreatment 
(days)
Enzyme activity 
(pmoles product/gm. liver/hour)
*
changeControl Treated
1 4.4 + 0.0 (2) 7.3 + 0 . 2  (2) + 67
2 4.5 + 0.2 (2) 7.2 + 0 . 6  (2) + 60
3 4.6 +0.2 (2) 7.4 + 0.2 (2) + 61
4 4.5 + 0.2 (2) 7.3 + 0.2 (2) + 62
7 4.5 + 0.3 (2) 6.7 + 0.1 (2) + 49
10 4.3 + 0.1 (2) 6.3 + 0.1 (2> + 47
. 14 4.0 + 0.1 (2) 7.2 + 0.0 (2) + 80
21 3.8 + 0.2 (2) 7.6 + 0.1 (2) + 100
28 3.1 + 0.1 (2) 5.6 + 0.5 (2) + 81
Table A.71,
Effect of chronic pretreatment of rats with 3-ionone on the p-nitrobenzoic
acid reductase activity of liver microsomes
Period of 
pretreatment 
(days)
Enzyme activity 
(pmoles product/gm, liver/hour)
Control Pretreated
• f .
change
1 .1.4 + 0.1 (2)^ 2.0 + 0.3 (2) + 43
2 1.5 + 0.1 (2} 2.2 + 0,2 (2) + 46
3 1.6 + 0.2 (2) 2.8 +  0.3 (2) + 75
4 1.6 + 0.1 (2} 2.8 + 0 . 2  (2) + 75
7 1.5 + 0.0 (2) 2.6 + 0.1 (2) 73 j
I
10 1 . 4 +  0.2 (2) 2,6 + 0.2 (2) + 86
14 1.5 + 0 . 3  (2) 2.3 + 0.3 (2) + 53
21 1.5 + 0.2 (2) 2.5 + 0.1 (2) + 66
28 1.4 + 0.1 (2) 2.3 + 0.2 (2) + 64
Table A,72,
Effect of chronic pretreatment of rats with g-ionone on the 4-methyl~
mnbelliferone glucuronyl transferase activity of liver microsomes
Period of 
pretreatment 
(days)
Enzyme activity 
(pinoles product/gm. liver/hour)
1o
changeControls Pretreated
1 46 + 2 . (2) 6 0 + 4  (2) + 30
2 42 + 4 (2) 62 + 2 (2) + 47
3 5 1 + 3  (2) 7 3 + 7  (2) + 43
4 47 + 2 (2) 7 0 + 8  (2) + 49
7 4 5 + 2  (2) 6 3 + 6  (2) + 40 |
I
10 4 8 + 3  (2) 7 9 + 5  (2) + 65
14 4 6 + 8  (2) 9 0 + 4  (2) + 96
, 21 38 + 4 (2) 7 3 + 5  (2) + 92
0
0CM 38 + 4- (2) 5 3 + 5  (2) + 39
Table A#73.
Effect of chronic pretreatment of rats with 3-ionone on the cytochrome
P-450 content of liver microsomes
Period of 
pretreatment 
(days)
Cytochrome P—450 
(lipnoles/gm. liver)
c hingeControls Pretreated
1 2 3 + 2  (2) 32 + 2 (2) + 39
2 19. + 2 (2) 3 0 + 1  (2) + 57
3 1 8 + 0  (2) 2 6 + 0  (2) + 44
4 27 + 0 (2) 4 3 + 1  (2) + 59
7 2 7 + 0  (2) 4 9 + 3  (2) + 81
10 29 + 0 (2) 4 8 + 4  (2) + 66
14 2 5 + 1  (2) 4 4 + 3  (2) + 76
21 2 8 + 2  (2} 5 3 + 1  (2) + 89
28 2 7 + 0  (2) 4 9 + 5  (2) + 81
Table A.74.
Effect of chronic pretreatment of rats with 3-ionone on the
liver microsomal protein content
Period of 
pretreatment 
(days)
Protein content 
(mg./gm. liver)
$
changeControls Pretreated
1 30 + 0 - (2) 34 + 1 (2) + 13
2 3 3 + 1  (2) 37 + 2 (2) + 12
3 3 1 + 1  (2) 3 5 + 0  (2) + 13
4 3 0 + 1  (2) 3 2 + 0  (2) + 7
7 33 + 0 (2) 3 8 + 3  (2)
i
+ 15 |
10 34 + 0 (2) 3 9 + 0  (2) + 15
14 3 1 + 1  (2) 3 7 + 2  (2) + 19
21 3 5 + 1  (2) 3 9 + 1  (2) + 12
28 36 + P (2) 4 1 + 2  (2) + 14
Table A.75.
Change in liver weight after chronic pretreatment of rats
with phenobarbitone
Period of 
pretreatment 
(days)
Livpr weight 
Body weight
Controls Pretreated
f
change
1 4.8 + 0.1 (2) 5.2 + 0.2 (2) + 8
2 4.9 + 0.2 (2) 6.0 + 0.0 (2) + 22
j
3 4.9 + 0.2 '(2) 5.8 + 0.1 (2) \ + 18
4 4.8 + 0.0 (2) 5.7 + 0.1 .(2) + 19
7 4.7 + 0 . 0  (2) 5.4 + 0.0 (2) + 15
10 4.8 + 0.3 (2) 5.6 + 0 . 3  (2) + 17
14 4.6 + 0.1 (2) 5.5 + 0.2 (2) •+ 20
21 4.9 + 0.2 (2> 5.7 + 0.3 (2) + 16
28 4.7 +0.2 (2) 5.9 + 0.2 (2) + 25
Table A,76#
Effect of chronic pretreatment of rats with phenobarbitone on the
biphenyl—4-hydroxylase activity of liver-microsomes
Period of 
pretreatment 
(days)
Enzyme activity 
(pmoles product/gm.liver/hour) '
Controls Pretreated
t
change
1 4.3 + 0.1 (2) 7.7 + 0.2 (2) -+80
2 4.2 + 0.3 (2)
/
6.1 + 0 . 0  (2) + 45
3 4.5 + 0.1 (2) 7.5 + 0,1 (2) + 66
4
i
4.2 + 0.0 (2) 7.0 + 0.2 (2) + 66
7 4.3 + 0.2 (2) 6.9 + 0,1 (2) + 60
10 4.4 + 0.2 (2) 6.6 + 0,2 (2) + 50
14
v ■
4.1 + 0.1 (2) 6.6 + 0 . 3  (2) + 61
21
:
4.0 + 0.2 (2) 6.7 + 0.2 (2) + 68
28 4.3 + 0 . 1  (2) 7.2 + 0.0 (2)
I
+ 67
Table A. 77,
Effect of chronic pretreatment of rats with ‘phenobarbitone on the
p-nitrobenzoic acid reductase activity of liver microsomes
Period of 
pre treatment 
(days)
Enzyme activity 
(pmoles product/gm, liver/hour)
f
changeControls Pretreated
1 1.4 + 0.2 (2)
<V-
2.1 + 0.1 (2) + 50
2 1.2 + 0,1 (2) 2.1 + 0.2 (2) + 75
‘ 3 1.6 + 0.1 (2) 2,6 + 0.2 (2) + 63
4 1.2 + 0.0 (2) 2.3 + 0.2 (2) + 92
7 1.3 + 0,1 (2) 1,8 + 0.0 (2) + 38
10 1.4 + 0 . 1  (2) 2.1 + 0.0 (2) + 50
14 1.4 + 0.0 (2) 2.0 + 0.0 (2) + 42
21 1.3 + 0.1 (2) 1,8 + 0 . 2  (2) + 38
28 1,6 + -0.0 (2) 2.1 + 0.1 (2) , + 31
Table A.78.
Effect of chronic pretreatment of rats with phenobarbitone on the
4~methylumbelliferone glucuronosyl transferase activity of liver microsomes
Period of 
pre treatment 
(days)
Enzyme activity 
(ymoles product/gm. liver/hour)
Controls Pretreated
*
change
1 5 1 + 1  (2) 56 + 1 (2) + 10
2 .47 +.2 (2) 5 2 + 2  (2) + 10
3 4 4 + 6  (2) 59 + 4 (2) + 34
4 52 + 4 (2) 68 + 11 (2) + 31?
7 52 + 12 (2) 6 9 + 5  (2) + 33
10 5 5 + 8  (2) 85 + 2 (2) + 55
*4 50 + 3 (2) 7 5 + 4  (2) +  50
21 4 9 + 2  (2) 7 5 + 2  (2) + 53
28
» —  . . . . . . . . . . . . . . . .  . . . . . . . . L:. -
4 8 + 0  (2) 5 5 + 2  (2)
i
+- 15
Table A.79.
Effect of chronic pretreatment of rats with phenobarbitone
on the cytochrome P-450 content of liver microsomes
Period of 
pretreatment 
(days)
Cyiochrome P-450 
(mpmoles/gm. liver)
changeControls Pretreated
1 28 + 1 ' (2) 47 + 1 (2) + 68
2 2 8 + 4  (2) 5 9 + 7  (2) + 111
3
%
30 + 1 (2) 75 + 1 (2) + 150
4 2 8 + 2  (2) 8 4 + 5  (2) + 200
7 2 6 + 5  (2) 77 + 4 (2) 
<•
+ 196 ,
. I
10 28 + 2  (2) 7 7 + 5  (2) + 173
14 2 8 + 3  (2) 7 8 + 4  (2) + 179
21 2 7 + 1  (2) 7 4 + 4  (2) . + 174
28 2 9 + 1  (2) 6 0 + 2  (2) +- 107
Table A.80.
Effect of chronic .pretreatment of rats with phenobarbitone
on the liver microsomal protein content
Period of 
pretreatment 
(days)
Protein content 
• (mg./gm.liver)
I
changeControls Pretreated
1 33 + 1 (2) 3 7 + 1  (2) + 12
2 3 2 + 1  (2) 38 + 1 (2) + 19
•  -  i  -  !
3 3 1 + 2  (2) 39 + 2  (2) + 26
4 3 3 + 1  (2) 3 9 + 2  (2) + 18
7 33 + 1  (2) 3 9 + 1  (2) + 18
j
i
1
10 3 3 + 2  (2) 4 1 + 0  (2)
i
+ 24
14 3 1 + 0  (2) 3 9 + 2  (2) + 26
21 • 3 2 + 1  (2) 4 1 + 1  (2) + 28
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